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Chapter! 
GENERAL INTRODUCTION 
The most obvious hallmark of all metazoans is the specialization of particular 
cell types to carry out different function. This specialization is reflected by 
the expression of specific genes who's products are required to carry out the 
specialized tasks of the cell. Thus, red blood cells produce massive amounts 
of hemoglobin to transport oxygen from the lungs to all parts of the body. 
liver cells produce albumin, 8-lymphocytes antibodies, eye-lens cells 
crystal lines and so on. Yet the cells that make up the adult organism are all 
derived from a single cell, the fertilized egg. At the onset of embryogenesis 
the fertilized egg starts to divide and multiply. The newly generated cells 
organize themselves into primordial germ layers, from which all the 
embryonic and extraembryonic tissues are derived, and create body form and 
structure through a regulated process of further cell division, migration and 
differentiation. Since each cell within the developing organism contains the 
full complement of genetic information (except for 8 and T cells) the central 
problem in developmental genetics can be phrased as; How is the genetic 
information regulated during development so that cells acquire a stable 
differentiated phenotype? 
Studies on Drosophila and Caenorhabditis elegans embryogenesis have 
suggested the existence of a hierarchy of regulatory genes. The sequential 
activation of these genes accomplish the transformation of genetic 
information into body form and structure through a spatial and temporal 
regulation of effector genes, which in turn determine cell identity. Because 
of the lack of a large number of developmental mutants, a similar genetic 
approach to identify developmental control genes in vertebrates is not 
feasible. Instead a 'reverse' approach has been taken by identifying genes 
in the genomes of higher organisms that are structuraly related to 
developmental control genes in Drosophila (see [ 1] for review). Thus, the 
vertebrate Hox genes were identified on the basis of structural homology 
with the antennapaedia homeo box, while the Pax genes contain a sequence 
that is homologous to the paired box as present in the paired gene in 
Drosphila. Three members (Pax3, 6 and 7) of the Pax gene family contain in 
addition to the paired box a class specific homeo box; the paired type homeo 
box. It is assumed that many of these genes, like the Pax and Hox genes 
play a similar role in higher organisms like Xenopus, mouse and human. 
Consistent with this idea, Hox and Pax genes are expressed during mouse 
development in a spatially and temporally restricted way. Moreover, the 
direct involvement in development of at least the Pax genes is becoming 
evident now that mutations in a number of these genes are associated with 
genetic developmentally aberrant traits in mouse and human: 1. the Splotch 
mutation in mouse and van Waardenburg syndrome in human are associated 
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with a mutation in the mouse and human Pax-3 genes respectively [2, 3, 4]. 
Because of similarities in phenotype it was suggested previously that the 
Splotch mutation would provide an adequate animal model for this human 
trait. 2. Mutations in the Pax-6 gene are associated with the small eye 
mutation in mice and with aniridia in man, while 3. the Pax-1 gene was 
found to be mutated in the genome of the mouse mutant undulated [5, 6, 7]. 
An alternative approach to isolate developmentally important regulatory 
genes would be to start at the bottom of the proposed hierarchy of 
regulatory events, i.e. with the proteins that interact with cis-acting elements 
that govern cell type specific expression of the linked genes. Of special 
interest would be those proteins that are expressed during development and 
show a cell type restricted expression pattern. Using the well characterized 
'octamer' DNA element, this approach has led to the identification of a 
family of sequence specific DNA-binding factors (Oct factors) that show a 
cell type specific expression pattern and are expressed at different stages of 
mouse development ([8-13], for review see [14]). The cloning and 
characterization of eDNA molecules encoding the Oct1 and Oct2 proteins 
revealed that they are structurally related to each other and to another 
mammalian pituitary specific transcription factor, Pit1 (also called GHF-1), 
and the C. elegans regulatory protein Unc86 [ 1 5-21]. The structural 
homology between the DNA binding domain of these proteins defined a new 
family of cell type specific transcription factors: The POU domain (gene) 
family (POU being the acronym for Pit-1, Oct1/2, Unc86) which is illustrated 
in Figure 1 [22, 23, 24]. Using the structural similarity between these genes 
as a tool, several other members of this family were identified and 
characterized [1 0, 25-40]. 
In the work described in this thesis, we have used the approach 
described above to identify octamer binding factors that could play a role 
during the terminal cytodifferentiation of sperm cells (chapter IV and V) in 
the mouse, and in early embryogenesis, using mouse embryonal carcinoma 
cells as an in vitro model (chapter VI). This work led to the cloning of eDNA 
molecules encoding octamer binding factors expressed during specific stages 
of differentiation. 
In the following paragraphs, I will briefly review some aspects of the POU 
domain protein family. Then I will discuss two members of the POU domain 
family for which genetic data are available, to illustrate the role these 
proteins play in determining cell identity. In the last paragraph of this general 
introduction, 1 will give an outline of the experimental work described in this 
thesis. 
The Octamer sequence and POU proteins. 
The octamer sequence A TGCAAA T was first identified as a conserved 
element in the promoters (and enhancer) of both the light and heavy chain 
immunoglobulin genes [ 41, 42, 43]. The octamer element plays an important 
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role in the 8-cell specific act1v1ty of these promoters [42, 43, 44]. This 
correlates with the observation that two 8-cell specific nuclear factors 
(0ct2A and Oct28) and a ubiquitous factor (0ct1) interact with this element 
in in vitro binding assays [8, 12, 45]. Unexpectedly, this same conserved 
element was also found in a number of ubiquitously expressed genes such 
as the histone H2B and the small nuclear RNA genes [46, 47]. Moreover it 
is also present in the origin of replication of adenoviruses (see [48]). The 
octamer element in the H28 promoter confers cell-cycle dependent regulation 
on this gene through interaction with Oct1, while the same combination is 
also involved in replication of the adenovirus genome [ 48-51]. Apart from 
being a strong B-cell specific enhancer and promoter element, the octamer 
sequence also stimulates transcription from a linked gene promoter in 
embryonic stem cells and embryonal carcinoma cells [52]. These cells 
express Oct1 and two additional factors called Oct3/4 and Oct6 [ 11, 53]. 
In fact, using the octamer element in gel retardation assays a number of 
additional octamer binding factors were identified in a variety of organs and 
tissues and at different developmental stages of the mouse [ 11] (reviewed 
in [14]). Thus, through the interaction with a whole family of cell type 
specific nuclear factors, the octamer element is involved in a number of 
biological regulatory mechanisms. All the octamer binding proteins 
characterized so far belong to the POU domain family of proteins. It is 
POU domain 
Oct-2 
Pit-1 
Oct-1 
unc-86 
Figure 1. Structural organization and alignment of the four founding fathers of the POU 
domain protein family. The proteins are aligned with respect to the POU domain as 
indicated. There is no further homology among these proteins outside the POU domain. 
The Oct2 protein is also called OTF2 or NF~A2; Pit-1 is also called GHF-1, and Oct1 is also 
called OBP1 00, OTF-1, NF-A 1 or NFAIII. PO Us is the POU-specific domain and POUHo is 
the POU-homeo domain. This figure was adapted from [23]. 
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expected that all other octamer binding proteins that have not been 
characterized yet will belong to this family also. 
Structure of the POU domain. 
As mentioned before, the POU domain was first recognized as a region that 
is highly conserved among the three mammalian transcription factors Pit-1 
and Oct1 10ct2 and the C. elegans gene Unc86 (see Figure 1 ). The 
characterization of additional members of the POU domain gene family and 
pair wise comparison of the primary structure of the POU domain enabled a 
further classification of these proteins into five groups [29, 36] (Figure 2). 
The POU domain is 150-160 amino acid residues in length and can be 
subdivided in two major regions of very high homology; the POU-specific 
(POU5 ) and the POU-homeo (POUHol domain. The POU specific region can be 
further subdivided into two regions referred to as the POU5 -A and POU5-B 
region (see Figure 2). A short 14-25 amino acid long linker sequence 
separates the POU5 from the POUHo domain. This linker is poorly conserved 
between members of different classes but highly conserved among class Ill 
members. The 60 amino acid POUHo domain is distantly related to the 
classical Drosophila homeo box [54]. The homeo domain of the POU proteins 
shares 22 invariant amino acid residues, 13 of which are also found in the 
Drosophila antennapedia homeo box at similar positions (Figure 2). Thus the 
homeo domain of the POU proteins are more related to family members than 
to the homeo domain of Drosophila homeobox proteins and the vertebrate 
hox genes. Therefore they define a new class of homeo proteins. Using the 
Chou-Fasman algorithm it is predicted that this region will contain three 
a-helical structures similar to those in the Drosophila homeo domain proteins 
(see below). The POUHo domain contains clusters of basic amino acids at 
both ends while the POU 5 domain has a similar cluster at its amino terminus. 
The highest homology within the POUHo domain is found in the carboxyl 
terminal part, as all members of the POU family contain the sequence 
RVWFCN. This region shows also the highest homology with the classical 
homeobox proteins. The cystein residue being characteristic for the POU 
homeo proteins, as most Drosophila homeo box proteins have a glutamine 
(Q) residue, or a serine (S) residue in case of the Pax type homeo box, at this 
position. It has been suggested that different functional domains of proteins 
will be encoded by separate exons. This does not seem to be true for the 
POU gene family, as the different homologous domains of the POU domain 
are not encoded by separate exons ([55-58], and chapter VIII of this thesis). 
In fact, the number of exons encoding the different POU proteins various 
from 1 (0ct6) to over 14 (0ct2) and intronlexon borders in multi exon POU 
genes are not found in homologous positions. This, together with the fact 
that POU genes have been cloned from species as diverse as worms, 
insects, amphibians, birds and mammals, is indicative of their long 
evolutionary history. 
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Figure 2. Primary sequence comparison of a family of POU proteins defines five classes of related proteins. Homologies are boxed and identities 
are highlighted on a black background. The consensus (cons) amino acid sequence is shown under the POU5 and the POUHo domains. The 
antennapaedia homeo domain is shown with the positions of three helical domains indicated as H1, H2 and H3. The species from which factors 
were cloned are rat (r), mouse (m), C. elegans {n), Drosophila (d) and human (h). The factor Tst-1 is also called SCIP and Oct6. Alternative names 
for the factors Octl, Oct2 and Pit-1 are mentioned in the legend to figure 1. This figure is taken from (96]. 
The POU domain and DNA binding. 
The demonstration that the POU domain constitutes the DNA binding domain 
of the POU proteins provided the first conclusive evidence that the homeo 
motif is a DNA binding domain [24]. Recently the detailed structure of the 
engrailed homeodomain bound to DNA has been described using X-ray 
crystallography [59]. The homeo domain is folded in three a-helices (see 
Figure 3). Helices 2 and 3 form a helix-turn-helix motif related to the 
structure of prokaryotic regulatory proteins, such as the lambda cro protein 
and the phage 434 repressor (see [60]). a-Helix 3, the "recognition" helix, 
binds to the major groove of the DNA helix via specific hydrogen bonding 
between amino acid side chains and bases. Helices 2 and 1 lay in an 
anti-parallel orientation perpendicular to the major groove and make 
hydrophobic contacts with helix 3. Furthermore, two amino acid residues N-
terminal of helix 1 contact bases via the minor groove (Figure 38). Although 
no X-Ray or NMR data are available yet, it is anticipated that the overall 
structure of the PO U homeodomain bound to DNA will be very similar to that 
of the engrailed homeodomain. Supportive evidence for this assumption 
comes from the characterization of the 1-POU protein in Drosophila [38]. This 
protein fails to bind DNA but instead strongly forms heterodimers with 
another POU protein, Cf1 a [31]. It was shown that the inability of the 1-POU 
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Figure 3. A. Schematic drawing showing the relationship of the engrailed homeo domain 
a helices with respect to the double helical DNA. Cylinders represent the a helices 
(numbered 1 to 3), while ribbons are used to show the sugar-phosphate backbone of the 
DNA. The B figure is as A, but rotated 90, 0 and gives a view along the axis of helix 3 
which lies in the major groove. Critical contacts between amino acid side chains and bases 
are indicated. These figures are taken from reference [59]. 
protein to bind DNA is due to the absence of two basic amino acid residues 
{RK), N-terminal of helix 1 . These two amino acid residues are in a similar 
position as the two basic residues that make minor groove contacts in the 
engrailed protein. Reintroduction of these residues into 1-POU turns the 
polypeptide into a DNA binding protein that is no longer capable of binding 
to Cf1 a. Furthermore a mutation in the carboxyl terminal basic cluster within 
the Pit-1 homeodomain {substituting the arginine for a glycine residue 
directly flanking the WFCN motif) completely abolished DNA binding [61]. 
Introduction of a proline residue in the third helix had the same detrimental 
effect on DNA binding, underscoring the importance of the recognition helix 
in DNA binding. However the mutation of the cysteine residue within the 
WFCN motif into a glutamine {which is representative of the antennapaedia 
class of homeo proteins) did not effect DNA binding, while in the classic 
homeo proteins this residue is important for specificity [61, 62, 63]. 
Deletion analysis of various other POU domain proteins shows that, 
whereas an intact homeo domain is required for DNA binding, the 
contribution of the POU specific domain is variable and depends on the exact 
sequence of the DNA binding site [61, 64]. For the Pit-1 protein, the 
homeodomain suffices for low affinity binding with relaxed sequence 
specificity, while the presence of the POU5 domain increases site specificity 
and affinity {see further Ingraham et a!. [61] for a detailed mutational 
analysis of the POU 5 domain). A detailed analysis of the contributions of the 
Oct1 POU5 domain in binding of the POU domain to the ad2 octamer 
sequence was undertaken by Verrijzer eta!. [64]. Their results showed that 
the POU5 domain contacts the 5' half of the ATGATAAT sequence, while the 
homeodomain contacts the 3' half of this sequence. At high protein 
concentrations, the isolated POU5 domain was shown to bind to the the 
5'part of several octamer and related binding sites. Hydroxy radical 
footprinting showed that the majority of the backbone contacts are made by 
the POUHD· The specificity of binding is determined by base contacts, while 
the binding energy stems almost completely from electrostatic interactions 
between the protein and the phosphate backbone [60]. Curiously enough, 
the presence of the POU 5 domain greatly increases the affinity of the POU 
domain for the ad2 octamer element. This could indicate that part of the 
binding energy of the POU domain stems from protein-protein interactions, 
possibly between the POU5 and the POUHD domains. The contributions of the 
POU5 domain to DNA binding affinity depends on the specific recognition 
site. The Oct1 POU domain was also shown to induce conformational 
changes {bending) in the bound DNA and is sufficient to stimulate adenovirus 
DNA replication in an in vitro replication assay [51, 65]. Both functions are 
lost upon deletion of the POU 5 domain. 
Recently it was shown that the DNA binding affinity of the Pit-1 protein 
can be modulated by phosphorylation. Phosphorylation of a serine residue, 
next to the amino terminal basic cluster in the POUH0 , modifies the 
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conformation of Pit-1 on DNA recognition sites and results in either 
decreased or increased affinity depending on the flanking nucleotide 
sequence [66]. Furthermore, phosphorylation of the Oct1 protein was shown 
to be modulated as a function of the cell cycle correlating with the proposed 
involvement of this protein in the cell cycle regulated expression of the H2B 
gene [49, 50]. Thus phosphorylation is an important mechanism through 
which the (DNA binding) activity of these POU proteins can be regulated. 
The POU domain and protein-protein interactions. 
Several studies have indicated that the POU domain is not only a DNA 
binding motif but is also involved in protein-protein interactions. For example, 
together with at least one other cellular factor, the Oct1 protein is recruted 
by the Herpes Simplex Virus (HSV) protein VP16 (also called a-TIF and 
Vmw65) into a multiprotein complex on the TAATGARAT response 
elements, to stimulate transcription of the immediate early gene promoters 
of HSV [67-71]. The Oct1 protein alone binds with low affinity to this 
response site, but DNA binding is greatly increased upon interaction with 
VP1 6 and other proteins. VP16 itself does not bind to DNA with high 
affinity, but instead contributes a strong transactivation domain to the 
complex. The interaction between VP1 6 and Oct1 is specific for Oct1, as the 
closely related Oct2 protein fails to form a complex with VP1 6. A detailed 
mutational analysis by Stern eta!. revealed that seven amino acid differences 
between helix 1 and helix 2 of the Oct1 and Oct2 POUHo domains dictates 
the specificity of interaction with VP16 [72]. As discussed above, the helices 
1 and 2 are not directly involved in DNA binding but instead function in 
highly specific protein-protein interactions (see below). The VP16/0ct1 
interaction clearly illustrates how non DNA binding proteins can specifically 
influence differential transcriptional regulation of two proteins that have 
identical DNA binding specificities. It also presents an extreme example of 
modularity in the sense that the DNA binding interface (0ct1) and the 
transcriptional activation domain (VP16) are located on separate proteins. 
The case of VP16 has stimulated a lot of speculation about the possible 
existence of similar cellular factors. Such factors have not been described to 
date. 
As already mentioned in the previous paragraph, the Drosophila 1-POU 
protein does not bind DNA, but forms heterodimers with the Cf1 a and not 
with any of the other known POU factors [38, 73]. The region required for 
heterodimer formation is entirely limited to the POUHo domain and 
encompasses only the amino terminal basic region and helices 1 and 2. The 
1-POU protein does not dimerize with the Brn-2 protein, another octamer 
binding factor, although this protein has a POUHo domain that differs only in 
three positions in helix 1 with Cf1-a. Only when all three amino acid residues 
in the Brn-2 protein are mutated to the corresponding residues in Cf1-a the 
protein is able to dimerize with 1-POU. It appears that protein-protein 
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interaction in both cases (0ct1 /VP16 and I-POU/Cf1-a) relies on critical 
determinants in the POUHo helices 1 and 2. These regions in the POUHo show 
the highest variability in primary sequence between the different classes (see 
Figure 2). This variability would provide a structural basis for selective 
protein-protein interaction between POU proteins and other factors. 
Interestingly, the amino acid sequence separating helix 1 and 2 is identical 
for the Oct6 (called tst-1 in Figure 2) and Oct3/4 proteins [36]. These 
proteins belong to different classes and are both expressed in 
undifferentiated ES and EC cells. It has been suggested by Scholer eta!. that 
the conserved linker sequence between helices 1 and 2 in these proteins 
could provide an interaction interface for an ES/EC cell specific factor [36]. 
Most of the POU proteins bind as monomers to their recognition 
sequence, except the Pit-1 protein which binds as a dimer as a consequence 
of synergistic, DNA binding dependent, protein-protein interactions. Dimer 
formation of Pit-1 on DNA requires the POUs domain [61]. Furthermore, 
cooperative binding of the Oct1 protein to flanking octamer and heptamer 
sequences in the lg promoters was shown to depend on the POUs domain 
as well [74]. Whether the POU5 domain of other POU proteins plays a role 
in protein-protein interactions remains to be established. 
Transactivation domains of POU proteins. 
Most transcription factors contain a transactivation domain that can be 
physically separated from the DNA binding domain (see for example [75]). 
The POU proteins do not seem to form an exception to this general rule, 
although it has been suggested that the amino terminal part of the Oct2 
POU5 domain could function in transactivation [76]. The transactivation 
domains of the Oct1 [77], Oct2 [76, 77, 78], Oct3/4 [34, 79], Oct6 ([80] 
this thesis) and Pit-1 /GHF-1 [61, 81] proteins have been determined. The 
different transactivation domains do not share an overall similar structure, 
but instead are characterized by an abundance of one or a few particular 
amino acid residues [82]. Thus the Oct1 protein has a carboxyl terminal 
(relative to the POU domain) serine/threonine- and an amino terminal 
glutamine-rich activation domain, while the Oct2 protein has an amino 
terminal glutamine/leucine/proline- and a carboxyl terminal serine/threonine-
rich domain. The transactivation domain of Oct3/4 is rather proline-rich and 
is located at the extreme amino terminus of the protein. Oct6 has a 
glycine/alanine-rich transactivation domain located in the amino terminal third 
of the protein. The Pit-1 /GHF-1 transactivation domain is also located in the 
amino terminus of the protein and is rich in serine/threonine residues. This 
great diversity in transactivation domains might indicate that the different 
POU proteins interact with different components of the basic transcription 
machinery or with different auxiliary factors [83]. All these proteins have 
been analyzed in the context of transcriptional activation, using either 
artificial or natural promoters. However, the Oct6 (tst-1 /SCIP) protein has 
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also been shown to function as a transcritional repressor of the P 0 gene 
promoter [84, 85]. The P0 gene is a member of the immunoglobulin 
superfamily and is specifically expressed in glia cells of the peripheral 
nervous system [86]. Furthermore, the relative importance of the different 
activation domains in Oct2 seem to depend, to a certain extent, on the 
reporter construct used [76, 77]. Thus the validity of the results of this type 
of experiments should be treated cautiously. 
The Unc86 and Pit-1 POU proteins and development. 
In contrast to the classical Drosophila and mammalian homeobox genes, 
most POU homeo genes show a highly cell type restricted expression 
pattern. From these expression data alone, it is not clear whether the POU 
proteins play an active role in cellular differentiation or that they are only 
involved in maintaining a fully differentiated phenotype. The genetic data 
available for the C.elegans Unc86 and murine Pit-1 (GHF-1 I gene suggest 
that these POU proteins are indeed actively involved in differentiation, in that 
they link a particular cell identity to cell lineage. 
Unc86 and cell lineage. 
The effects of Unc86 mutations are seen in three post-embryonic neuroblast 
lineages. Figure 4A shows the lineage of the V5.paa neuroblast. In wild type 
animals, Unc86 protein appears within a few minutes after neuroblast 
division in one daughter cell but not in the other [87]. The daughter cell that 
does not express Unc86 will differentiate into a dopaminergic neuron, while 
the Unc86 expressing daughter will undergo another cell division, giving rise 
to a different type of neuron and a programmed cell death. In the absence 
of functional Unc86 protein the daughter repeats the division pattern of the 
parental cell generating a chain of dopaminergic neurons (Figure 4A). Thus 
the Unc86 protein is required to distinguish one daugther from its mother cell 
by reprogramming the expression of an unknown number of genes. The 
appearance of the Unc86 protein is sensitive to an asymmetric feature of the 
cell division, probably in a way that does not involve cell-cell interactions. 
Besides its role in cell lineage, the Unc86 protein also participates in the 
determination of certain neural identities. The 57 neurons (approximately 
one-fifth of the total 302 neurons in the adult organism) that express the 
Unc86 protein comprise 27 different types of neurons, which share no 
common feature. This is taken to suggest that the Unc86 protein controls 
different sets of genes in different cell types. One candidate for control by 
Unc86 is the homeo domain gene mec-3 [88]. Although expression of this 
gene depends on Unc86, this is clearly not sufficient as only 1 0 cells of the 
57 Unc86 expressing cells do actually express the mec-3 gene. This is 
suggestive for the Unc86 protein being part of a combinatorial code that 
establishes cellular identity. 
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Pit-1 and pituitary gland development. 
In mammals, the anterior pituitary gland originates from an invagination of 
the oral ectoderm at the roof of the primitive mouth. This structure, known 
as Rathke's pouch, appears at around day 8.5 of embryonic development of 
the mouse. By embryonic day 12, Rathke's pouch detaches from the oral 
ectoderm and becomes an independent structure. The anterior pituitary 
originates from the ventral part of rathke's pouch while the dorsal part gives 
rise to the intermediate lobe of the pituitary. Five phenotypically distinct cell 
A 
wild-type 
V5.paa 
I 
ON 
N 
B 
Rath.J..::c's 
pouch 
I 
!4d 
I 
X 
unc86 -mutant 
V5.paa 
I 
DN 
D ~ ,..---'-------,: 
DN 
16/17d 17d 
Figure 4. A. Schematic representation of the C. elegans V5.paa neuroblast lineage. The 
other two neuroblast lineages that are affected by unc86 mutations are the Q and the T.pp 
neuroblasts. The thick line represent cells that express the unc86 protein in wild type 
animals. ON is a dopaminergic neuron and N is a sensory neuron that expresses the homeo 
box gene mec3. X is a programmed cell death. In uncBO mutant animals, the division 
pattern of the parental cell is repeated resulting in the generation of a chain of 
dopaminergic neurons. The figure is taken from reference [87]. 
B. Schematic representation of the five different cell types that develop in the anterior 
pituitary gland. The time points during embryonic development of the rat at which these 
cell types become identifiable, on the basis of the trophic factor they express, is indicated. 
The Pit-1 protein is expressed in thyrotrophs, somatotrophs and lactotrophs (indicated in 
black). These cell types are depleted in dwarf mutant mice. Thyrotrophs appear before the 
Pit-1 protein is detectable. ACTH is adrenocorticotropin hormone, TSH is thyroid 
stimulating hormone, LH is luteinizing hormone, FSH is follicle stimulating hormone, GH 
is growth hormone (somatotropin), Prl is prolactin. This figure is taken from {96]. 
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types will differentiate from the anterior pituitary anlagen in a stereotypical 
order (see Figure 48). These cell types are defined by the factor they 
produce (corticotrophs, thyrotrophs, gonadotrophs, somatotrophs and 
lactotrophs). Pit-1 gene expression is first detected in all five distinct cell 
types in the anterior pituitary around day 1 5 of embryonic development of 
the rat [89)(see also [90]). The Pit-1 protein is detected at low levels around 
this time, but is restricted to thyrotrophs, lactotrophs and somatotrophs, and 
precedes the expression of prolactin and growth hormone genes on 
embryonic day 1 6-1 7. This is consistent with the proposed role for Pit-1 in 
activation of these two transcription units [91].(1t should be noted here that 
there is some disagreement in the literature over the role of Pit-1 in prolactin 
gene activation and in the cell types in which the Pit-1 gene is expressed; 
see [92]) 
A role for Pit-1 in pituitary gland development was firmly established with 
the molecular characterization of a form of dwarfism (dw locus) in mouse 
[55]. These genetic dwarf mice produce no detectable levels of growth 
hormone (GH). prolactin (Prl) and thyroid-stimulating hormone (TSH). and 
mature somatotrophic, lactotrophic and thyrotrophic cell types are depleted. 
Two alleles of the dw locus were shown to result from mutations in the Pit-1 
transcription unit. In the dwarf Jackson mouse there is a large ( > 4 kb) 
disruption (an inversion or insertion) in the Pit-1 gene, while the Snell dwarf 
mouse is characterized by a point mutation in the homeobox of the gene. 
This point mutation converts the tryptophan residue in the RVWFCN motif 
in the recognition helix to a cysteine residue (RVCFCN), resulting in a protein 
that is no longer able to bind to its recognition elements. The low levels of 
Pit-1 mRNA in Snell dwarf pituitaries, and the presence of Pit-1 binding sites 
in the Pit-1 gene promoter is consistent with a mechanism in which Pit-1 
boosts its own transcription [93, 94]. Thus the loss of three pituitary cell 
types in the dw mutants indicates that Pit-1 is involved in at least a part of 
the pituitary developmental program. It also suggests that the Pit-1 protein 
is directly or indirectly involved in the proliferation and survival of these cell 
types. Indeed, inhibition of Pit-1 synthesis by complementary oligo-
nucleotides led to a decrease in proliferation of somatotrophic cell lines and 
a decrease in GH and Prl expression. The fact that the GH gene and Prl gene 
are expressed only in a subset of the pituitary cells that express the Pit-1 
protein further suggests the existence of additional mechanisms that restrict 
the actions of this protein [89, 95]. Mutations at a second dwarf locus (df) 
result in a phenotype that is similar to the two allelic dw mutants including 
the depletion of somatotrophic, lactotrophic and thyrotrophic cell types in 
homozygous Ames dwarf animals. No Pit-1 expression could be detected in 
the hypoplastic pituitaries of Ames dwarf mice [55]. This could suggest that 
the df gene is involved in the regulation of the Pit-1 gene, or, together with 
Pit-1, is involved in the specification and/or maintenance of the three 
pituitary cell types affected by the mutation. 
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Outline of this thesis. 
The work described in this thesis aims at the elucidation of mechanisms that 
govern cellular differentiation events in male germ cell development 
(spermatogenesis), especially during the post-meiotic phase 
(spermiogenesis). and in embryonal carcinoma cells. Chapter II describes the 
molecular characterization of a variant c-abl mANA (TSabl) that is specifically 
expressed at high levels during spermiogenesis and was suggested to play 
an important role in this proces. The TSabl mANA is transcribed from the 
proximal of the two c-abl promoters and is alternatively processed resulting 
in a removal of most of the 3'UTA, without an effect on the coding capicity 
of the mANAs. The high levels of this shortened mANA in post-meiotic male 
germ cells could be due to two not mutually exclusive mechanisms, i.e. a 
higher mANA stability or/and continued transcription of the gene during the 
later phases of spermiogenesis. Chapter Ill describes experiments that tried 
to address the question whether the TSabl mANA has a longer half life as a 
consequence of the removal of most of the 3'UTA. In chapter IV a 
preliminary analysis of the c-abl promoter is presented, using DNAsel 
footprinting and gel retardation assays. The results of these experiments 
hinted at the possibility that there exists a testis specific octamer binding 
factor that could be involved in the haploid specific regulation of gene 
expression. This stimulated us to undertake the experiments described in 
chapter V that aimed at the cloning of testis specific cDNAs encoding 
octamer binding factors. We show that the POU domain gene Oct2 is highly 
expressed in spermatogenic cells, generating two transcripts through a 
mechanism of alternative processing and/or promoter usage. This chapter 
closes with a discussion of testis specific gene expression. 
The temporally regulated expression of a family of octamer binding 
factors during 'neuronal 'differentiation of P19 EC cells is described in 
chapter VI. One factor, Oct6, is expressed in a bi-phasic pattern, suggesting 
that it might play a role at different stages of development. This factor is 
further characterized by cloning of the cognate eDNA and was found to be 
the mouse homologue of the rat Tst-1 POU gene [29]. This gene is highly 
expressed in rat testis but not in mouse testis (this thesis). Chapter VII 
describes the functional mapping of the protein domains involved in 
transcriptional activation and DNA binding. In chapter VIII the genomic 
organization of the Oct6 gene is described. Furthermore, we present an initial 
characterization of the Oct6 promoter, to begin to address the important 
question of how this transcriptional regulator is regulated itself. In the last 
chapter some aspects of the Oct6 gene are discussed in relation to its 
possible function in differentiation, drawing on examples from other 
members of the POU domain gene family. 
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Molecular characterization of the testis specific c-abl mRNA in 
mouse 
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The c-ahl gene encodes a protein tyrosine kinase and is trans-
cribed f~om at least two promoters _giving rise to transcripts 
of two SIZe classes of -5 and 6 kb m length. These mRNAs 
on1y differ in their most 5' e:xon and encode proteins of similar 
size but vvith different N-term.ini. In the mouse testis an addi-
tional abundant c-ahf mRNA of 4 kb is detected. This m.RNA 
was shown to be expressed in the haploid male germ cells of 
the adult mouse. Here we describe the clonin<> and molecular 
characterization of a eDNA representing th"'e testis specific 
c-ahl transcript. We show that the 4 kb c-ab! mRNA arises 
from alternative polyadenylation of an R..."lA transcribed from 
the same promoter as the 5 kb mRNA. The site of polv-
adenylation is unusual in this shorter transcript as it is nOt 
preceded by the highly conserved hexanucleotide AAUAAA. 
The use of this polyadenylation site removes 1.2 kb of 3' 
sequences present in the somatic c-ab! mRNAs. but does not 
~~ the ~ai.n o~ reading frame of the trariscript. Using 
rn Sliu hybndu:anon on whole testis sections it is shown that 
the~ kb c-ab! mRNA is most abundant in the eJongating sper-
matids. 
Key words: c-abl/sperm::nogenesis/polyadenylation/differential 
expression/eDNA 
Introduction 
The mouse cellular c-abl gene is the homologue of the v-abl on-
~ogene. pr~nt in the genome of the acutely transforming 
~belson munne leubemia virus (AMuLV). The c-ahl gene is 
h1ghly conserved during evolution and c-abl rel:ued genes have 
been detected in the genomes of a l:rrge variety of org:misms such 
as hamster. chicken, rabbit. man (Goff er a.l .• 1980). Drosophila 
melanogaster (Shilo and Weinberg. 1981) and Caenorhabdites 
elegans (Goddard et al.. 1986). The c-abl gene was shown to 
be a single copy locus in the mouse genome CVVang et aL. 1984). 
In all murine tissues examined. the gene is rranscnbed into mainly 
two RNA species of -6 and 5 kb that are translated into a 150 kd 
protein. exhibiting tyrosine specific protein kinase activity 
(Konopka and Witte, 1985). The genomic organization and the 
relationship between the two mRNAs have now been descnbed 
(Wang et al.. 1984. Ben-Neriah et aL, 1986). The c-abl gene 
c?nsists of a body of 10 small exons and one large 3' exon. span-
rung >30 kb of mouse DNA. Recent eDNA cloning of c-abl 
mRNAs from a mouse lymphoid cell line identified an additional 
series of four 5' exons (Ben-Neriah et aL. 1986). Each of these 
exons can be spliced onto the common set of 11 body exons. 
producing four different c-abl mRNAs with heterogeneous 5' 
© IRL Press Limit~d. Oxford. England 
ends. This is the basis for the difference in size between the two 
c-abl mRNAs. as the two predominantly used 5' exons (called 
type I and type IV) differ by > 1 kb in length. These type I and 
type IV exons arc conserved in humans and they arc both 
preceded by a transcriptional promoter (Shtivelman er al .. 1986; 
Bernards et al.. 1987). So the two major c-abl mRNAs are thus 
transcribed from two separate promoters. The remaining two 
transcripts. i.e. type II and type m mRNAs. are probably very 
mrc. The type I and type IV transcripts encode proteins of 1123 
and 1142 amino acids and differ only in their most N-term.inal 
26 and 45 amino acids. respectively. Both N-termini arc relatively 
hydrophilic and do not resemble transmcmbr:mc or signal se-
quences. However. the type IV mRNA encoded protein initiates 
with the sequence Mct·Gly-Gln. which is used as an acceptor 
site for myristic acid in the v-ahl and scr-proteins. Such a hydro--
phobic modi.•"lcation might result in membrane anchorage of the 
protein. 
None of the c-abl transcripts described above can account for 
an additional c-abl mRNA of 3.7-4.7 kb found in the mouse 
testis (MUller et al .. 1982). Th.is mR.NA was shown to be 
specifically expressed in the bploid germ cells, present in the 
mature testis (Ponzeno and Wolgemuth. 1985). Here we describe 
the cloning and characterization of this testis specific c--abl 
~ 
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Fig. 1. Expression of the c-ab! gene in different tissues. Equal :unounts of 
poly(A)• RNA(IO ~g) ~rerun on denaturing O.S% agarose ~ls. 
tr=;ferred to rutroeellulosc nnd_ hybridized with (a) a c-ab! eDNA probe 
(covenng the protein tyrosine: kinase domain) or (b) a type IV spo:cific c-ab! 
eDNA probe (Ben·Nena.h et al.. 191?.6). 
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tr:mscript. We show that this c-abl mRNA is transcribed from 
the type I promoter and is altemati,·ely polyadenyla.ted. RNAs 
transcribed from the type IV promoter can be alternatively 
polyadenylated as well. but they represent a minor species in 
testis. The encoded c-abl protein remains unaltered. Using in situ 
hybridization we show that the short c-abl transcript is most abun-
dant in the later stages of spennatogenesis. The possible func-
tion of this mRNA in germ cells is discussed. 
Results 
Cloning of a testis specific c-abl eDNA 
RNA extracted from BCBA mouse brain and testis was poly(A) 
selected. separated on a denaturing agaroselformaldehyde gel and 
blotted onto nitrocellulose. Hybridization of this Northern blot 
with a c-abl eDNA probe. encompassing the protein tyrosine 
kinase domain. showed that the c-abl gene expresSes two 
tranSCripts of 5 and 6 kb (Figure 1a). In testis the predominant 
c-abl mRNA is a transcript of 4 kb. as was shown before by 
Miiller et aL (1982). In order to characterize this mRNA in more 
detail eDNA molecules representing this transcript were cloned 
from a mouse testis eDNA library. 
The poly( A)+- RNA from testis was used to synthesize eDNA 
primed with oligo(dT). The eDNA was tailed with dGTP using 
terminal deox:ynucleotidyl transferase and cloned into Agt10 using 
a synthetic &oRI-dC adaptor according to LeBouc et al. (1986). 
Recombinant phages were plated onto Escherichia coli BNN102 
and the resulting plaques (1 X Icf) were screened with a 3' 
v-abl Sali-Hindill probe (Reddy et al .• 1983). More tlum 50 
positive clones were obtained. Inserts from phages longer than 
1.2 kb (12) were subcloned into the EcoRI site of pUC19 and 
mapped for the presence of known restriction enzyme cleavage 
sites. Based on their restriction map. the cDNAs could be grouped 
into two classes. One class (two clones) contained inserts. that 
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were colinear with the previously described 1.2 kb 3' eDNA 
clone, isolated from a mouse L-cell eDNA hbrury by Wanger 
aL (1984). It contains a poly(A) signal and terminates in a poly(A) 
tail. This eDNA represents the 3' end of both 6 and 5 kb c-abl 
mRNAs. 
The second class of clones were co linear with v-abl sequences. 
but were Jacking all sequences contained in the 3' eDNA clone 
mentioned above. The restriction maps indicated that all eDNA 
inserts in this class were primed at exactly the same position. 
making it unlikely that they were ::uti.facts of cloning. 
To detennine whether these clones arose from alternatively 
polyadenylated or spliced transcripts. the 3' part of three in-
dependently derived cDNAs was sequenced. It was found that 
all three were colinear with the published v-abl sequence up to 
nucleotide 4469 (Reddy et aL. 1983). The 3' sequence of these 
cDNAs is depicted in Figure 2. From these results we conclude 
that the clones arose from polyadenylated transcripts, contain-
ing a poly(A) tail 1171 nucleotides upstream of the normal 
poly(A) addition site. used in the generation of the somatic 5 and 
6 kb transcripts (Wang et al .. 1984. Ben-Neri:lh et al .• 1986). 
Sl nuclease mapping further showed that this poly(A) addition 
site is abundantly used in testis. whereas it is not used to a detec-
table extent in brain (Figure 3B). 
As the longest testis specific eDNA is only 2.6 kb. we con-
structed a full length clone (TS c-ab{) with 2.5 kb of upstream 
genomic sequences. using two other independently derived partial 
cDNAs and a genomic DNA fragment containing the type I exon 
(Figure 3A). The latter was isolated from a mouse genomic 
library. using a type I exon probe. To check the integrity of this 
construct. we performed S1 nuclease mapping experiments on 
testis RNA using brain or cell line 70Z RNA as controL (70Z 
is a pre-B cell line of :&lb/c origin. known to express relatively 
high levels of c·abl mRNA (Paige et aL. 1978; Wang et al .• 
1983). The results of these experiments are shown in Figure 3A. 
Clanin~ of the testis specific c-ab/ mRNA 
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Fig. 3(A), Stroe!Ure of the testis specific type ! eDNA. Th<: upper pan of the figure show~ the restriction map of the TS c-ab/ eDNA done. The tlt.ick: line 
representS eDNA !-<:quences. while the thin line represc:nts genomic DNA sequences. RestriCJion sites a:-e indicated by leners. B "' Bgm, P = Pvuil. H ""' Hindill, 
He = Hincll. Si probes used to cho::k the intej;rity of the construcr arc shown below the map (a.,b.c). Hybridizations were done at 55"C using 20 1-<S of 
wtu.l RNA. Probes band c were derived from subclones of the TS abl eDNA in pUC19. The thick lines represent plasmid sequences. Input bands run high 
t~p in the gd and are not visible in lanes a, b and c (.n) Sl analysis with probe (a) with I. 70Z RNA, 2. testis RNA (b) probe (b) with 1. testis RNA 2. br:Un 
RNA (c) probe c with !. testiS RNA 2. bmin RNA. Different exposure times for lanes 1 and 2 arc shown to rillow a bene. comparison of the Sl protected 
bands. (B) Conf!T!ll:ltion of the position of the testi5 ~-peeifie poly(A) ~ddition site. The Si probe used is ~ 1540 bp Pvuil fmgment derived from a 3' c-abl 
eDNA clone isolated from a brain eDNA library and cover:; 1445 nt of 3' UTR including the poly(A) consensus sequence used to generate the somatic c-
ab/ transcnprs. The open bo;o; indicate plnsm.id sequen=;. The probe was bbelled using a 'replacement synthesis' protoCOl according ro Maniatis t:t aL 
(1982). Protected fmgmenrs are indicated below the autoradiogram. Input (1540) and fully proteeted fmgmenrs (1450) are not sepamted on this gel. The 
272 nt fmgment proteCted by testis RNA (arrow) eonf= the posiuon of the poly(A) addition site as shown in Figure 2. 
The first probe (a) covering the first (type I), the second and 
part of the third exon yielded protected fragments of 278 
nucleotides (nt), a set of two minor f'ragments of 450 and 455 nt 
and two major fragments of 435 and 500 nt. The 278 nt frag-
ment corresponds to the 5' common exon border (Ben-Neriah 
et aL, 1986) and represents non-type I mRNAs (mainly type IV). 
The two sets of major and minor bands probabty correspond to 
different tr.ltlSCriptional start sites of the type I promoter. The 
two minor bands were also seen when 70Z RNA was used to 
protect probe (a). while the two major bands were absent. It is 
possible that the minor fragments represent stan sites in diploid 
cells in the testis. while the major fragments represent the start 
sites in the haploid spennatids. We did not investigate this obser-
vation further. 
Probes (b) and (c) derived from our TS c-abl clone were fully 
protected by RNA from. testis and brain, (arrows in panels b and 
c) indicating that no alternative splicing takes place in testis c-
ab! mRNA downstream from the 5' Hindll site (the 5' Hindll 
site maps within the 3rd exon). 
As the last 3' exon. in whlch alternative polyadenylation occurs. 
is also present in the 6 kb type rv transcript. the question arose 
whether this transcript is also alternatively polyadenylated in 
testis. To address this question. a Northern blot containing 
poly(A)+ RNA from liver. brain and testis was hybridized with 
a type IV specific probe. As can be seen in Figure lb this probe 
detects in liver and brain only the 6 kb mRNA. while in testis 
RNA an additional band of5 kb is observed and one minor band 
of -3.5 kb. We do not !mow the nature of this minor transcript. 
The 5 kb mRNA probably represents an alternatively 
polyadenylated type IV transcript. We conclude that both major 
c-abl transcripts are subject to alternative polyadenylation in testis. 
Alternative polyadeny!mion does not affect the l1'lOin open reading 
frame 
The 3' pan of the c-ab! transcripts is encoded by one large exon 
of 3 kb (\Vang et aL. 1984). This exon contains a long un-
rranslated region (UTR, ± 1630 bp). As alternative polyadenyla-
tion of c-ablmRNAs ta.lces place 1171 nt upstream of the nonnal 
poly(A) addition site, the use of this upstream polyadenylation 
site does not affect the main open reading frame (ORF) and 
therefore should encode the same protein as the somatic 5 kb 
mRNA. To obuin further evidence. we used full length eDNA 
clones representing both type I mRNAs to transcribe RNA in 
vitro in the presence of the Cap analogue 7m GpppG. using T7 
RNA polymerase. Both RNAs were translated in a cell free 
translation system (rabbit reticulocyte lysate) in the presence of 
[35S]methionine. It was found that both RNAs were translated 
into proteins with a mol. wt of 150 kd (Figure 4) which could 
be precipitated with anti c-abl antibodies (not shown). Although 
the in vitro transcribed RNA is translated into a 150 kd c-ab! 
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Fig. 4. In vitro tr:mslation of in vitro tr:mscribcd RNA. RNA w.lS trnnscribed 
from CO!lSmiCIS l'l:pres<:nting me testis specific 4 kb c-ab/ m.RNA and the 
somatic :5 kb mRNA. In vitro translation products wel'l: separated on a 
7.:5% SDS-polyucryl.am.ide gel. l. Protein U":lllSlated from the testis 
specific 4 kb mRNA. 2. Protein uc;msla.ted from the somatic :5 kb mRNA. 
protein this does not necessarily mean th:lt the 4 kb is translated 
in vivo also. 
The 3' untranslated region of different genes has been shown 
to be involved in regulation of expression (Shaw and Kamen. 
1986: Owen md Kiihn. 1987). Regulation of the stability of a 
transcript can be a possible mechanism of control. This hypothesis 
was examined by measuring the half-life of the c-abl transcripts 
in the cell line 702 and in isolated spennarids. Results of these 
experiments are shown in Figure 5a. RNA was extrncted from 
702 cells and isolated spermatids before and after treannent with 
5 ~g/ml of actinomycin D at various times (0-6 h). The RNA 
samples were subsequently electrophoresed in agaroselfor-
maldchyde gels and blotted onto nitrocellulose. The Northern 
blot containing 70Z R.i'l"A samples was hybridized with a c-abl. 
a myc and a glyceraldehyde-3-phosphate-dehydrogenase 
(GAPDH) probe. The half-life of the myc and GAPDH transcripts 
have been reponed 2nd were chosen as reference (Dani er al.. 
1984). Figure 5a shows that the myc tr:mscript is rnpid.ly depleted 
from the RNA pool. while the GAPDH transcript seems almost 
constant over the 6 h time period. The half-life of the myc 
transcript was estimated to be - 20 min in accordance with earlier 
reports (Dani eral.. 1984: Linial et at.. 1985). Tbec-ablmRNAs 
of 5 and 6 kb seem to be relatively st:lble over the first 2 h of 
actinomycin D incubation. but then rapidly decay with an 
estimated half-life of -30 min. The 6 kb c-abl transcript seems 
to be slightly more stable than the 5 kb transcript. 
A similar experiment was performed using spermatids isolated 
from mouse testis. As shown in Figure 5b the results of this 
experiment clearly indicate the higher stability of the c-abl 
mRNAs in spermatids. In fact the 6 kb c-abl mRNA seems to 
be more stable in spermatids too. This blot was also probed with 
a pim~I probe. pim-1 is a gene that is frequently activated by 
proviral insertion in murine leukaemia virus-induced T cell lym-
phomas (Selten et al .. 1986). The pim-1 gene expresses a 2.8 kb 
rnRNA in lymphoid cells and encodes a protein kinase. In mouse 
testis the pim-1 gene is expressed as a 2.3 kb mRNA (M. von 
Lindem. unpublished results). This 2.3 kb pim-1 transcript in 
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spermatids is more stable than the 2.8 kb pim-1 in 70Z cells. 
where we measured a half-life of -30 min (dat:l not shown;,_ 
The myc gene is not expressed in spermatids. These results can 
be explained in two ways. Either all or most transcripts are more 
st:lble in isolated spcrmatids than in somatic cells. or the actino-
mycin D is not able to block transcription in spcnnatids. The 
Iauer explanation is ruled out since it W;)S observed that 2.5 p:g/rrJ 
actinomycin D essentially blocks ('H]uridine incorporation in 
isolated spermatids (2.6 x 106 isolated spcrmatids incorporated 
± 1600 c. p.m. eHJuridine in 1 h while in the presence of 
2.5 p.g/ml actinomycin D only 20 c.p.m. were incorporated). 
In situ hybridi:;arivn on ...,fw[e testis sections 
Using isolated populations of male germ cells Ponzeno and 
Wolgemuth (1985) demonstrated that the shorter testis specific 
c-ab! mRNA is present in spcrmatids and elongating spcrmatids 
but not in mid-pachytene spermatocytes. We used in situ 
bybridizatior, on whole testis sections to study the expression of 
the shorter c-abl mRNA. The unique structure of the 3' end of 
the 4 kb c-abl mRNA made it possible to synthesize an 
oligonucleot~de that would only hybridize to the shorter c-abl 
transcripts under appropriate hybridization and washing condi-
tions. The oligonucleotide synthesized was a 30-mer. covering 
the first 20 nucleotides preceeding the upstrC3111 polyadenylation 
site and 10 adenine residues of the poly(A) tail of the shorter 
transcript (sec F!gure 2). Hybridization and washing conditions 
were selective for a full 30-mer hybrid. The specific hybridiza-
rior, to the testis 4 kb c-abl mRNA was checked on Northern 
blots under these conditions (final stringency 2 X SSC. 56"C). 
Analysis of cross sections of different seminiferous tubules. con-
taining different stages of maturation indicated that the short c-ab! 
mRNA is most abundant in the elongating spermatids. One such 
cross-section of a tubule is shown in Figure 6a. To rule out the 
possibility that this oligonucleotide hybridizes non-specifically 
to structures present in the elongating spermatids. a series of con-
trol exp·.!riments were performed. We synthesized an 
oligonucleotide that covers the poly(A) addition site of )3-major 
globin of the mouse and 10 A residues of the poly(A) tail. No 
labelling above background of any cell type present in the testis 
was observed using this oligonucleotide. In nnother experiment 
we used a DNA probe specific for rRNA. As cnn be seen in 
Figure 6b this probe labels all cells. but in particular those close 
to the tubular wall. No non-specific labelling of late spermatids 
was obsen-ed. 
Discussion 
Here we have shown that the 4 kb testis specific c-ahl transcript 
results from the use of nn alternative polyadenylation site 1172 nt 
upstream of the normal addition site. We have further 
demonstrated that this alternative polyadenylation site is specific 
for the haploid st:lge of spermatogenesis. 
Polyadenylation of the c-abl transcripts in spermatids is unusucl 
as the site of poly(A) addition is not preceeded by the highly 
conserved hexanucleotidc AAUAAA (Proudfoot nnd Brownlee 
1976). Many studies concerning 3' processing of polyadenylated 
transcripts have demonstrated the importance of this hex:;.-
nucleotide in cleavage!polyadenylation (reviewed in Birnstiel et 
aL. 1985). As shown in Figure 2 a sequence TACAAA is pre-
sent - 11 nt upstream of the poly(A) addition site used in sper-
matids and remotely resembles this conserved hexanucleotide. 
However. this sequence contains two mut:ltions one of which 
(U-C) was shown to prevent cleavage!polyadenylation in SV40 
late transcription (Wickens and Stephenson. 1984). Moreover, 
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Fig. 5. Actinomycin D chase experiments. Cells and isolated ~-permatids were treated with or without minomycin D for various times (0-6 h). RNA was 
prepared. separ ..lled on den:ltllring 0.8% formaldehyde gel~ ;md blotted onto nitrocd!Wose. The blots wue $ubsequently probed with a c-chl, GAPDH and a 
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Fig. 6. In siru hybridization on whole testis sc:c:tions U5ing the testis specific c-abl oligonucleotide (a) or an rRNA probe (b). The pictures shQw one = 
section of a sc:mininiferous robule. 
the same trans.iti.on in the ,8-globin polyadenylation sequence was 
found to be the sole cause of a 13-thaJJassaemia in humans (Orkin 
et aL. 1985). 
Although these srudies show that the AAUA.A.A element is 
necessary for proper 3' processing of prc-RNAs. it cannot be 
the only prerequisite. as this sequence frequently occurs in 
transcripts. where it does not direct cleavage/polyadenylation. 
It has been shown that in addition to the upstream A.AUAAA 
signal. sequences downstream from the addition site are required 
as well (Kessler et al.. 1986: McDevitt er al .• 1986: Gil and 
Proudfoot. 1987). These sequence elements are very weakly con-
served and are generally referred to as GT or T -rich sequences. 
McLauchlan et al. (1985) compiled a large number of 
downstre:un sequences from different genes and derived a con-
sensus sequence YGTGITYY ('{ = pyrimidine residue) located 
-30 ntdownstream of the addition site in 67% of the genes ex-
amined. A perfect match to this consensus sequence is found at 
the appropriate d.isunce downstream from the spermatid specific 
poly(A) addltion site (ovcrlined in Figure 2). Berget (1984) also 
provided evidence for the conservation of a sequence CA YUG, 
located immediately downstream and upstream from the poly( A) 
addition site in a number of genes. Two pentanucleotides. 
perfectly matching this consensus. are also present downstream 
of the testis specific addltion site (underlined in Figure 2). 
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It is very likely that these sequence elements play a role in 
the formation of the shorter c--abl tr::mscripts. Nevertheless. a 
cell type specific factor or mechanism must exist that 
discriminates between the two poly(A) addition sites that can be 
used. It has been suggested that smill ribonucleoprotein particles 
(snRNPs) are involved in 3' processing ofmRNAs on the basis 
of partial complementarity between the sm:ill U4-RNA and 
sequences surrounding the poly(A) addition site. including the 
highly conserved hexanucleotide and the more weakly conserv-
ed CA YUG sequence (Berget, 1984). Although there is no direct 
evidence for a role of U-RNAs in 3' processing of polyadenylated 
mRNAs, involvement of small RNAs has been demonstrated for 
the maturation of a non-polyadenylJ.ted histon mRNA in SC:l 
urchin (see Birnstiel et al., 1985). It is tempting to specubte that 
different U-RNAs might direct the choice of different potential 
cleavage sites to be used. 
Alternative polyndenylation has been demonstrated for a 
number of genes. In the calcitonin/CGRP gene (A.m:tr:l er al., 
1984) and the mouse ~-immunoglobulin gene (Early et al.. 1980). 
polyadcnylation can occur in two different coding exons, thereby 
directing the protein to be synthesized. In contrnSt, alternative 
polyadenylation in testis of the c-ahl transcripts does not affect 
the coding capacity of the transcripts. as was also observed in 
the case of the mouse a-amylase (Tosi et al., 1981) chicken 
vimentin, (Zehner and Paterson, 1983), chicken ovalbumin 
(LeMeur et al., 1984) and mouse dihyd.rofolate reductase 
(DHFR) gene (Setzer et al., 1980, 1982). For the latter genes, 
no tissue specificity in the usc of poly(A) addition site was 
observed although Kaufman and Sharp (1983) demonstrated a 
correlation with the metabolic state of the cell in the case of 
DHFR polyadenylation. The minor polyadenylation sites utilized 
in the shorter ovalbumin and DHFR transcripts arc not prccccdcd 
by the polyadenylation signal AAUAAA as well. 
It is of interest to note that the Drosophila c--abl homologue, 
Dash, contains a large 3' ex:on, that is processed in several alter-
native ways (Telford et aL, 1985). Sl mapping of the 3' end 
revealed five different ends. presumably corresponding to dif-
ferent polyadenylation sites. Three of these sites are used in the 
ovaries of the fly while the other two are utilized during develop-
ment. The materill specific poly(A) addition sites generate shorter 
transcripts. In this respect the 3' processing of the Dash mRNAs 
in Drosophila ovaries resembles the 3' processing of the c--abl 
m.RNAs in the mouse male germinal cells. 
It was shown by Ponzetto and Wolgemuth. 1985 and illusrrated 
in Figure 5b. that the 4 kb mRNA is the predominant c--abl 
transcript present in isol:rted spermatids. The high abundance of 
this mRNA. compared to the nonnal mRNAs could be due to 
several mechanisms: (i) The 4 kb c-abl mRNA is more stable 
and has a longer half-life than the normal mRNAs. due to dele-
tion of sequences that make the transcript unstable. (ii) The trun-
cated mRNA is the only transcript produced during the haploid 
expression of the c-abl gene and continues to a far later stage 
in the developing genn cells than expression of the normal 
mRNAS. (iii) A combination of possibilities (i) and (ii). 
(i) The 3' untranslated region of a number of genes have been 
shown to play an important role in gene expression. Shaw and 
Kamen (1986) demonstrated the existence of a specific AU-rich 
sequence (AUUUA) within the 3' UTR of a number of tranSiently 
expressed genes, that renders the transcripts unstable. Owen and 
KUhn (1987) recently demonstrated that the non-coding 3' part 
of the mmsferrin receptor gene is required for regulation by iron. 
The c-abl gene of the mouse contains a long 3' UTR that con-
tains sequences that are conserved in the human c-abl gene, as 
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detected by cross hybridization at relatively high stringency 
(0.3 X SSC, 56"C, data not shown). These sequences are 
removed from the mRNAs. by the use of the upstream 
polyadenylation site in spennatids and might be an important 
mechanism of regulation. Part of the 3' UTR of mouse c-abl 
and all of the 3' UTR contained in v-abl has been sequenced 
(Wanger al., !984: Reddy er al., 1983). Although the 3' UTR 
does contain an AT -rich stretch, it does not contain a copy of 
the destabilizer motif described by Shaw :lnd Kamen (1986). 
However. our results with the actinomycin D chase experiments 
indicate that the shorter TS transcript is more stable in spennatids 
than the regular c--abl mRNAs in 702 cells. In the latter, the c-
ab! transcripts display a relatively high stability. but after 2 h 
they rapidly decay (t'l,-30 min). This mitial relative stability 
of the c--abl tr.mscripts can be explained by the presence of a 
pool of nuclear pre-RNAs that replenish the cytoplasmic pool 
of mRNA by RNA splicing after transcription has stopped. until 
the pre-RNA pool is exhausted. We are currently testing this 
hypothesis. However, nltemative explanations arc also possible. 
In isolated spermatids all transcripts were found to be stable 
over the 6 h time course. This makes it impossible to test our 
hypothesis on a longer half-life of the 4 kb c--abl mRNA. 
Also. the shorter pim-1 transcript is more stable than the nor-
mal 2.8 kb transcript which has a half-life of -30 min. In-
terestingly, the i'!Ormal pim-1 mRNA contains a tandem of 
AUUUA sequences (Seltcn er al., 1986) in its 3' UTR. 
Preliminary data suggest that th~e sequences are no longer pre-
sent in the testis specific pim transcript, which might explain the 
higher stability of this tr:mscripL in spermatids. 
The data discussed above pro,. ide circumstantial evidence for 
a. higher stability of the testis specific shorter c-abl transcript. 
Proof for the involvement of the c--abl 3' UTR in determining 
messenger stability must await mutational analysis and expres-
sion of the TS c-abl gene construct in normal cells. A higher 
stability of mRNAs might well be a prerequisite for genes ex-
pressed in spermatids. For instance it has been shown that the 
mouse protamine mRNAs are present in spermatids, days before 
they are translated during steps 12-15 of spermiogenesis, in-
dicating that they are under translational control (Hecht, 1986). 
Although the exact time is not known. it is believed that transcrip-
tion stops around step 12 of spermiogenesis. From this point on. 
the cell continues to change its morphology, which is probably 
mediated by the rcgubted translation of mRNA, transcribed at 
an earlier stage in spermiogenesis. 
(ii) Alternatively. accumulation of the 4 kb c--ab! transcript in 
the late stages of spermiogenesis is not due to increased stability 
of the mRNA but to late transcription of this mRNA. This raises 
the question of what function the truncation of the mRNA serves. 
Possibly, it affects the translation of the mRNA, by altering the 
conformation of the transcript. or changes its ability to bind 
cellular factors. As the short c-abl transcript is present in large 
quantities until the later stages of spermiogenesis, the c--abl pro-
tein could play a role in the terminal differentiation of the germ 
cells. 
MateriaJs and methods 
Sources of tissue and cell lines 
Adult BCBA ;mel NIH Swiss mice were used a.~ sources of tissuo: in all expo;riments. 
Animals were kilkrl by ceMc:al dislocation and the tissues were irMlediatdy frozen 
in liquid nitrogo:n :md subseque:mly u:;ed to <:Xtr::tct RNA. The: 70Z cell lin<: is 
a pn:·B lymphoid cell of Balbte o,gm (Pu.ig<: ct al.. 1978). This cdl line was 
grown in RPMI mt:dium. supph.:rn<:ll~ with \5% tlCN born c:ilf serom and 70 ,.M 
,8-mercaptoethano\. 
Cdl .wpar{lliOn 
Spcnnatogenic cells were isolated from decapsulated testis fro;n Nrn Swiss mice, 
ll.'iing collagenase mx:1 tryp5in. The cell$ were sulx.equently fractionated, using 
sedimentation :>t unit gravity (Sw.put procedure). followed by den.~ity gradient 
centrifugation (Pcrcoll gradient<;) as described by Grootegoo:l et al. (1986}. The 
different cell population.s wen: immediately frozen in liquid nitrogen for ~ubse­
quent RNA extraction. Spcrmatids for actinomycin D chase experiments were 
incubated in Eagles MEIVI. supplemented with 5 ml\1" sodium-t-lactate ;md 0.4% 
~w/v) BSA (fraction V) and =d im.medi:uely. To measure the inhibition of 
tran.--cription in isoklted spermatid.~ by aetinomycin D. 2.6 x 10" ~pennatid5 
.,.·ere incubated for I h in medium (as above) containing 2.5 I'Cilmi eHJuridine 
(5 Cilmmol) with or without actinomycin D (1.5 J.<g/mi) at 37"C. 5% C~. Cells 
were washe<l twice with PBS/0.5 m!VI uridine before r:'Hluridine incorpor.~ted 
in TCA precipilllted materi:!l wa:; m=rcd. 
RNA isolation and Northern bWt hybn"di::.{llian 
RNA wns isok11ed using either t~e LiCllurea (see Maniatis el al.. 1982) or the 
guanidinium-isothiocy=te prot,-col (Collins rr al., 1984). Poly(A)+ R.."<A was 
selected by one or two cycle:; of ol:go(dl) ccllul= (Boc:hringer) chrom:!IO.(:r.lphy. 
Rl'>'A was denatured in fonno.midc/formaJdchyde at 55"C for 15 min prior to 
ciCI..""trOphoresi.s on denaturing 0.8% ngaro.>e/form:lidehyde gels. blotted onto nitro-
,ellulose for4-14 hand baked for 1 hat 80"C. Prehybridization offJ..Iters was 
carried out for 1 h at 42"C in hybridization liquid containing 50% fonnamide. 
l 0% dexDolnSl.llfate, 3 X sse. 0.1% SDS ;md I 00 /tg/ml denarurcd ~ ~'j)Cml 
DNA. Probes for hybridzution were labelled with . .::p by random oligonucleotide 
klbelling (Feinberg and Vogelst6n. 1983). denatured in boiling water for 5 min 
quenched on ice and directly added to the hybridization mix. Following over-
night hybridi7.>~tion :l.t 42°C the filters wen: washed to a tina.! strinsency of 
0.3 x SSC. 65"C. Filtc!TS were scn.led in a pl:Jstic bag and exposed to Kodak 
XAR fl.lm at -70°C for variOliS lengths of time. 
eDNA /ibrory preparar:an and screemng 
Rl"\!A 'W:l$ isoklted from teste:; u:;ing the guanidinium-isodl.iocy:mate method. 
poly(A) • sc:Jected twice. as described above and u:;ed to prepare a eDNA libnuy 
in phage Agt!IJ (Huynh t!l al .• 1984). Oligo(dT) w;c; used to prime the first strnnd 
$ynthesis usi.1g reverse tr.~nscriptase. Second strand eDNA was obtrtined with 
Klenow cnzync: after taJingofthe first strand with dGTP and TdT usi.ng oligo(dC} 
a:; a primer. Double st.-:mdcd eDNA wns miled with dGTP and TdT and cloned 
into Agt!O using n synthetic EcoRI adapter (l.ebouc er aL. 1986). Recombinant 
phages wen: plated on £roli strain BNNI02 {I x !0~ p.f.u.) and grown to con-
fluency. Duplicate filters were prepared and $Creened with :1 3' v-abl probe 
Sali-Hind.ID. 1.1 kb, according to Maniatis er al. (1982). Positive clone:; were 
plaque-purified in a s-::cond screening and the in=ts were subcloned into the EcaRI 
site of pUC19 (Ynniseb-Perron er al., 1985). 
In siru. hybridcy,tian 
In suu hybridization on whole tissue 'ectiorrs w;c; performed according ton pro-
tocol developed by two of ll.'i (D.T. :md G.D.Y.). Th.i5 protocol is based on 
published methods. used for in situ hybridization on DrasophiEa sections (Akam. 
1983, Hafen -:raJ., 1983). A detailed descnption of !hi:; method will be published. 
el-;ewhere by G.D.V. and D.T. The following oligonucleotides were synthesized. 
using an Apphed Biosystc:ms DNA synthesizer. Testis specific c-abl 
oligonucleotide: GCIT ACAAACTGCCCCGAGAAAAAAAAAAA $-globin ma-
jor oligonucleotide: ATAAAAAGCA TITATGlTCACTGCA.AAAAAAAAA. 
The mclti.ng temperature of RNA-DNA duplexes formed by these oligonucleotides 
was calculated using the Wallace role (Suggs et al., 1981). The oligonucleotides 
were labelled by priming. u:;ing e~s]dA TP and K.lenow enzyme. 
DNA .sequencing 
DNA frngments end labelled. at appropriate sites were :sequenced. ~g the 
chemical degradation method of Maxam and Gilbert (1980). 
Sl mapping 
Total RNA (10 1-'g) was hybridized with hea.t denatured J:p_ 5' or 3' end labelled 
DNA frnsment5 according to established methods (see Mani:ais et aL. 1982) at 
55"C for 18 h. Sl digestion was carried outat37"C with 1000 U/ml of the ero;yme 
{Boehringer) in 300 !t1 digestion buffer (300 ml\1" NaCl/50 m!VI Na-acet:lte pH 
4.4; 2.5 m!VI ZnSO.J. 
In vitro transcriptionltransla!ion 
Fr.~gment<; to be =cnbcd were cloned in the polylinkcr of p TZI9 (Pharmacia) 
3' of the TI promcxer. RNA w;c; trnn.scribed with TI polymer= (Biolabs) in 
the presence of250 j.<M GpppG (Pharrnacia). oo:ording to the manufacturers pro-
tocol (Biolabs). After removal of the template by DNase! digestion. the RNA 
wa:; purified by phenol/chloroform extraction and precipitated three times with 
2M NH..·acetate and 3 vol ethanol. RNA w;c; subsequently translated in a cell 
free tr:ms.l;~tion syst~m (Rabbit reticulocyte lysate Promega). in the presence of 
e5s]mcth.ion.ine. Samples were clectrophorcsc:d on 7.5% SDS-polyacrylam.ide 
Cloning of the testis specific c-ab/. xnRNA 
gel. The gel w;c; treated with enhancer (Amctsham). dried and expo:;ed to :nno-
rodiogrnphic fllm (Kodak XAR-5). 
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Chapter Ill 
On the possible role of the c-ab/ 3'UTR m 
determining messenger RNA half life 
Dies Meijer, Anneke Graus and Gerard Grosveld 
MGC, Department of Cell Biology and Genetics, Erasmus University, 
Rotterdam, The Netherlands 
ABSTRACT 
Through the use of an alternative polyadenyiation site, the testis specific c-abl (TSabll transcript 
of 4kb lacks 1.2kb of 3'UTR sequences that are otherwise present in the 5.3 and 6.5kb c-abl 
mRNAs. The TSabl RNA is abundantly expressed in post-meiotic male germ cells where it is 
very stable {1112 >> 6hrs). In contrast, the somatic 5.3 and 6.5kb mRNAs have a much shorter 
half life (t112 30-60 min.). This suggested that the 3'UTR of c-ab! is involved in the regulation 
of c-abl expression through influencing mRNA half life. Here we test this hypothesis by ectopic 
expression of the TSab! RNA and derivatives thereof, in COS cells. The results of these 
experiments show that the ectopically expressed TSabl RNA has a similar short half life as the 
somatic c-abl mRNAs, thereby weakening the hypothesis that the 3'UTR of c-abl is involved 
in determining messenger half life. These results further suggest that the higher stability of 
TSabl mRNA in round spermatids is not a result of its 3' truncation, but rather that the 
mechanism(sl that regulate c-abl mRNA degradation in somatic cells are not operational in the 
haploid male germ cells. 
RESULTS AND DISCUSSION 
The mouse c-abl gene is the cellular homologue of the v-abl gene, the 
transforming oncogene of Abelson murine leukemia virus. The gene encodes 
a non-receptor type tyrosine specific kinase enzyme of 1 50 kD (reviewed in 
[1 ]). Two c-abl mRNAs of 5.3 (Type I) and 6.5kb (Type IV) in length are 
present in all tissues and cell lines examined [2, 3, 4]. The genomic 
organization of the c-abl gene and the relationship between the two mRNAs 
have been described [2, 5, 6, 7]. The two c-abl RNAs arise through 
alternative splicing of two different 5' exons (called typel and typeiV in 
mouse and 1 A and 1 B in human ) to a common set of ten 3' exons. 
Transcription of the two different 5' exons is initiated from separate 
promoters [6, 7]). The difference in size of the two c-abl RNAs is due to the 
difference in size of the first 5' exons. Since translation initiates within the 
first 5' exon, the two mRNAs encode proteins with different NH2 termini. 
In addition to the two c-abl mRNAs of 5.3 and 6.5kb, a shorter abundant 
transcript of 4kb is present in mouse testis [3] . This transcript was shown 
to be uniquely present in the post-meiotic germ cells within the testis [8]. 
eDNA cloning of this 4 kb testis specific c-abl (TSabl) transcript revealed that 
it is 1 .2kb shorter at its 3' end as compared to the 5.3 and 6.5kb c-abl RNAs 
through the use of an alternative polyadenylation site (g, 1 OJ. This 
alternative polyadenylation site is unusual in that it is not preceded by the 
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highly conserved hexanucleotide AAUAAA but instead contains a sequence 
remotely resembling this motif (UACAAA). Since this alternative 
polyadenylation site is well within the 3' UTR the open reading frame (ORF) 
is not affected. Furthermore the TSabl transcript contains a Typel 5' exon 
and is probably initiated from the same promoter as the 5.3kb mRNA. The 
high level of the TSabl mRNA in transcriptionally inactive elongating 
spermatids and residual bodies suggested that the transcript is very stable. 
Indeed, direct measurement of the stability of the TSabl RNA in round 
spermatids revealed a long half life I> 6hrs). In contrast the halt life of the 
5.3 and 6.5kb c-abl mRNAs were shown to be in the order of 30 minutes to 
one hour in the pre 8-cell line 70Z [9). 
We hypothesized, that the higher stability of the TSabl mRNA is a direct 
result of the lack of 1 .2kb of 3'UTR sequences. A longer half life of the 
TSabl mRNA could be linked to the progressive transcriptional inactivation 
of the spermatid nucleus during spermiogenesis. The stable TSabl mRNA 
could serve as a template for translation at a stage at which transcription has 
ceased. The 3'UTR of many eukaryotic mRNAs have been shown to be 
involved in regulation of expression [11-14]. The sequences important for 
h CTTGGTATGCATCTTTTATAGACGCTCTTTTCTAAGTGGCGTGTGCATAGCGTCCTGCCC 
II II I Ill I IIIII I I Ill II I Ill II II II I 
m ~ATAGA CTT G CGCTC TTATAAATGACATGTAAATAG TTCACCATC 
Dral 
h TGCCCCCTCGGCCTGTGGTGGCTCCCCCTCTGCTTCTCGGGGTCCAGTGCATTTTGTTTC 
Ill IIIII I I I I I II II 1111111 II 11111111 I 
51 m TGCTCCCTCTGGCACACCAACAGCATTCCCCTTTTTTCTCAGTCCAGTACATTTTGTTTC 
h TGTATATGATTCTCTGTGGTTTTTTTTGAATCCAAATCTGTCCTCTGTAGTATTTTTTAA 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I+ 
m TGTATATGA CTG TTTTTTGAATCCAAATCT CTCTGTAGTATTTTTTAA 
Oral 
h ATAAATCAGTGTTTACATTA I 
+++++ I I I I I I I I I 
159 m ATAAA TGTTTACAGAACTATCGACAGACTGCTTGGTCTGTGATTCATCTCTGCAAG 
m CCCTCATGTCCCAGCCCGTGTGTCCCGAGCATATCGTTGCCAGCTGCCCAGCTCTTGGCA 
275 m GCCTCACAGCAGATGGTAGTGTCCTGTGTCGGGCCGGAAGTAGGAGCGGCTAAGCACCTG 
335 m AGATTCTTGCTGGCGGAGTGAGTCCCTCCCCGGCATGCCTCTGCCTTCAGCCGCTCAGTG 
395 m CTCTCTCTCTCTCATGTGGCTTCGGGTGCCAGCTGTTAGGCTTCAGTGGACAGTGAACAA 
455 m ACGCCTCGGCAGGCTCCGTGGACTATGCTTCAGTCACTGGAGCTC 
Figure 1. Partial sequence of the mouse c-abl 3'UTR plus flanking genomic fragment. The 
sequence is aligned with the last 200bp of the human c-abl 3'UTR {top strand) to show 
the regions of high homology in this region [15]. A SacJ fragment of 1 .1 kb (fragment 
pSS09 in [2]} was subcloned from a large genomic clone in AEMBL3. This genomic phage 
which was isolated from a mouse Balb/C genomic library and contained the last large c-ab! 
exon plus flanking sequences. The !1' Sac! site of the 1 .1 kb fragment maps within the 
3'UTR of the last c-abl exon [2]. The fragment was sequenced on both strands after 
subcloning in the M13 phages mp18 and mp19. Only the last 525bp of this fragment are 
shown here. The Oral sites at position 3 and 156 were used to insert Clal linkers. The 
conserved sequences resembling the destabi!izer motif AUUUA are boxed. The poly{A) 
signal is underlined and the poly(AJ addition site in the mouse sequence is indicated with 
an arrow. The GT-rich sequences 3' of the polyadenylation/cleavage site are overlined. 
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regulation within these RNAs are likely to be phylogenetically conserved. A 
comparison between the human c-abl 3' UTR and the mouse c-abl 3' UTR 
revealed one region of high homology [ 1 5]. This region which is located at 
the extreme 3' end of the c-abl mRNAs includes two conserved elements 
resembling the "destabilizing element" AUUUA found in the 3'UTR of 
lymphokine and cytokine mRNAs and some proto-oncogenes like c-fos and 
c-myc {see Figure 1; [11, 16]). In general these elements are found in the 
3'UTR of genes that can be rapidly and transiently induced by an external 
signal. Although the c-abl gene does not belong to this class of genes, it is 
possible that the AU rich sequences within the c-abl 3'UTR do play a role in 
determining c-abl mRNA stability. 
In order to address the role of these sequences in mRNA stability we 
constructed four different c-abl expression plasmids {see Figure 2). The 
" l " 1 .5 • • 0 a " 0 SV40 Pe ~ w 
pSVab! 
" 1 " 1 .5 • 
0 
" 
0 
SV40 Pe ~ w 
pSVabl/ A Ora 
" .. 1.5 • 0 1 
" 
0 
SV40 Pe "' 
w 
pSVTSabl 
" .. • • 
0 
! " a 
0 
SV40 Pe "' 
w 
pSVTSabl!Dra 
Figure 2. Schematic representation of the different c-abl expression plasmids. Transcription 
of c-abl mutants is initiated from the SV40 early promoter. The SV40 sequences are 
represented here by a box. Apart from the SV40 early promoter/enhancer this fragment 
also contains the SV40 origin of replication and a small intron [24]. The plasmid 
background is pTZ19. The thick line represents the c-abl eDNA sequence and the thin line 
the genomic sequence 3' of the poly(A) addition site (see figure 1 ). The position of the 
start and termination codons of the c-abl ORF is indicated by vertical arrows. The Clal 
restriction sites were introduced by ligating Cia! linkers into the Oral sites of the 1.1 kb 
genomic Sac! fragment. Using the unique Neal and Sail sites, full length clones were 
constructed (pSVabl and pSVablhDra). The C!al restriction site at the testis specific 
poly(A) addition site was introduced by PCR. Two oligonucleotides were synthesized: 
CAGTGAGCAATCGATCTCGGGGAC and GACTGAGAAAGCCTGTGCC. The first (anti 
sense) oligonucleotide maps to the testis specific poly(A) addition site while the second 
(sense) oligonucleotide maps upstream of the unique Sal! site. The type! c-ab! eDNA was 
used as a template and the resulting amplification product was cut with C!al and Sail and 
subcloned to create pSVTSabl and pSVTSabi/Dra. All cloning manipulations were done as 
described [25]. The double headed arrow indicates the fragment of which the sequence 
is shown in figure 1. 
29 
proper 3' processing (cleavage and polyadenylation) of primary transcripts 
requires certain sequences 5' as well as 3' of the poly(A) addition site 
(reviewed by [ 1 7, 1 8]). Since cDNAs are derived from processed transcripts 
they do not contain the necessary downstream sequences. In order to be 
able to express the c-abl eDNA constructs in eukaryotic cells, the 3' end of 
the cDNAs were replaced by genomic sequences extending 340bp beyond 
the poly(A) addition site. The nucleotide sequence of the genomic fragment 
is shown in Figure 1 . Downstream of the poly(A) addition site (indicated by 
an arrow) there is a GU rich region which was recognized as a second 
important cis element in 3' end processing [ 1 9]. Further experimentation 
showed, that this fragment supports the efficient 3' end processing of the 
c-abl transcripts. Cia I restriction sites were introduced by ligating Cia I linkers 
into the Oral site at position 3 or/and at position 178, directly flanking the 
poly(A) signal (see Figure 1 ). A Cia I restriction site was further created by 
PCR at the testis specific poly(A) addition site of the TSabl eDNA. Using the 
unique Clal restriction sites, four different clones were constructed. These 
clones were placed under control of the SV40 early promoter. A small SV40 
derived intron is present in the expression plasm ids. The resulting constructs 
are schematically depicted in Figure 2. Clone pSVabl contains the entire type I 
c-abl eDNA and contains a Cia I linker in the Oral site preceding the poly(A) 
signal sequence. The second construct pSVablhDra is derived from pSVabl 
but lacks the 175bp Oral fragment containing the conserved sequences (see 
Figure 1 ). The pSVTSabl construct represent the TSabl eDNA and the 
pSVTSabi/Dra construct in addition contains the 175bp Oral fragment. All 
four constructs were transiently expressed in COS cells and assayed for the 
stability of the c-abl RNAs. These experiments could not be done in isolated 
spermatids as a suitable transfection protocol for these cells does not exist 
as yet. The results of these experiments are presented in Figure 3. All four 
constructs expressed c-abl RNAs of the expected size indicating that the 3' 
genomic sequences are sufficient for proper 3'end processing of the primary 
transcripts. When transcription was blocked by ActinomycinD, all c-abl 
transcripts decay at a similar rate, while the endogenous GAPDH mRNA is 
stable. Therefore, removal of the 175bp Oral fragment does not result in a 
more stable RNA (compare panel A with panel D). Furthermore, the TSabl 
RNA is not more stable than the Typel c-abl RNA in COS cells (panel 8), and 
inclusion of the 1 75bp Oral fragment in the pSVTSabl does not result in a 
drastic destabilization of the transcript either. (panel C). As we did not 
quantitate the intensity of the hybridizing signal, we cannot rule out that the 
Oral fragment or the sequences from the testis specific poly A addition site 
to the Oral site at position 3 (Figure 1 I have a subtle effect on messenger 
stability. However the qualitative picture is clear in that these sequences do 
not influence mRNA stability to the extent expected from the half life 
measurements of the TSabl RNA in round spermatids. These results argue 
against a role of these c-abl 3'UTR sequences in mRNA destabilization. 
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Instead these experiments suggest that the mechanism(s) that regulate c-abl 
degradation in COS cells are not operational in spermatids. However it should 
be noted that all four mutant c-abl RNAs share the last 20 nucleotides 
directly upstream of the polyA addition site, including the polyA signal. 
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figure 3. ActinomycinD chase experiments. COS cells were transiently transfected as 
described I26]. At day 3 of the transfection procedure the medium was changed for 
medium containing 10 ,ug/ml Actinomycin D. Cells were harvested at the indicated time (in 
hours) after addition of the actinomycinD containing medium and RNA was prepared using 
the Urea/LiCI method. Equal amounts of RNA was electrophoresed through denaturing 1% 
agarose gels and blotted onto nitrocellulose I27]. Blots were hybridized overnight at 42°C 
with a 32P labelled mouse c-abl probe (a 2.2kb Bg!ll eDNA fragment) and a human GAPDH 
probe in a hybridization buffer containing 50% formamide. Blots were washed to a final 
stringency of 0.1 xSSC at 65 °C and exposed for several hours. The human GAPDH probe 
detects the endogenous monkey GAPDH mRNA which is very stable [28]. The mouse c-abl 
probe detects the c-abl RNAs transcribed from the expression plasmids. Exposure times 
are too short to allow the detection of the endogenous monkey c-abl mRNAs. 
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Although it is unlikely that the poly A signal itself is involved in destabilizing 
the RNA we cannot rule out such a role for the 14 nucleotides separating the 
poly(A) signal from the poly(A) addition site. Destabilization of mRNAs have 
been shown to be linked to ongoing protein synthesis in a number of cases 
(for a review see [20]). If such a mechanism also operates on the TSabl RNA 
it is conceivable that the TSabl RNA is only poorly translated if at all. 
However the shorter 3'UTR of the TSabl transcript does not seem to affect 
the translatability of this mRNA intrinsically as it is an equally good template 
for translation in vitro as is the 5.3kb c-abl mRNA [9]. Polysome analysis 
experiments presented by Zakeri eta!. has shown that a portion of the TSabl 
mRNA is found in the polysome fraction, indicating that at least some of the 
TSabl mRNA is translated in testis [21 ]. Furthermore Ponzetto et at. showed 
that the 1 50kD c-abl protein is present in spermatids and residual bodies, 
suggesting that the TSabl transcript is indeed translated in vivo [22]. The 
same distribution over the polysome, monosome and RNP fraction was found 
for the 5.3 and 6.5kb c-abl mRNAs as for the TSabl mRNA [21 ]. This 
suggests that the shorter 3'UTR of the TSabl mRNA does not influence the 
distribution of the RNA over these fractions either. Therefore, it remains 
unclear what function the alternative polyadenylation plays in TSabl RNA 
maturation and what factors cause the high stability of the transcript in 
spermatids. It has been suggested that the high level expression of the c-abl 
gene during spermiogenesis indicates an important role for the abl protein in 
the terminally differentiating germ cells. Recently Tybulewicz eta!. described 
the generation of a c-abl null-mutant mouse [23]. It was shown that a male 
mouse homozygous for this mutation was fertile. Although this does not 
mean that the c-abl protein does not play a role in spermiogenesis, it shows 
that the protein is not essential. It's function could be redundant and may be 
taken over by other non-receptor tyrosine protein kinases. 
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ABSTRACT 
The 4.2kb testis specific c-abl (TSabl) transcript is transcribed from the same promoter region 
as the type I 5,3kb c-abl mRNA that is expressed in every cell type. The TSabl RNA is 
abundantly expressed in the post-meiotic male germ cells. The high level of TSabl in round and 
elongating spermatids could be due to the high stability of the transcript {see Chapters II & Ill) 
and/or to ongoing transcription of the gene during spermiogenesis up to the point of genome 
inactivation.S1 nuclease protection analysis of the c-ab! RNAs expressed in testis revealed the 
presence of two major CAP sites within the type I promoter region (Chapter II). These two 
transcriptional initiation sites were distinct from the major CAP sites observed with pre-S cell 
RNA. This suggested the possible involvement of tissue specific factors in forming the initiation 
complex. In this chapter we describe an analysis of the c-ab! Type I proximal promoter region 
using DNAsel footprinting and gel retardation assays. We show that there are no differences 
in footprinting patterns in the Type I promoter region up to position -250 (position 1 is here 
taken as the first nucleotide of the AUG start codon), using crude nuclear extracts from testis, 
spermatids, liver and pre-S cells. However in a gel retardation assay we observed a testis 
specific complex with a probe containing the octamer binding site {position -260). This testis 
specific octamer complex is shown to result from proteolytic degradation of the ubiquitous Oct1 
protein. 
INTRODUCTION 
The mouse c-ab! gene is the cellular homologue of the viral oncogene present 
in the genome of the acutely transforming Abelson murine leukemia virus 
(reviewed in [1]). The c-abl gene gives rise to two major transcripts of 5.3 
and 6.5kb (termed Type! and TypeiV respectively) [2, 3]. These two mRNAs 
originate from the alternative splicing of two different 5' exons onto a set of 
1 0 common exons [2]. Transcription of these 5' exons is initiated from 
separate promoters [4, 5]. The two transcripts encode c-abl proteins which 
differ only in their amino termini. Both proteins have a tyrosine specific 
protein kinase activity and are thought to play an important role in an as yet 
unidentified signal transduction pathway. The gene is transcribed in all cell 
types examined and throughout embryogenesis[3, 6, 7]. 
Apart from the 5.3 and 6.5kb c-abl mRNAs a testis specific c-abl 
transcript of 4.2kb is present in the post-meiotic male germ cells [8]. The 
cloning of a eDNA corresponding to this mRNA revealed that it is 1.2kb 
shorter at its 3' end as compared to the 5.3 and 6.5kb c-abl mRNAs through 
the use of an alternative polyadenylation site [9, 1 0]. The alternative 
polyadenylation site is located within the 3' UTR and thus does not affect 
the ORF of the open reading frame of the mRNA. The TSabl mRNA contains 
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a Typel 5' exon and is probably transcribed from the same promoter region 
as the 5.3kb mRNA. 
The high level of this testis specific c-abl transcript could be due to 
different, not mutually exclusive mechanisms; a) the TSabl mRNA is more 
stable and has a longer half-life than the normal c-abl mRNAs, and b) the 
truncated 4.2 kb c-abl RNA is the only transcript produced during the haploid 
expression of the c-abl gene and continues to be transcribed to a far later 
stage in the developing germ cells than the normal c-abl mRNAs. The 
stability of the TSabl mRNA has been discussed in the previous chapters. 
Here we concentrate on the Typel promoter region, from which the TSabl 
mRNA is transcribed, and the nuclear factors that interact with sequence 
elements within the promoter. Nuclease Sl protection analysis of testis RNA 
revealed the presence of two major transcription initiation sites (CAP sites) 
within the Typel promoter region [9]. These transcription initiation sites are 
distinct from the major CAP site used in the pre-B cell line 70Z/3. This 
suggested the involvement of tissue specific factors in forming the initiation 
complex. Here we describe DNAsel footprint and gel retardation experiments 
aiming at the identification of DNA elements, and nuclear factors that 
interact with these elements, that might play a role in the haploid specific 
expression of this promoter. 
RESULTS AND DISCUSSION 
The type I c-abl promoter region and its human homologue 1 A, have been 
cloned and sequenced [ 4, 5]. Using nuclease Sl protection assays the 
transcription initition sites in 70Z/3 cells (a pre-8 cell line) and testis have 
been mapped [9]. The chromosomal organization of the c-abl gene is 
schematically depicted in Figure 1 . The approximate position of the testis 
specific and B cell specific CAP sites are also indicated in Figure 1 with 
arrows. It should be noted that the CAP sites in 70Z/3 cells have been 
mapped at the single nucleotide level, while the CAP sites in testis are 
approximate. The two major transcription initiation sites in testis are distinct 
from the transcription initiation sites in 70Z/3 cells. The Type I c-abl promoter 
is rather rich in the dinucleotide CG and lacks a TAT A-box and CCAAT box 
sequence. Transcription from TATA-Iess promoters is mostly promiscuous 
with respect to the initiation site used. The results of the nuclease Sl 
experiments suggested the involvement of tissue specific factors in 
forming/positioning the initiation complex in 70Z/3 cells versus testis. 
In order to identify DNA binding proteins that might be involved in the 
testis specific regulation of the Type I c-abl promoter, we performed DNAsel 
footprint experiments using DNA probes derived from this promoter and 
crude nuclear extracts from testis, spermatids, 70Z/3 cells and liver. The 
DNA probes we used for this analysis contain the transcription initiation sites 
in testis and 70Z/3 cells. DNA fragments were labelled at the A val or the 
Pvull site using y{'2 P)-ATP and T4 polynucleotide kinase. Four areas were 
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identified that were protected from limited DNAsel digestion by nuclear 
proteins from testis, liver and 70Z/3 cells. The results of these experiments 
are schematically shown in Figure 1. The most proximal protected area maps 
over the cluster of CAP sites that are used in 70Z/3 cells. This footprint 
partially overlaps with a three times repeated motif GGCGGGA. The 
repetition of these motifs creates two junction motifs; GGGAGGC that 
resemble the concensus binding site for the nuclear factor Spl (GGGCGG).A 
mutational analysis by Letovsky and Dynan[ 11] of the central cytosine 
residue within this recognition sequence showed that a C->A mutation 
resulted in only a three fold reduction of the binding affinity of Spl for this 
site. It is of interest to note here that this part of the Typel promoter is 
highly conserved between the human and mouse gene. However the A 
residue in the two distal GGCGGGA repeat elements is a C residue in the 
human Ia promoter sequence. The junction of these two elements create a 
concensus Spl binding site (GGG.C.GGC). It is likely that the GGGAGGC motif 
represents a true binding site for Spl and that protection results from binding 
of this factor. The second and third protected regions most likely also result 
from binding of Spl. The protected region around position -140 contains a 
concensus high affinity Spl binding site (GGGGCGGGGC) and a concensus 
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Figure 1 . Schematic representation of the c-abl gene and its type! promoter. The four 
regions that were protected from limited ONAse 1 digestion by all four nuclear extracts 
used, are indicated by ovals. The DNAsel footprint analysis was performed with crude 
nuclear extracts from testis, spermatids, liver and 70Z/3 cells. The approximate position 
of the testis specific CAP sites are indicated by large arrows and the CAP sites in 70Z/3 
cells by small arrows. CAP sites were mapped by S1 nuclease protection. The position of 
the protected fragments is indicated relative to the AUG start codon. 
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binding site for the factor GCF. The last factor is involved in the 
transcriptional repression of the EGF-R gene [ 12]. The third protected region 
around position -1 90 contains the lower affinity Spl binding site 
GGGGAGGGC. The major CAP sites in testis map 3' of the two lower affinity 
Spl binding sites present in protected region I and Ill. 
The fourth protected region maps around position -275 and contains a 
perfect match with the concensus octamer binding site A TTTGCA T as 
present in the promoters of light and heavy chain immunoglobulin genes and 
the lgH enhancer [13, 14, 15]. This element is not conserved in the human 
1 A promoter sequence (but might be located in a more upstream position for 
which no sequence data are available yet). Interestingly, no abundant TSabl 
mRNA is observed in human testis. The octamer element was shown to be 
the major element that confers cell-type specificity on immunoglobuline gene 
promoters and enhancers [15, 16, 17]. This DNA motif was shown to be a 
binding site for the ubiquitous nuclear factor Oct1 (also called NFIII, OTF1, 
OBP1 00 etc) and for a large number of other nuclear proteins present in a 
more restricted set of cell types [ 1 8-23]. These tissue specific octamer 
binding factors establish tissue specific expression patterns through 
interaction with a common DNA element [14, 24]. The B-cell specific 
expression of immunoglobulin genes can at least in part be explained by the 
B-cell specific octamer binding factors Oct2A and Oct2B [14, 16, 22, 25]. 
These proteins cannot be distinghuised on the basis of their footprints over 
the octamer sequence as they produce similar footprints. However in a gel 
retardation assay the different proteins binding to the octamer element can 
be easily distinghuised on the basis of the electrophoretic mobility of the 
protein/DNA complexes they form. Thus although we could not detect 
differences in footprints over the Type I promoter region when using testis, 
spermatid, liver or 70Z/3 cell nuclear extracts it is possible that these prints 
resulted from binding of different tissue specific factors with the same DNA 
element. In this respect it is of interest that a testis specific octamer binding 
factor has been described in sea urchin [20, 26]. It is possible that a similar 
factor exists in mouse. Such a factor could be involved in the spermatid 
specific regulation of the the Typel c-abl promoter. We therefore decided to 
perform gel retardation experiments using a DNA probe containing the 
octamer motif and nuclear extracts from testis, spermatids, liver and a B-cell 
line (BMG). The results of this experiment are shown in Figure 2. All four 
extracts contain the Octl protein. B cells contain in addition to Oct1 the 
B-cell specific octamer binding factors Oct2A and Oct2B [22L while testis 
nuclear extracts produce a complex with a mobility in between that of 
Oct2A and Oct2B. Furthermore this complex was also observed when using 
nuclear extracts of spermatids, indicating that the protein is present in the 
germ cells. This complex was tentavily named TSoct. 
The Oct1 and Oct2 proteins are encoded by different genes that belong 
to a large gene family [27]. This gene family is characterized by the presence 
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of a large stretch of homology which was first noted when the protein 
sequence of the Oct1 and Oct2 proteins was compared with the sequence 
of the rat pituitary specific transcription factor Pit1/GHF1 and the C. elegans 
gene Unc86 ([27] and references therein). This region of homology, the POU 
domain, was subsequently shown to constitute the DNA binding domain of 
the different proteins [28, 29, 30]. The POU domain consists of 
approximately 1 60 aminoacids and can be subdivided into two conserved 
regions, The aminoterminal POU-specific (POU5 ) region of aproximately 75 
residues is connected by a short diverged linker sequence to a second 
conserved domain of aproximately 65 aminoacids that shows extensive 
homology to the Drosophila hom eo box proteins (POU homeodomain; POU"0 ). 
As the testis specific octamer binding factor binds to the same sequence as 
the Oct1 and Oct2 proteins it is possible that the protein is encoded by one 
of these two genes or by another member of the POU domain gene family. 
(It is of interest to note here that we have found that the mouse Oct2 gene 
is highly expressed in testis, making this gene the prime candidate to encode 
the TSoct protein). The expression of the Oct2 gene in testis and the cloning 
of testis specific Oct2 cDNAs is described in the next chapter. 
To further characterize the TSoct protein and to establish its relation with 
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Figure 2. Bandshift experiment showing that distinct acta mer binding factors are expressed 
in different cell types or tissues. A radiolabelled 30bp double stranded oligonucleotide 
containing the acta mer motif was incubated with 5 pgram of crude nuclear extract from 
liver, testis, spermatids and a 8-cell line (BMG). Protein/DNA complexes were resolved on 
a native 4% polyacrylamide gel. 
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the Oct1 and Oct2 proteins we performed protease clipping bandshift assays 
(PCBA; [22]). Nuclear extracts from testis, a 8 cell line (ROS) and a cell line 
that only expresses Oct1 (Epi7) were incubated with the octamer probe for 
1 5 minutes at roomtemperature with different amounts of the endoprotease 
Arg-C. This protease hydrolysis peptide bonds at the carboxy end of arginine 
residues. Proteolytic degradation products that are still capable of forming 
a complex (ie fragments that retain the DNA binding domain) with the 
octamer probe are visualized after seperation on a native polacry/amide gel. 
In this way a protease specific degradation pattern of the octamer binding 
factor is produced. The results of these experiments are shown in Figure 3. 
Comparison of the degradation patterns of the testis complexes with the 
degradation pattern of the 8-cell complexes reveal major differences. While 
the degradation pattern of the testis complexes is quite similar to the Oct1 
degradation pattern (compare panel Band C in Figure 3). This indicates that 
the protein in the TSoct complex is more related to the Oct1 protein than to 
the Oct2 protein. To test whether the TSoct protein is also related 
antigenically to Oct1, we used antibodies directed against the Oct1 protein 
[31] in combination with a bandshift assay. As can be seen in Figure 4, 
preincubation of nuclear extracts with increasing amounts of Oct1 antibodies 
resulted in a progressive decrease in intensity of the Oct1 complex as well 
as the TSoct complex. The intensity of the Oct2 complex was only slightly 
decreased when 8-cell nuclear extracts were preincubated with Oct1 
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Figure 3. Protease clipping bandshift assay. Radiolabe!led probe was incubated at 
roomtemperature with nuclear extracts of a 8-cell line (RQS-1 ; left panel), Epi7 cells 
(middle panel) and testis (right panel). After ten minutes the indicated amount of the 
endoprotease Arg-C was added. Incubation at roomtemperature was continued for another 
ten minutes, before loading the samples on gel. The position of the degradation products 
is indicated with a triangle. Free probe is not shown. 
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antibodies (panel B in Figure 4). These results strongly suggest that the 
protein in the TSoct complex is related to Oct1 and not Oct2. The TSoct 
protein might therefore be encoded by a testis specific Oct1 mRNA, a related 
POU gene or the protein is a degradation product of Oct1. To test the latter 
possibility, the octamer probe was incubated with testis nuclear extracts for 
longer periods of time at roomtemperature, on ice and at roomtemperature 
in the presence of a wide spectrum cocktail of protease inhibitors. As is 
evident from Figure 5 the TSoct complex results from proteolytic degradation 
of the Oct1 protein. Degradation of Oct1 was never observed in nuclear 
extracts of brain, kidney, spleen, liver and a large number of cell lines. 
Despite the extensive precautions to prevent degradation of nuclear proteins 
during their isolation we have to conclude that a specific protease activity 
copurifies with the testis derived nuclear proteins. It is possible that this 
proteolytic activity resides in the acrosome or acrosomal membrane that is 
thightly associated with the spermatid nucleus. Thus, despite the fact that 
the Oct2 gene is highly expressed in testis, we must conclude that in mouse 
testis Oct1 is the only octamer binding factor detected and that binding of 
Testis XT 
pre-1mm (,ul) 1 25 5 - -
a-oct1 (ul) - - - 1 25 5 
oct1-. 
TSoct>-
A 
••. ,. 
•• • • • 
B-Cell XT 
pre-1mm (pi) i 25 5 
a-oct 1 (.ul) -
oct 1:::-
oct2A>-
B 
2.5 5 
Figure 4. The TSoct complex contains Oct1 immunoreactive material. Testis nuclear 
extracts were incubated with the radiolabelled octamer probe in the presence of increasing 
amounts of a non-specific serum or Oct1 anti-serum as indicated above the lanes (panel 
Al. Panel B shows a similar experiment with B-ee II nuclear extracts. Note that the presence 
of Oct1 antibodies does not result in a supershift of Oct1 containing complexes but rather 
in a decrease in the number (intensity} of these complexes. 
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this protein results in the observed footprint IV. 
CONClUDING REMARKS 
The proximal part of the typel c-abl promoter contains at least four DNA 
elements that interact with nuclear factors present in testis, spermatids, 
70Z/3 cells and liver. Three of these DNA elements (footprint I to Ill) 
probably interact with the transcription factor Sp 1, while the fourth DNA 
element interacts with the transcription factor Oct1. These transcription 
factors are probably involved in the activation of transcription from the type 
I c-abl promoter region. As we did not positively identify Sp 1 as the 
transcription factor interacting with the DNA elements I to Ill it is possible 
that other factors, like GCF [12], that have a high affinity for DNA elements 
related to the Sp 1 binding site are responsible for the footprints I to Ill. 
Two other DNA motifs that are conserved between the mouse type I and 
human 1 A promoter were not protected from limited DNAsel digestion 
(GGGGTTAAGG around position -160 and TGGGCCCTTTGTTA around 
position -1 20). These elements, which are located at either site of the 
concensus Sp 1 site, do not match any of the DNA motifs known to be 
involved in transcriptional regulation. However, the high conservation of 
min. 10 20 30 40 50 60 10 20 30 40 50 60 30 60 
oct1:o- ---
TSoct:o- ---····· 
llllrl!llllllllltlllllt•ll•ll -F 
RT iCE 
L__j 
RT 
+ 
inhibitors 
Figure 5. The TSoct complex results from proteolytic degradation of the Oct1 complex. 
Equal amounts of freshly prepared testis nuclear extracts were incubated with the 
radiolabelled octamer probe over an increasing time span either at roomtemperature or on 
ice (time indicated in minutes above the lanes}. Two other samples were incubated at 
roomtemperature in the presence of a cocktail of protease inhibitors. 
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these elements in the otherwise diverged promoter region suggests that they 
may be important. It is possible that these DNA motifs do interact with 
nuclear proteins but that these interactions are not detected in our footprint 
assays as we used crude nuclear extracts. 
It has been suggested by Zhu eta!. [32] that the TT AA motif present in 
these conserved elements represents a functional TAT A box. TheTA TA box 
was shown to be important in determining the exact site of transcription 
initiation in a number of cases. Deletion of theTA TA element from the rabbit 
,8-globin promoter was shown to affect the rate of transcriptional initiation 
in vitro. Furthermore initiation was shown to occur randomly over a stretch 
of DNA [33]. Given the observation that transcription initiation from the 
mouse type I c-abl promoter occurs over a large stretch of DNA it is not likely 
that the TTAA element represents an efficient TA TA box. 
From the footprinting analysis presented here it is not clear if any of 
these DNA elements is involved in the activity of the type! promoter in 
spermatids. It is clear that a functional analysis of the type I c-abl promoter 
is needed to answer this question. Since a suitable transient transfection 
system for spermatogenic cells is missing, such an analysis must involve the 
generation of transgenic mice carrying different promoter deletion 
constructs. 
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MATERIALS AND METHODS 
Cell separation and nuclear extract preparation 
Different populations of spermatogenic cells were isolated using a sedimentation method 
(Staput procedure) followed by density gradient centrifugation (Percell gradients) as described 
by Grootegoed er a/.[34]. This resulted in a highly purified population of round spermatids. 
Nuclear extracts from spermatids were prepared exactly as described [20]. Nuclear extracts 
from whole tissues was done as described by Lichtsteiner et a/.[35] During the whole isolation 
procedure a mixture of protease inhibitors was included in the buffers (1mM PMSF, 5JJg/ml 
leupeptin, 5JJg/ml pepstatin, 5 mM Benzamidin, 5 JJ9/m 1 chymostatin). Protein concentrations 
of the nuclear extracts were determined with the direct photospectrometric method of Kalb and 
Bernlohr [36]. 
Bandshift and footprint assays 
Electrophoretic mobility shift assays were performed as described I37] using a double stranded 
oligonucleotide that was labelled with re2P]-ATP and T4 polynucletide kinase (Boehringer). 
Typically, 2 fmoles of probe was combined with 5 JJ9 of nuclear extract in 20 J.ll bandshift 
buffer (1 0 mM Hepes-KOH pH7 .6. 60mM KCI. 1 mM EDTA, 1 mM OTT. 4% Ficoll. 100 pg/ml 
poly[d!-dC]). and incubated at roomtemperature for 30 minutes. Samples were electrophoresed 
through a 4% {29:1) polyacrylamide gel in 0.25xTBE. After fixation in 10% acetic acid/1 0% 
methanol, the gel was dried and exposed to an autoradiographic film. ONAsel protection assays 
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were performed as described by Barberis eta!. [20) Probes derived from the type! c-ab! promoter 
were endlabelled on different restriction enzyme sites, either at the 5' end or 3' end, and 
purified from preparative low melting agarose gels. Probes were incubated on ice with 10 to 
25 JJg of crude nuclear extract in 25 JJI of footprint buffer (20mM Hepes-KOH pH7.6, 60mM 
KCI, 1mM OTT, 0.8 mM MgCI2 , 0.2 mM PMSF, 8% glycerol,1 t/9 poly!dl-dC]). Then 1 to 10 
f.Jg of DNAsel was added and incubated for 90 seconds on ice. The reaction was terminated 
by adding 80 t~l of stopmix (20mM Tris-HCI pH7.5, 10 mM EDTA, 0.5% SDSI. The DNA was 
extracted by phenol/chloroform, ethanol precipetated, washed once with 70% ethanol and 
dissolved in sequence gel loading buffer. DNA samples were electrophoresed through a 8% 
polyacrylamide/7.5M Urea sequence gel together with a partially chemically degraded G +A 
sequence ladder of the probe as marker. After fixation and drying, the gel was exposed to 
autoradiographic film at -70°C using an intensifying screen. 
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Chapter V 
Oct2 gene expression and spermatogenesis 
Dies Meijer, Anneke Graus, Petra Mackenbach·, Anton Grootegoed· and 
Gerard Grosveld 
ABSTRACT 
MGC, Department of Cell Biology and Genetics 
·Department of Endocrinology and Reproduction. 
Erasmus University, Rotterdam The Netherlands 
Using Northern blot analysis we show that the mouse Oct2 gene is highly expressed in testis. 
Two major transcripts of 7.2 and 6.8 kb were observed in testis and one major Oct2 MRNA of 
7kb in brain and spleen. Cell separation experiments indicate that the Oct2 gene is abundantly 
expressed in spermatocytes but not in spermatids. Oct2 cDNAs were isolated from a testis 
eDNA library and through PCR amplification of testis eDNA. Two eDNA constructs (1-ts0ct2 
and 2-ts0ct2) were obtained that represent the ORF of the 7 .2kb Oct2 mRNA. This mRNA 
results from alternative splicing of Oct2 exons and is possibly transcribed from a testis specific 
promoter. The ts0ct2 cDNAs do not contain sequences encoded by the Oct2 exons 1 to 7a 
(1~ts0ct2) or 1 to 7b (2~ts0ct2). The Oct2 proteins potentially encoded by these cDNAs {44kD 
and 39kD respectively) are initiated from in frame methionine residues and are therefore 
truncated of the first 190 (1-ts0ct2) or the first 249 (2-ts0ct2) amino acids. This truncation 
of the 2-ts0ct2 ORF includes most of the POU5 -A box, resulting in a severe reduction in DNA 
binding affinity of this protein. Alternative splicing of a small 74nt exon (exon13) results in a 
carboxyl terminus of the ts0ct2 proteins that is identical to that of the 8-cell Oct2B protein. 
Expression of the ts0ct2 cDNAs and analysis of the produced proteins in a bandshift assay 
gave rise to complexes with a much higher mobility than the Oct1 and Oct2A complexes. 
However these ts0ct2 generated complexes were not observed in testis nuclear extracts. 
INTRODUCTION 
Male germ cell formation in mammals, in particular rats and mice, is a well 
characterized developmental process. A self renewing population of 
spermatogonial stem cells exists within the seminiferous epithelium in the 
testis. These spermatogonia produce daughter cells that go through meiosis 
(spermatocytes) and give rise to four haploid round spermatids. The round 
spermatids then differentiate to elongated spermatids and finally to 
spermatozoa. During the post-meiotic period the germ cells undergo dramatic 
morphological changes as they acquire the flagellum, the acrosome and 
adopts its species specific head shape. The major part of the cytoplasm is 
shed as a residual body that is subsequently resorbed by Sertoli cells. 
Underlying these processes is the temporally controlled expression of an 
as yet undefined number of genes. Some of these are uniquely expressed 
during spermatogenesis, while others express a testis specific form of a 
protein or transcript (for review see; [1-4]). The control of expression of these 
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genes can be at the transcriptional and/or post-transcriptional level. For 
example, the mouse protamine 1 gene (MP1) is expressed shortly after the 
second meiotic division but the mRNA is translated only days later during the 
later stages of spermiogenesis. Another example is the testis specific 
phosphoglycerate kinase 2 (PGK2) gene that is first transcribed during 
prophase of meiosis but translation of the mRNA occurs during 
spermiogenesis [5). Both genes, MP1 and PGK2, are under transcriptional as 
well as translational control. In the case of MP1, sequences within the 3' 
untranslated region of the gene seem to be involved in the proper timing of 
translation [6]. Other genes such as the oncogenes int-1, c-mos and c-abl 
show temporally controlled expression during spermatogenesis as well 
(reviewed in [3]). It is very likely that specific transcription factors are 
involved in the temporally controlled expression of these genes. Identification 
and subsequent characterisation of these factors may give insight into the 
male germ cell differentiation pattern at the molecular level. These factors 
might be uniquely expressed in testis or might represent variations of factors 
that are also expressed in other cell types. 
Many transcription factors are known to interact through common DNA 
elements. One such DNA element is the octamer sequence (ATTTGCAT), 
which is known to be a binding site for several transcription factors. This 
sequence was originally defined as a conserved element within the 
promoters and enhancer of the immunoglobulin genes [7, 8]. The octamer 
element was shown to confer B-cell specific expression to a non B cell 
specific promoter [9, 1 OJ. This sequence was also found in the regulatory 
regions of genes that are not B cell specific, such as the histone H2b genes, 
the snRNA genes, and the mouse c-abl gene. Initially two proteins, called 
Oct1 and Oct2, have been described to interact with this element. Oct1 is 
a ubiquitous factor involved in cell cycle regulation of the histone H2b gene, 
the replication of adenovirus DNA, and expression of the snRNA genes [11-
1 8]. The second factor Oct2 was originally described as B cell specific and 
as such assumed to be involved in the regulation of the immunoglobulin 
genes [ 1 9]. The two proteins have been purified and cDNAs encoding these 
proteins have been isolated and characterized [20-23]. Sequence comparison 
between these two cDNAs revealed a large stretch of homology which was 
also found in the rat pituitary specific factor Pit-1 /GHF-1 and the C. elegans 
gene unc86 ([24] and references therein). This region of homology (called 
the POU domain) was shown to be the DNA binding domain [25, 26, 27]. 
The POU domain is approximately 160 amino acids long and contains two 
subdomains. The amino terminal POU-specific (POU5 ) region of approx. 75 
amino acid residues is connected through a short linker sequence to the 65 
amino acid POU-homeo domain (POU"0 ). This last domain is related to the 
homeobox, a conserved region originally found in many Drosophila genes 
involved in development [28]. Over the past years, additional factors binding 
to the octamer motif have been identified [29-33]. Noteworthy with respect 
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to the work described here is the identification of a specific octamer factor 
in sea urchin testis [29]. It is possible that these distinct factors are involved 
in the tissue specific regulation of a large number of genes. 
The presence of an octamer element within the mouse Type I c-abl 
promoter region [34], and our initial observation of a testis specific octamer 
binding factor (see previous chapter) suggested the involvement of this 
factor in the haploid specific expression of the c-abl gene. We therefore set 
out to clone eDNA molecules encoding octamer binding factors that are 
specifically expressed in the testis. Here we describe the cloning of cDNAs 
potentially encoding Oct2 proteins that are uniquely expressed during 
spermatogenesis. The possible involvement is discussed of these proteins in 
the processes described above. 
RESUlTS 
Cloning of a CDNA encoding an octamer binding factor 
The approach we took to isolate cDNAs from testis RNA potentially encoding 
octamer binding factors was based on the high homology within the POU 
homeo domain of the Oct1 and Oct2 cDNAs (Figure 1 ). Fully degenerated 
oligonucleotides were used to generate eDNA from testis RNA, that was 
subsequently amplified using Taq1 polymerase (PCR). cDNAs hybridizing 
with an internal degenerated oligonucleotide were subcloned in the plasmid 
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Figure. 1 eDNA PCR amplification of testis mRNAs encoding POU domain proteins. Fully 
degenerate oligonucleotides (see M&M} were synthesized based on amino acid sequences 
conserved between the human Oct1 and Oct2 proteins. Amplification products were 
separated on agarose gels and blotted onto nitrocellulose. The filters were probed with a 
POUHo specific oligonucleotide. Positive bands were excised from the gel, cloned and 
sequenced. 
B. Cloning of a testis specific Oct2 eDNA. A partial eDNA was isolated from a Agt1 0 testis 
eDNA library by use -of a POU domain probe. Five prime extensions were cloned by 
exploiting the RACE protocol. The structural relationship between the partial Oct2 eDNA 
and the 5' extension clones is depicted. Restriction enzyme sites are: N =Neal, H = Hindlll, 
P = Pstl, S =Sail, Sa= Sac I, E = EcoRI. The Sail and EcoRI sites are artificial cloning sites. 
The 5' extension clones were joined at the Neal site with the Agt1 0 Oct2 clone resulting 
in two clones: 1-ts0ct2 (950 PCR) and 2-ts0ct2 (750 PCR). 
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vector pTZ18. Sequencing of these clones showed them to be identical to 
the Oct2 POU domain. Using this eDNA as a probe, a testis eDNA library 
was screened. This yielded one positive clone (0ctAgt1 0 in Figure 1 8), and 
the eDNA insert was subcloned into pTZ19 and sequenced. Sequence 
analysis of this clone indicated that the eDNA was truncated at its 5' side. 
To obtain full length eDNA, 5' extensions were cloned using the RACE 
protocol ([35], see Materials and Methods) and distinct 5' cDNAs were 
obtained (Oct PCR950 and Oct PCR 700 in Figure 1 8). Using the unique 
overlapping Nco1 site in the 5' extended cDNAs and the original octAgt1 0 
eDNA two full length cDNAs were constructed; 1-ts0ct2 representing the 
longer clone and 2-ts0ct2 representing the shorter one. The relation between 
the two 5' PCR products is schematically depicted in Figure 1 B. 
The Oct2 gene is highly expressed in testis 
Previously it has been reported that the Oct2 gene is exclusively expressed 
in lymphoid cells [20, 21, 22]. More recently, He et a!. [36] also 
demonstrated expression of the Oct2 gene in rat brain, but not in rat testis. 
Therefore it is surprising that we isolated an Oct2 related eDNA from a 
mouse testis eDNA library. As we only isolated a single eDNA related to 
Oct2 from our testis eDNA library there is a possibility that the RNA, used 
to construct the library, contained some lymphoid RNA due to the presence 
of lymphoid cells in the testis. 
We investigated the expression pattern of the Oct2 gene using Northern 
blot analysis of RNA from testis, spermatocytes, round spermatids and brain. 
As a probe we used the Oct2 eDNA from OctAgt1 0. In brain one major 
transcript of approximately 7kb was present while in testis two transcripts 
of approximately 7.2 and 6.8kb were detected (Figure 2A). These two RNAs 
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Figure 2. Northern blot analysis of Oct2 RNA from various sources as indicated. A. The 
probe consisted of a 490bp Ncoi/Hindlll Oct2 eDNA fragment {see figure 4) spanning most 
of the PO Us and all of the POUHo domain. The position of 28S rRNA is indicated. 
B. The probe used was a 430bp Saci·Sacl! fragment derived from the 5' end of the 
1·tsoct2 eDNA. The amount of total RNA in each lane is 10 J19· 
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were also detected at a high level in RNA from spermatocytes, but at a much 
lower level in RNA from round spermatids. This clearly indicates that the 
Oct2 gene is actively transcribed during meiosis and is down-regulated after 
completion of the meiotic divisions. The probe used in the experiment 
described above only contains sequences that are also present in the cDNAs 
cloned from human and mouse B-cell libraries. However the 5' part of the 
ts0ct2 cDNAs is distinct and fails to show any homology with B-cell derived 
Oct2 cDNAs (see below). To establish the relationship between the ts0ct2 
cDNAs and the two Oct2 RNAs detected in testis and spermatocytes, a 
probe derived from the unique 5' part of the eDNA (a 430bp Saci-Sacll 
fragment) was used to screen a Northern blot containing RNA from spleen, 
brain, testis, spermatocytes and spermatids. This probe only detects the 
higher molecular weight transcript in testis and spermatocytes (Figure 2B). 
Therefore, the ts0ct2 cDNAs represent the longer transcript observed in 
testis. As we selected two amplified 5' eDNA ends for further 
characterization, it is possible that the shorter of the two PCR products 
represents the other testis specific Oct2 RNA. 
Sequence analysis 
The nucleotide sequence of the 1-ts0ct2 and 2-ts0ct2 constructs was 
determined on both strands. The sequence is presented in Figure 3. 
Sequences that are not present in the 2-ts0ct2 eDNA are underlined. Both 
cDNAs contain a long ORF encompassing the POU domain. In the 1-ts0ct2 
clone the reading frame starts at position 61 4 and terminates at position 
1 907 while in the 2-ts0ct2 clone the reading frame starts at position 791 
and terminates at position 1907. Thus the 2-ts0ct2 ORF represents an 
amino terminal twncation of the 1-ts0ct2 frame and lacks most of 
subdomain A of the POU specific box. The calculated molecular weights of 
the proteins potentially encoded by the 1-ts0ct2 and 2-ts0ct2 are 44kD and 
39 kD, respectively. Both cDNAs contain a long 5'UTR that contains multiple 
short open reading frames. The nucleotide sequence of the Oct PCR750 
clone that was used to construct 2-ts0ct2 is identical to the Oct PCR950 
sequence, except that nucleotides between nt432 and nt659 are missing 
(underlined sequence in Figure 3). This sequence has the hallmark of an 
intron. At the 5' side there is a GT dinucleotide and at the 3' side there is an 
AG dinucleotide preceded by a long stretch of pyrimidine residues. It is likely 
that these sequences represent an alternatively spliced intron within the 
PCR950 Oct2 eDNA. The sequence upstream of nt 432 that is shared by 
both PCR cDNAs, contain multiple splice donor/acceptor sites indicating that 
they may contain even more non-spliced sequences. The two independent 
PCR eDNA molecules start at the same position (nt1). This nucleotide could 
therefore represent the transcriptional initiation site (see below). 
Downstream of nt 61 0 the eDNA sequence is homologous with the 
previously described Oct2 cDNAs cloned from B-celllibraries [20, 21, 22]. 
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Only a few amino acid differences are found between the mouse and human 
sequence, none of them within the highly conserved POU domain. It should 
be noted that the methionine codon that opens the 1-ts0ct2 reading frame 
is a valine codon in the human Oct2 sequence [20, 21]. 
Recently the genomic organization of the mouse Oct2 gene has been 
described [37, 38]. The gene consists of at least 14 exons spread over 35kb 
of genomic DNA. Six different 8-cell specific Oct2 mRNAs have been 
characterized that arise through alternative splicing. Comparing the ts0ct2 
eDNA with the Oct2 exon sequences showed that the sequence up to nt61 0 
is unique to the testis specific Oct2 cDNAs. Downstream of nt 611 the 
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Figure 3. Nucleotide sequence and deduced amino acid sequence of the ts0ct2 eDNA 
constructs. The sequence that is not present in the 2-ts0ct2 eDNA is underlined. Exon 
assignment and numbering is according to Wirth eta!. ([38]; see also Figure 7). The exon 
junctions are indicated by a vertical bar. The 74nt exon (exon13) that is subject to tissue 
specific alternative splicing is boxed (see also Figure 4). 
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ts0ct2 sequence is composed of exons 7a to 14 (indicated in Figure 3, see 
also Figure 7). Interestingly, the ts0ct2 eDNA contains exon 13. This 74nt 
exon was shown to be subject to alternative splicing in B cells. The splicing 
in of this exon results in a shift of reading frame, extending the ORF with 
132 amino acids. B cell specific Oct2 mRNAs containing this exon encode 
the Oct2B protein, a second Oct factor in B cells [37, 38, 39]. Thus the 
putative ts0ct2 proteins have the same carboxyl terminus as the Oct2B 
protein. This part of the protein is rich in serine residues, a property it shares 
with the human Oct1 protein [23] 
Splicing of the 74nt 3' ex on 
To prove that the 74 nt sequence indeed represents a bona fide exon, 
genomic sequences were cloned from a phage library, mapped and 
sequenced. The result of this analysis is shown in Figure 4A. The exon is 
located on a 5kb Hindlll genomic fragment and is flanked by consensus 
splice acceptor/donor sites. The two flanking exons are also located on this 
fragment. The 7 4nt ex on is separated by a 122bp intron from its 5' 
neighbouring exon and by a 284bp intron from its downstream neighbour. 
This 74nt exon is conserved in human, since the eDNA sequence of one of 
the B-cell Oct2 cDNAs presented by Clerc eta/. [20] contains this exon plus 
the 5' flanking intron and part of the 3' flanking intron. To demonstrate 
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Figure 4. Tissue specific alternative splicing of a 3' exon, its genomic organization and 
sequence. Using a probe from the 3' part of the eDNA, a Skb Hindlll fragment was 
subcloned from a genomic clone in A phage EMBL3. The fragment was mapped and 
partially sequenced (the two Ava! fragments were sequenced on both strands). Numbering 
of the exons is according to Wirth et a!. [38]. Exons are not exactly drawn to scale. B. 
Sequence of the A val fragments. Exon sequences are represented by a capital lettertype, 
introns by a small lettertype. Splice donor and acceptor sequences are underlined. The 
oligonucleotides that were used to amplify Oct2 cDNAs are indicated (oligo1 and oligo3). 
Alternative splicing of exon13 will give rise to amplified eDNA products of 158bp and 
232bp. These amplified products were detected with a third oligonucleotide(oligo2l on 
Southern blots of amplified material (C). 
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tissue specific alternative splicing of this exon, we employed the eDNA PCR 
technique. An Oct2 specific oligo was used to generate eDNA from mouse 
testis and spleen RNA. These cDNAs were subsequently amplified by PCR 
using the oligo's as indicated in Figure 4A. Amplified products were 
separated on a 2% agarose gel and blotted onto nitrocellulose. An internal 
oligo was used to detect the amplified products. As can be seen in Figure 48 
the spliced-in product is the most abundant transcript in testis (232bp) while 
the spliced-out product is the most abundant transcript in spleen. In 
conclusion, the 74nt exon is subject to alternative splicing and this process 
seems to be regulated in a tissue specific fashion. 
Is Oct2 gene expression in testis initiated from a tissue specific promoter? 
As the two 5'PCR Oct2 eDNA molecules start at the same nucleotide, it is 
possible that this nucleotide represents the transcription initiation site. 
Furthermore, a probe derived from the 5' part of these cDNAs only detects 
the largest of the two testis specific Oct2 mRNAs (Figure 2). Since the 
sequence upstream of nt 61 0 shows a perfect match with the splice 
acceptor consensus, and these sequences are not homologous to Oct2 
exons 1 to 6, it is possible that transcription is initiated from a testis specific 
promoter located in intron 6. To map the position of the 5' part of the ts0ct2 
cDNAs, a genomic clone covering intron 6 was obtained (a kind gift of Dr T 
Wirth). Using a probe derived from the 5' part of the eDNA, it could be 
shown that these sequences mapped to intron 6 (not shown). Sequence 
analysis showed that the ts0ct2 sequences are colinear with the genomic 
sequence upstream of exon 7a. A 440bp genomic Hindlll fragment was 
subcloned and sequenced, covering the most 5' part of our PCR cDNAs (3' 
Hindlll site at position 163 in Figure 3) and mapping 447bp upstream of exon 
AAGCTTCTTATTTTTAATTTAAATTTATTTATATTTTGGTATTACTAGAG 
AGTCAATCCAGAATTTTTAGTATACTAGGCAGGGGCTCTACCACTGAGCC 
ACACCCCCAGCCCTCTATTCATATTTTATTTTGAGATGGTCTTTCTGAGT 
TGCTCAGGCTGGCiTTGAACTCACTCTGTAGTTCAAGCTGACCTTAAAAG 
AATCCCTCTGCCTTGTTCTCTGGAGCAGCTATATGTTTGCTGTCAGGCCT 
TAATTTTTTTTTTAGAGCAGTTTTAAATGCACAGTGAAACTGAGCTCAAG 
ATAGATCCCATATGTCTCCTGTCCTCCACGTGCACCACCTCCCTCTTTCA 
GCATCCTCGACCCATATAATACCCATCTGTAGTCCAGGCATCTACATGTC 
AGTGTCACATCTATAGACAGAACCTCAAGCTT 
Figure 5. Sequence of the 440bp Hindlll fragment derived from intron 6. The sequence 
represented in the ts0ct2 cDNAs is underlined. Overlined sequence motifs are discussed 
in the text. 
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7a. The sequence of this fragment is shown in Figure 5. The 3' part of the 
sequence is co linear with the ts0ct2 eDNA sequences (underlined in Figure 
5). Directly upstream of nt 1 of the ts0ct2 eDNA sequence there is a stretch 
of 1 0 T residues. At position -30 (taking the first nucleotide of the ts0ct2 
eDNA as position 1) a TATA box sequence is present, and at position -95 
there is an inverted CAAT box. These typical promoter elements might form 
the testis specific Oct2 promoter. However, an alternative explanation why 
the two PCR eDNA products start at the same nucleotide is provided by the 
presence of the 10 T residues upstream of nt 1. First strand eDNA molecules 
were tailed using TdT and dATP. Second strand synthesis was subsequently 
primed by a polylinker-oligodT oligonucleotide (see M&M). Obviously, this 
primer can anneal to internal A stretches (in the first strand eDNA) and 
generate truncated cDNAs. Thus, despite the presence of a TA TA box and 
a CAA T box at typical distances, we cannot conclude that these sequences 
represent the actual promoter from which testis specific Oct2 gene 
expression is initiated. 
The ts0ct2 cDNAs encode functional octamer binding proteins 
The 1-ts0ct2 and the 2-ts0ct2 cDNAs potentially encode proteins that differ 
in size considerably. However, in gel retardation experiments using testis 
nuclear extracts and the c-abl octamer element as a probe, only the 
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Figure 6. In vivo expression of ts0ct2 cDNAs. The ts0ct2 eDNA were expressed in COS 
cells under control of the SV40 early promoter/enhancer (see M&MJ. Mini nuclear extracts 
of transfected and mock transfected COS cells were used in a bandshift assay with a 
radio labelled acta mer probe (paneiAl. The arrow points at the ts0ct2 encoded proteins and 
the free probe is indicated with an F. For comparison, Panel 8 shows the octamer 
complexes that are formed with testis and B-cell (RQS cell line) nuclear extracts. 
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ubiquitous Oct1 complex is observed (Figure 68 and the previous chapter). 
One explanation for the failure to detect testis specific Oct complexes could 
be that the ts0ct2 mRNAs are poor templates for translation. Both 1-ts0ct2 
and 2-ts0ct2 have long 5' untranslated regions containing multiple short 
open reading frames. It has been suggested that the presence of multiple 
potential start codons within the mRNA leader sequence severely reduces 
the efficiency of translation from a downstream start codon [40]. To test 
whether the ts0ct2 cDNAs could encode functional octamer binding 
proteins, we performed bandshift assays using nuclear extracts of COS cells 
expressing the ts0ct2 cDNAs from the SV40 promoter. The results of these 
experiments are shown in Figure 6. Clearly the ts0ct2 RNAs are efficiently 
translated in vivo, giving rise to protein/DNA complexes that have a higher 
mobility than the Oct1 complex. These complexes are not observed with 
testis nuclear extracts (Figure 68). Identical results were obtained with in 
vitro translated proteins. The weaker intensity of the 2-ts0ct2 complex is 
probably not due to inefficient translation of the 2-ts0ct2 mRNA, but to the 
fact that the protein misses most of subdomain A of the POU5 domain. 
Mutations and truncations of the POU5 domain of the Oct1 and Oct2 
proteins impairs DNA binding to a different extent [26, 41 ]. Thus, the failure 
to detect these complexes in testis nuclear extracts is not due to an intrinsic 
poor translatability of these mRNAs. 
DISCUSSION 
In this paper we show that the mouse Oct2 gene is abundantly expressed in 
the germ cells of the testis. Two uniquely sized mRNAs of approximately 6.8 
and 7.2 kb are detected at a high level in spermatocytes and at a much 
lower level in the post-meiotic round spermatids. In brain, spleen and thymus 
only one abundant transcript of 7 kb was detected. The expression of the 
Oct2 gene was further analyzed by cloning of Oct2 cDNAs from testis RNA. 
Oct2 expression in testis 
The genomic structure of the mouse Oct2 gene has recently been described 
[37, 38]. It is a single gene copy in the mouse genome and consists of at 
least 14 exons spread over 35kb of genomic DNA. The Oct2 gene was 
shown to generate at least 6 different mRNAs through alternative splicing, 
encoding different forms of the Oct2 protein. The exons that were shown to 
be subject to alternative splicing in 8-cells are exon 4a and 4b, exon 7a, 
exon 12a and exon 13 (see Figure 7). From a comparison of the ts0ct2 
cDNAs and the 8-cell Oct2 cDNAs, the following picture emerges. The 
1-ts0ct2 eDNA contains the exon sequences from exon 7a to 14, while 
2-ts0ct2 contains exon 7b to 14. Upstream of nt 611 the ts0ct2 cDNAs 
don't show any homology to the published Oct2 sequence, nor to any other 
sequence in the EMBL DNA database. Consistent with this finding is that a 
probe derived from the 5' part of the ts0ct2 cDNAs detected the longer of 
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the two testis Oct2 RNAs and none of the Oct2 transcripts in spleen, 
thymus or brain (Figure 28). The ts0ct2 eDNA sequence directly preceding 
exon 7a (at nt611) shows a perfect match to a splice acceptor site, 
suggesting that these sequences are derived from the intron between exon 
6 and 7. Indeed, cloning, mapping and sequencing of genomic intron 6 
sequences showed that the first 61 0 nt of the ts0ct2 cDNAs are derived 
from intron 6. The 750 PCR oct2 eDNA molecule derives from a mRNA that 
arose through splicing of an intronic cryptic splice donor to the splice 
acceptor of exon 7b, skipping the exon 7a splice acceptor. It is of interest 
to note here that in 8-cells the 7b splice acceptor is more frequently used 
than the 7a splice acceptor, resulting in a low frequency of Oct2 mRNAs 
containing exon 7a (5%; [38]). As both Oct2 cDNAs have an identical 5' end 
that uniquely detects the longer of the two testis specific Oct2 mRNAs, it 
is possible that these mRNAs are transcribed from a unique promoter that is 
located in intron 6. Sequence analysis of the genomic region upstream of the 
PCR eDNA 5' end reveals the presence of TA TA and CAA T box-like elements 
at typical distances. This is not very surprising as the whole region is rather 
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Figure 7. Schematic representation of the mouse Oct2 gene as described by Wirth et a/. 
[38]. The way the ts0ct2 cON As arose through a combination of alternative splicing and 
promoter usage from the Oct2 gene is schematically depicted underneath an enlarged 
portion of the Oct2 map. 
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A/T rich. It is more likely that the same 5' end of the two independent PCR 
cDNAs is caused by internal priming on the stretch of 10 A residues in the 
first strand eDNA molecules. Conventional primer extension experiments to 
determine the transcriptional start site of the ts0ct2 mRNAs have not been 
successful so far. Further experiments need to be done to map the promoter 
region that generates Oct2 transcripts in testis. As stated above, the 5' ends 
of the characterized ts0ct2 cDNAs detect the 7 .2kb Oct2 mRNA in testis 
and not the 6.8kb mRNA. This indicates that this mRNA has a different 5' 
end. This mRNA is detected with a probe covering sequences encoded by 
exon 8 to exon 11 (Figure 2A). 
It was shown by Wirth eta!. [38] that exons downstream of the exons 
encoding the POU domain (exon 7b to exon 1 0) are also subject to 
alternative splicing (exon 12b and 13). We isolated one eDNA from a testis 
eDNA library that contained both ex on 12b and ex on 13. Ex on 1 2b was 
shown to be present in the majority of B-cell Oct2 mRNAs ( > 90%) while 
exon 13 was only present in 18% of the B-cell Oct2 mRNAs. We 
investigated the alternative splicing of ex on 13 in testis and spleen (Figure 7) 
using the eDNA PCR technique. We showed that exon 13 is present in the 
majority of testis Oct2 transcripts while it was only present in a minority of 
B-cell Oct2 RNAs. This finding is in agreement with the results obtained by 
Hatzopoulos eta!. [37] who used a RNAse protection assay to study the 
alternative splicing of exon 13 in different tissues. 
As we combined a eDNA cloned from a eDNA library with 5' extensions 
obtained through PCR the possibility exists that full length cDNAs are 
constructed that do not represent all of the different RNAs observed in vivo. 
It is possible that Oct2 RNAs are produced in testis that have the same 
5'end as our ts0ct2 cDNAs but lack exon13. 
As shown by us and others the inclusion of exon 13 results in a shift of 
reading frame. This alternative reading frame terminates at a more 
downstream stopcodon. It was shown that B-ee II Oct2 mRNA containing this 
exon encodes the low abundance Oct2B protein observed in B-cell nuclear 
extracts [37,38,39]. 
The ts0ct2 cDNAs encode amino-terminal truncated Oct2 proteins 
Because the ts0ct2 cDNAs do not contain the Oct2 sequences encoded by 
exon 1 to 6, the ORFs in these cDNAs encode severely truncated versions 
of the B-cell Oct2 proteins. As the testis specific sequences in the Oct2 
cDNAs do not provide a start codon, the open reading frames of the two 
ts0ct2 cDNAs start at in frame methionine codons. As a consequence, the 
ts0ct2 encoded proteins do not contain the three glutamine rich regions 
located in the amino terminal part of the B-cell Oct2 proteins. Recently, these 
glutamine rich regions have been shown to be involved in the transcriptional 
activation function of the Oct2 protein [41, 42, 43]. A second domain 
involved in transactivation was shown to be located carboxyl terminal of the 
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POU domain of Oct2. Furthermore, it was suggested that the cluster of 
acidic residues in the amino terminal part of the POU domain constitutes a 
third transactivation domain. This cluster of acidic residues (aa 27-36 in the 
1-ts0ct2 ORF) is not present in the 2-ts0ct2 encoded protein. Whether the 
ts0ct2 proteins can activate a promoter containing an octamer motif, in 
particular the c-abl type I promoter, remains to be determined. Even if the 
ts0ct2 proteins lack an intrinsic transactivation domain, it is still possible 
that through interactions with other proteins the ts0ct2 proteins can regulate 
responsive promoters via the octamer motif. Such combinatorial interactions 
have been studied in detail for the Oct1 protein and the Herpes Simplex 
Virus transactivating protein VP16 (also called VMW65 or a-TIF)[44-48]. A 
multiprotein complex of VP16, Oct1 and at least one other cellular factor can 
induce high level immediate early gene expression of HSV genes via the 
TAATGARAT motif, whereas Oct1 alone cannot. It is possible that similar 
interactions between the ts0ct2 proteins and other cellular proteins exist. 
Such interactions might be established through the POU"0 domain,as was 
shown to be the case for Oct1 /VP1 6 interaction [ 46], or through the putative 
leucine zipper that is located carboxyl terminal of the POU domain in the 
Oct2 proteins. However, it should be noted that the 2-ts0ct2 encoded 
protein misses a part of the POU5 p domain resulting in a severely reduced 
binding affinity for the octamer sequence. 
The possible role of Oct2 gene expression in the male germ line 
The peculiar transcription of the Oct2 gene in male germ cells is not 
exceptional. Testis specific transcription of a large number of genes have 
been described, among which many oncogenes (for review see [2, 3, 4]). For 
a number of these genes it is not clear whether the testis specific transcripts 
they generate are translated, and if so what function these proteins play in 
spermatogenesis. For example the mouse fer gene, a member of the tyrosine 
kinase gene family, expresses a uniquely sized transcript in the germ cells of 
the testis [49, 50]. Analysis of eDNA clones representing a testis specific fer 
transcript (ferT) showed that the transcript encodes an amino terminal 
truncated fer protein. The ferT transcript was shown to contain a non spliced 
intron. The ORF is preceded by a long 5' UTR and starts within this 
non-spliced intron. The fer protein, encoded by this ferT transcript, still 
contains all of the characteristic features of a tyrosine kinase protein. 
Although in vitro transcription/translation indicates that ferT mRNA can be 
translated, it is not clear whether the RNA is actually translated in vivo. 
Another example is the proopiomelanocortin (POMC) gene. This gene is 
predominantly expressed in the pituitary gland, but testis specific transcripts 
have been described in rat, mouse and human [51]. In rat testis, the POMC 
transcripts do not contain exon1 and 2 of the POMC gene (which consists 
of three exons). The 5'ends of this testis specific POMC transcript were 
mapped using primer extension and S1 nuclease protection assays and were 
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shown to be heterogeneous. Depending on its exact 5'end, the testis 
specific transcript would encode a truncated version of the polyhormone 
precursor missing its first 52 to 1 00 amino acid residues. Furthermore no 
signal sequence would be present, making it unlikely that these mRNAs 
produce functional polypeptides. 
As is the case for the ferT RNA, the ts0ct2 RNAs have long 5'UTR 
sequences that contain multiple short open reading frames. It has been 
suggested that the presence of multiple start codons in 5' UTR sequences 
reduces the efficiency of translation of the downstream open reading frame 
[40]. Our in vitro translation and COS cell expression experiments clearly 
show that the ts0ct2 RNAs can be translated. However, we could not detect 
complexes of the expected size in bandshift experiments using testis nuclear 
extracts (see Figure 68) or extracts from spermatocytes or spermatids. Thus, 
it remains unclear whether the Oct2 mRNAs are actually translated in male 
germ cells. It is possible that Oct2 mRNAs are translated during a short 
interval in late pachytene and that they are then rapidly turned over as the 
cells go through the meiotic divisions. Stage specific regulation of translation 
has been demonstrated for a number of gene transcripts during 
spermatogenesis. If so, then the low overall concentration of the ts0ct2 
proteins in nuclear extracts of total testis would make them undetectable in 
our bandshift experiments. Another possible explanation is offered by the 
recent characterization of a new member of the POU domain family [52]. 
This protein called 1-POU ('inhibitory POU') was isolated from Drosophila. 
The 1-POU protein does not bind DNA itself but forms a complex with the 
Drosophila Cf1 a POU protein, thereby inhibiting DNA binding of this protein 
to its recognition sequence. The characterization of the 1-POU protein adds 
an additional level of regulation of gene expression. This situation is similar 
to the regulation of DNA binding activity of the transcription factors NFkB 
and AP1 for which inhibitors have been characterized [53, 54, 55]. It is 
tempting to speculate on the presence of an 1-POU-Iike factor in male germ 
cells that would be able to regulate the DNA binding activity of the Oct2 
proteins through complex formation. Thus, the inability to detect the ts0ct2 
proteins in bandshift assays could be explained by the presence of an 
abundant 1-POU like protein that inhibits the binding of the ts0ct2 proteins 
to the octamer sequence by complex formation. In this respect, it is 
noteworthy that several additional POU genes are expressed in mouse testis 
[56]. It could be that one ofthese genes, or an as yet unidentified POU gene, 
expresses an 1-POU-Iike activity in testis. Thus, the question whether the 
ts0ct2 proteins are present at any stage in male germ cell development, can 
only be answered with the use of antibodies directed against the Oct2 
protein(s). 
As long as the presence of Oct2 proteins in testis has not been proven, 
the possibility exists that the Oct2 transcripts are not translated at all. If so, 
their translation is actively prevented, as our COS cell expression 
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experiments show that the Oct2 RNAs can be translated in vivo. We can 
only speculate as to why the Oct2 gene is transcribed in spermatocytes, but 
its RNA not translated. During the pachytene stage of the meiotic prophase, 
the chromosomes are aligned, the synaptonemal complex is formed and 
recombination occurs. It could be that transcription plays an unanticipated 
role in any of these processes. Alternatively transcription might be a side 
effect of the complex organization of chromatin during meiotic prophase, or 
transcription is linked with recombination in an as yet unknown fashion. In 
any case, in testis a mechanism must have evolved that distinguishes 
transcripts that are to be translated at a later stage, from transcripts that are 
not translated at all. 
MATERIALS AND METHODS 
Cloning of POU domain cDNAs after amplification by PCR 
Total RNA was extracted from testis by the LiCI/Urea method [57]. RNA (1 0 .ugl was 
precipitated with ethanol, washed once with 70% ethanol and dried. The RNA was dissolved 
in 9 pi annealing buffer (250 mM KCI, 10 mM Tris-HCI pH8.3, 1 mM ED TAl and 1 .ul (1 0 pmo[) 
of a fully degenerate anti sense oligonucleotide (5'-C(TG)(GA)TT(GAJCA(AGJAACCA(ACTG)-
AC(ACTG)C-3';3'amp primer in Figure 2A) was added. The sample was heated for 3 minutes 
at 80 °C and subsequently incubated at 60°C for 30 minutes. The sample was cooled over a 
time span of approximately one hour to 42°C. After addition of 15 ,ul eDNA buffer (24mM 
Tris-HCI pH8.3, 16mM MgC!2 , 8mM OTT, 0.4mM dNTPsl and 10 units of AMV reverse 
transcriptase, the sample was incubated for 60 minutes at 42 °C. Subsequently the eDNA was 
amplified by adding 55 ,ul of Taq polymerase buffer ( 1 OOmM Tris-HCI pH8.8, 30mM (NH4 ) 2S04 , 
6mM MgCI2 , 10 mM ,8-mercaptoethano!) 20 ,ul of dimethyl sulfoxide and 1 pi of a fully 
degenerate sense oligonucleotide (5'·AA(AGITGGCT(AGCTIAA(TCIGA(CTIGC(AGCTIGA·3'; 
5'amp primer in Figure 2A). The sample was denatured for 3 minutes at 93°C, and 1 unit of 
Taq polymerase was added. Twentyfour cycles were performed to amplify the eDNA: 5 min at 
72°C (extension). 2 min at 42°C {annealing) and 1 min at 93°C (denaturation). The 
amplification was repeated with 10% of the material produced in the first amplification 
experiment. Finally the samples were desalted over a G-50 Sephadex spin-column, ethanol 
precipitated and dissolved in TE (10mM Tris-HC! pH7.1, 1mM EDTA} Ten percent of the 
material was electrophoresed through a 2% agarose gel, blotted onto a nylon membrane (Zeta 
probe) and hybridized to a degenerate oligonucleotide probe (5'-CA(AG)AAGCCTACCTC-
(AG)GA(AGJGAGATC-3'; probe oligo in Figure 2Al. DNA corresponding to the hybridizing bands 
was purified from a preparative agarose gel by phenol extraction and precipitation. Using Sal1 
restriction enzyme sites incorporated in the amplification oligonucleotides the cDNAs were 
cloned in pTZ18. Positive clones were selected by colony hybridization using the probe 
oligonucleotide. Four positive clones were selected for further sequence analysis. 
Construction and screening of a mouse testis eDNA library 
The construction of the mouse testis llgt1 0 eDNA library has been described [58]. The library 
was screened with a radiolabelled probe covering the mouse Oct2 POU domain. This probe was 
obtained through PCR amplification of testis eDNA as described above. One positive clone was 
obtained. The insert of 1.4kb was subcloned in pTZ19. Five prime extensions of this eDNA 
were generated following the "rapid amplification of eDNA ends" (RACEJ protocol as developed 
by Frohman et a/.(35]. The following oligonucleotides were used; 
5"RT oligo 5"-GCTGCTCAGCTGGTTTGG-3" 
5' amp oligo 5' -GGTCGACGAATtCACAGACA T AGTCTCTGCG-3' 
PLdT15 oligo 5'-GTCGCGAATTCGTCGACGCGTTTTTTmTTTT-3' 
adaptor oligo 5"-GTCGCGAATTCGTCGACGCG-3'. 
Amplification products were electrophoresed through a 2% agarose gel and blotted onto 
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nitrocellulose filter. Five major bands, visualized by ethidium bromide staining of the gel, 
hybridized with a DNA probe representing the 5' part of the 1.4kb Oct2 eDNA. These bands 
ranged in size from 150 to 950bp. The two largest amplification products of 950bp en 750bp 
were subcloned and used for further analysis. The smaller amplification products have not been 
analyzed any further. 
Subcloning and sequencing 
The 1.4kb Oct2 eDNA isolated from the testis eDNA library as well as the 950bp and 750bp 
RACE products were further subcloned into the M13 derived phages mp18 and mp19 for 
dideoxysequencing with M13 universal primer. Sequencing was performed on single stranded 
recombinant phage DNA using T7 DNA polymerase (Pharmacial or Sequenase (USB) according 
to the manufacturers specifications. Sequence data were handled using the Microgenie 
software package (Beckman). 
Bandshift assays 
Electrophoretic mobility shift assays were performed as described [29] using a double stranded 
oligonucleotide that was labelled with v-e2P) ATP and T4 polynucleotide kinase (Boehringer). 
Typically, 2 fmoles of probe were combined with 5 JJ9 of nuclear extract in 20 .ul bandshift 
buffer {10mM Hepes-KOH pH7.6. 60mM KCI, 1mM EDTA, 1mM OTT, 4% F;coll, 100pg 
po!y{dl-dCll and the mixture was incubated at room temperature for 30 min. Samples were 
electrophoresed through a 4% (29:1) polyacrylamide gel in 0.25xTBE. After fixation in 10% 
acetic acid, 10% methanol, the gel was d6ed and exposed to an autoradiographic film. 
In vitro transcription and translation 
The 1-ts0ct2 and 2-ts0ct2 cDNAs were subcloned as Sall-EcoRI fragments into pBluescript and 
linearized with Sail or EcoRI. RNA was synthes·1zed us·1ng T3 RNA polymerase (sense RNA) or 
T7 RNA polymerase (a-sense RNA). In vitro translation was performed in rabbit reticulocyte 
lysates {Promega) according to the manufacturers specification. 1/50 of the in vitro translation 
mixture was used in a band shift assay. 
COS cell transfection 
COS cells were maintained in DMEM/F10 (1:1), 5% FKS at 37°C and 5% C02. Transfections 
were performed as described [59]. To obtain high level expression of the 1-ts0ct2 and 2-ts0ct2 
cONAs in vivo, the cONAs were subcloned in the eukaryotic SV40 based expression vector 
pCOX [60] and transfected to COS cells. Mini nuclear extracts were prepared according to 
Schreiber eta!. [61]. 
Isolation of RNA and Northern blotting 
Total RNA from tissues or cells was isolated by the LiCL/Urea method [57]. Electrophoresis of 
RNA and blotting onto nitrocellulose membranes was done as described [62]. 
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ABSTRACT 
We have cloned a eDNA encoding a novel octamer 
binding factor Oct6 that is expressed in undifferentiated 
ES cells. Expression of the Oct6 gene is downregulated 
upon differentiation of these cells by aggregate 
formation. Furthermore the gene is transiently up 
regulated during retinoic acid induced differentiation 
of P19 EC cells, reaching maximum levels of expression 
one day after RA addition. Sequence analysis of the 
eDNA encoding the Oct6 protein indicated that the Oct6 
gene is a member of the POU-HOMEO domain gene 
family. The gene expresses a 3 kb mRNA encoding a 
449 amino acid protein with an apparent molecular 
weight of 45 kO. The sequence of the Oct6 POU domain 
is identical to that of the rat SCIP (Tst-1) gene. The Oct6 
expression pattern suggests a role for this DNA binding 
protein in neurogenesis as welt as early 
embryogenesis. 
INTRODUCTION 
Cellular differentiation processes are believed to be the result 
of differential regulation of expression of the genetic content of 
the cell. That is. genes are turned on and off in response to intr:l· 
or extra cellular cues. Regulation of gene expression can operate 
at the transcriptional and/or posttranscriptionalleveL Although 
some well documented examples of regulation at the 
posttranscriptionallevel exb-r (l-4). the main mode of regulation 
of gene expression is at the tranSCriptional level. Regulation is 
:1chieved by sequence specific interaction of transcription factors 
·with cis·acting DNA elements in gene promoters and enhancers 
(5). Some of these cis elements are kno\VO to bind multiple related 
proteins (AP·I. CCAAT and Oct binding proteins: (6). An 
ex:lmple is the octamer motif ATITGCAT. which is a well 
defined cis element found in a variety of promoters and 
enhancers. The ocumer motif in the immunoglobulin heavy chain 
(lgH) gene promoter and enhancer confers lymphoid specific 
expression, through binding of the lymphoid specific binding 
factors Oct2A and Oct2B (7). In contraSt. the same motif is also 
found in the promoters of widely expressed genes. like U snRNA 
and histone genes. Probably the ubiquitous octamer binding f:lctor 
~To whom correspondence ~nould be addressed 
Octl is involved in the cell cycle dependent expression of these 
genes (8). Recently several additional (0ct3-0ctl0) octamer 
binding proteins were reported to be present in various adult 
mouse tissues and in embryos at different st<~ees of development 
(9). To date three of these octamer binding proteins (0ctl.Oct2 
ar,d Oet3/0ct4) have been defined by cloning of the 
corresponding cDNAs ( 10 -16). Sequence analysis showed that 
they are encoded by different genes belonging to the POU-
HOMEO domain (short: POU domain) gene family (17). 
Here we report on the expression and cloning of a fourth 
octarner bmding factor, Oct6, that is expressed in undifferentiated 
mouse embryo derived stem (ES) cells. Furthermore the Oct6 
gene shows a biphasic expression pattern during rctinoic acid 
(RA) induced neuronal differentiation of Pl9 embryonal 
carcinoma (EC) cells. Sequence analysis of a eDNA encoding 
the Oct6 protein identified a POU domain within the largest open 
reading frame. This POU domain is identical to the previously 
described SCIP(tst·l) POU domain (18. 19). The expression 
panem of the Oct6 gene suggests a role for this putative 
transcription factor in early embryogenesis as well as in 
neurogenesis. 
MATERIALS AND METHODS 
Cell culture, transfection and in vitro differentiation 
Pl9 EC cells were grown in DMEM/FIO (1:1) medium 
supplemented with 5% Foetal Calf Serum (FCS). penicillin and 
streptomycin. The cells were split every 3 to 4 days. CCE ES 
(20) cells were gro\VO on a feeder layer oflethally i.rrndiated STO 
fibroblasts in DMEM. supplemented with 10% FCS. non· 
essential amino acids (Gibco). 0.1 mM P·mercaptoethanol. 
penicillin and streptomycin. ES cells were subcultured every 2-3 
days on fresh feeder layers. 
RA induced differentiation of ?19 cells was done as described 
(21) with some modifications. Pl9 cells were trypsinized and 
seeded as a single cell suspension in petri dishes to form cell 
:tggregates. To prevent the cells from sticking to the petri dish. 
the bottom was first covered with a layer of 1% agar in culture 
medium. After 4 to 5 days. differentiation of the cell aggregates 
was induced by plating them on tissue culture dishes in full 
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medium, supplemented with 1 p.rnolar all trans retinoic acid 
(RA;Sigma). These modifications of the o:iginal protocol 
prevents massive cell death. occuring during aggregate formation 
in the presence of RA. 
DMSO induced differentiation of Pl9 cells was done as 
described (21). In vitro differentiation of ES cells to simple 
embryoid bodies and cystic embryoid bodies was performed 
according to Robertson (22). 
COS-I cells were grown in DMEM/FIO medium supplemented 
with 5% FCS. penicillin ;md streptomycin. COS-I cells were 
transfected using the DEAE/Dextran method. The day before 
transfection cells were subcultured by plating 0.5 X 1!1' cells in 
a 10 em dish. Two hours before tran$fcction the culture medium 
was refreshed. Cells were washed once with serumfree medium 
fo!lowed by addition of serum free medium containing 10 J.<.g of 
plasmid DNA and 100 J.<.g/rnl ofDEAEIDextr:m. After two hours 
the tr.msfection medium was removed and replaced by serumfree 
medium contalning 0.1 mM chloroquine. After another two 
hours. the chloroquine containing medium was replaced by 14 
ml of medium with 5% FCS. Three days after tr.msfcction. cells 
were h::t.rVested for prepar.:ttion of nuclear extracts ;md isolation 
of RNA. 
Nuclear e.xt:ract preparation and bandshift assay 
Cells were harvested by trypsinization. The single cell suspension 
was washed once with full medium and once with ice cold PBS. 
Preparation of nuclear extract (XT) and cytoplasmic RNA was 
done according to Schreiber et al (23) and Cough (24). Protein 
concentration Of the nuclearXTs was determined. using a direct 
spectrophotometric method of (25). Protein concentrations of 
nuclco.r XTs were typically in the order of 5 mg/ml. Bandshift 
assays were performed according to Barberis et al. (26). using 
a 3Zp end labelled double stranded synthetic oligonucleotide. The 
nucleotide sequence of this oligonucleotide used throughout this 
study was derived from the mouse type I c-abl promoter sequence 
(27) gagaggaA.TTTGCATnccaccgaccncc. Typically. 2 fmoles 
(10.000 cpm) of ds oligonucleotide wns incubated with 5 #-g of 
nuclear protein in 10 mM Hepes (pH 7.9). 60 mM KCl. 1 mM 
DTT. I mM EDTA. 4% Ficoll and 2 #-grams of poly dl-dC at 
room temperature. for twenty minutes. DNA~protein complexes 
were separated on a 4% polyacrylamide gel in 0.25 xTBE buffer. 
Electrophoresis was carried out at 150 Volts for 2 hours. using 
a protean II slab gel apparatus (Biorad). After electrophoresis. 
the gel was fixed in 10% methanol. 10% acetic acid for 20 
minutes. The dried gel was exposed to autoradiographic fJ.!m (Fuji 
RX) without intensifying screen. The proteolytic clipping band-
shift assay (PCBA) was done as described (28). Nuclear XT 
preparation of whole tissue (Brain) was done according to 
Lichtsteiner et aL (29). 
Sequence of the double str.mded oligonucleotides are. 
abl I TAGGAA17TGC17TTCCGATC 
U2 TGGTTGTGGCCGTCACAAAGAGGCGGGGCT 
""' od4 
ICP4 
abl I(mut): 
hep+oct+ ; 
hep"'oct- : 
AT~TAGGGTGTGCCGGGGCAGTCGGG 
AGGCCAATATGATAATGAGGGGGT 
CACGCCTTA~TATTACT 
AGGGCGGTAATGAGATGCCATGT 
TAGGAATG1TC4GITCCGATC 
CGAGTGCTC4TGAATA~1CAATTGG 
CGAGTGCTC4nGAATATCAGTCGCCATTGG 
The 300 bp EcoRI fragment used in the binding competition 
experiment (Fig.6) were derived from the pbsmids 
p6W,TKCAT (FD) and p6W,TKCAT(o-) (Fd) (9. 30). 
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Northern blot analysis 
Adult BCBA mice were used as a source of tissues for RNA 
extraction. Totul RNA was extracted. using the method of 
Auffrey and Rougeon (31). Cytoplasmic RNA from tissue culture 
cells wns prepared. according to the method of Cough (24). Ten 
#-g of dmatured total RNA was separated on a I% agaro:;e gel 
containing 0.66 M Formaldehyde (32). RNA was transferred to 
nitrocellulose (S&S) or Biotrans (Dupont) blotting mcmbmncs. 
by capillary action. Hybridization was done overnight at 42°C 
in hybridi.z:ltion buffer. containing 50% formamide. Hybriziation 
probes were labeled with [~-3~P1 d.ATP ;md [a--'~P] dCTP using 
the random hexamer primed labding method (33). Blots were 
washed to a fin::t.l stringency of 0.1 xSSC. 0.1% SDS at 65°C 
and expo~ed to Kodo.k X-AR5 films using an htensifylng .!>C"reen 
at -sooc. 
Cloning and sequencing 
Construction of the Brain eDNA librnry in J)gt!O wns essentially 
done as described (34). All screening and cloning manipulations 
were carried out following standard protocols (35). The library 
was screened with a mouse Oct2 POU domain probe. Positive 
clones were selected and SJbc!oncd into the EcoRl site ofpTZ18 
(Pharmo.cia). Suitable restriction endonuclease sites in the selected 
clones were used to construct subclones in the M!3 cloning 
vectors mpl8 and mpl9. Single stro.nded recombino.nt phage 
DNA was used JS template for sequencing according to the 
method of Sanger (36) using [a-35S] dATP and the Sequenase 
(USB) enzyme. S:!quence data were compiled o.nd o.na.lysed. using 
the Microgenie software packo.gc (Beckman). 
RESULTS 
A family of octamer binding factors is differentially expressed 
during EC cell differentiation 
Embryonal c:m;inoma cells provide an excellent in vitro system 
to study early embryonic events. Depending. on the culture 
conditions. these ceUs can differentiate into a wide spectrum of 
different cell types. We employed the Pl9 EC cell system to 
investigate expression of oct:lmer binding factors during rerinoic 
acid (RA.) and dimethylsulfoxide (DMSO) induced differentiation 
of these cells. Pl9 cells can be induced to differentiate into 
ncurectodennal cell types. m:rinly astroglia cells and neurons. 
by high levels ofRA. Treatment ofPI9 cells with DMSO results 
in mesodermal C.er:ivatives. including skeletal and cardiac muscle 
cell types (37. 38). PI9 cells were induced to differentiate 
following the RA and DMSO protocol ::md cells were harvested 
at the indicated day (Fig. IA.B). Nuclear extracts and cytoplasmic 
RNA were prepared from the same batch of cells. Using a double 
str.mded oligonucleotide containing o.n octamer motif. bandshift 
experiments were performed. Results of these experiments arc 
presented in Fig. !A.B. Nuclear extracts of undifferentiated PJ9 
cells gave rise to two complexes. The lower mobility complex 
is found in all cell lines tested and has been labelled Octl (also 
called NFAI. OTFI. NFID. OBP!OO (17)). The higher mobility 
complex was labelled Oct4 ns it comigratcd with the previously 
described ES/EC cell specific complex Oct4 (9) in a 
coelectrophoresis experiment (data not shown). \\Then the cells 
are aggregated. two changes are apparent (Fig. !A. dO). The 
most dmmatic change consists of induction of a second Oct4-like 
complex with a slightly higher mobility, concomino.nt with a 
decreased intensity of the Oct4 complex (small arrows in Fig. 
lA). At the same time. a weak complex appears that we refer 
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Fi~re I. Octamer binding factors in nuclear e~troct5 of differentiating ?19 andES cells. Radiolabelled probe was incubated with nuclear extr.lcts of Pl9 orES 
cell~ at c.iffcrcnt stases of differentiation. 3-5 p.g of extr.~ct was used per lane. The position of the Octl. Oct4 and Oct6 complexes are indic:ued. Small arrows 
locate th•! Oct4 and Oct4-like complex. Panel A; RA induced differentiation of ?19 cells. Nuclear extrncts of undifferentiated PIS. cells (lane - ). aggregates (dQ). 
at d:ly one ofRA induction (dl). day two (d2). day four (d4). and day eight {d8). As a control a bandshift of mOl>~ bnin nuclear extruct is shown. Panel B: DMSO 
induced :lifferentiation ofP19 cells. Indications as in panel A. ~.cl C: Differentiation ofES cells. Nuclearcxrrucrs ofund1fferentiatcd ES cell!; (ES). stmple embryoid 
bodies at day 4 of differentiation (EB4) and cysuc embryoid bodies at dayS of differentiation {EBS). Free probe is indicated by F. 
to as the Oct6 complex as it comigntes exactly with the EC/ES 
cell complex Oct6 (9). Culturing aggregates in tissue culture 
dishes. in the presence of R.1.. for one day. leads to a further 
increase in the amount of Oct6 complex and to further reduction 
of the Oct4 and Oct4-like complexes (dl). At day two (d2). the 
Oct4 complex is no longer detectable and also the Oct6 complex 
decreases in intensity. At day four (d4) a new complex appe:ll'S 
with a mobility that is slightly slower than the Oct4 complex. 
Funhennore a complex is observed with a mobility similar to 
Oct6. When electrophoresis was prolonged. it was evident that 
this complex has a lower mobility then the Oct6 complex observed 
in lanes dO, dl and d2 (dau not shown). At day 8. an additional 
complex is observed that migrates much slower then the Oct6 
complex. From day five onwards. many neuronal cells could be 
identified in the differentiating culrures by virtue of their long 
processes. Throughout differentiation of the cells. the intensity 
of the Octl complex remains roughly constant. Some of the 
octamer complexes observed during PI9 cell differentiation. :rre 
also seen when whole brain nuclear extr.:l.cts were used. It is dear 
from these results. that differentiation of PI9 cells along the 
neurectodennal pathway correlates with a highly complex 
temporally controlled expression pattern of a family of octamer 
binding factors. 
To check whether the observed differential expression of 
octamer factors was restricted to RA induced differentiation of 
P19 cells. we performed a similar experiment, now using DMSO 
as a differentiation inducing agent. Results of this experiment 
are shown in Fig. lB. This experiment differs from the previous 
one in that DMSO was already present during aggregate 
formation. Over the timespan studied. the only change observed 
in the expression of octamer binding factors is the gradual 
appearance of the higher mobility Oct4-like complex (small 
arrows Fig. lB). Again Oct! expression seems to be relatively 
constant. Therefore the temporal expression of ocramer binding 
factors appears to be specific for RA induced differentiation of 
Pl9 cells. 
P19 CeiiS+RA 
A 
ES Cells 
" "' (/) "' "' w w UJ 
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Figure ;!, Expre:;sion of mb, mR..'IA in dlffercmiating ?!9 and ES cell!;. 
Cytopla5mic RNA and nuclear er;tmct5 were prepared from the same batch of 
cells. Nucle:u- extracts were used in the bandsllift e;~;perimenl5 pr=nted in Fig. 
1. Twenty p.g of cytoplasmic RNA wa.s denatured. sep=ted on a 1% agarose 
gel in 0.66M fo!Tilllldchyde and blotted omo Biotr:J.n:. (NEN) membranes. The 
blOtS WCJ"t: probed with a 300 bp Pvuii mbl probe in hybndization buffer contllning 
50% formamide at42•c for 18 hour:;. BloL' were wa.,hed to a final ~mngcncy 
of o. 1 xssC.65°C. Expo:;ure was for three day~. lndicauon.s of the lane:> as in 
Fig.. l. 
EC cells are often regarded as closely resembling embryonic 
stem cells. We were therefore interested to see whether the 
observed octamer factors were also expressed during ES cell 
differentiation. ES cells can be induced to differentiate by gro\.Vth 
in suspension where they will fonn aggregates. After a few days. 
aggregates will fonn a layer of endoderm cells on their outer 
surface. The struCtures thus fonned arc tenned embryoid bodies. 
Continued culturing of these embryoid bodies in suspension leads 
to formation of cystic bodies and further differentiation of the 
cells into ectodermal and mesodennal cell types. When nuclear 
extr.lcts of undifferentiated ES cells were assayed for the presence 
of octamer binding factors. three complexes were observed; Oct I. 
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Fi{:Ure 3. Prot= clipping OO.ndshift 5s:JY of the Oct6 prOtcin. Radiol:J.bdled probe w.JS incubated :u roomtemperatun: with nuclear e.~!I"X!S of Oct6 mmsfected 
COS-I cells (left). YI'ES6&J2 (middle) o.nd Epi7 cells lri!,!htl. After ten minutes, !Jiffen.'llt ~mount~ of the cndoprotcase ArgC wus udded (amounl~ ~s indic:>.!ed ar 
tbe bonom of the l:J.nes). Incubation at roomtemperutun: was <:<>ntinued for :;mother ten minutes. before loadins the :<ample:; on the sel. The position of the Oct6 
degrudntion product:> an: indicated with a triangle. Oct! degradativ~ products are indicated with a dot. The po>!tion of undegradcd protein.~ Jre indic-..tted with an 
arrow. Free probe is indicated by F. 
Oct4 and Oct6 (Fig. 1 C). Previously. these complexes have been 
described to be present in D3 ES cells and F9 EC cells (9). 
Differentiation of ES cells correlates with a drastic decrc::tsc in 
intensity of the Oct4 and Oct6 complexes (Fig. lC: EB4. EBS). 
The residual intensity of the Oct4 and Oct6 complexes at day 
4 (EB4) is probably due to remaining undifferentiated ES cells 
in the core of the aggregates. Again. appearance of the higher 
mobility Oct4-like complex is observed during ES cell 
differentiation (Fig. I C). No additional complexes were observed. 
Clearly PI9 EC cells differ from true ES cells in that they do 
not express the Oct6 protcin(s) in the undifferentiated state. The 
regula.ted expression of the Oct6 complex during P19 cell 
differentiation and expression in undifferentiated ES cells suggests 
a role of this protein in both systems. As a first step in defining 
the role of the Oct6 protein in these systems. we set out to clone 
a eDNA encoding the Oct6 protein. 
Cloning of an Oct6 eDNA 
The three octamcr binding factors that have been identified to 
date, by cloning of the corresponding cDNAs. ore encoded by 
different members of the POU domain gene family. As the POU 
domain constitutes the DNA binding domain of these proteins 
it is tempting to assume that the oct:~mer factors identified here 
are also encoded by genes belonging to this fa.mily. Recently it 
was demonstrated that :l. number of additional POU domain genes 
are expressed in different regions of the rat brain. kidney and 
testis (19). The Oct6 protein in ES cells and differentiating P19 
cells may well be encoded by a member of this gene family. 
Given the high homology within the POU domain ::unong the 
different members of this gene family. we tried to clone a eDNA 
encoding the Oct6 protein based on this homology. Using a mouse 
Oct2 POU domain probe. derived from a testis specific Oct2 
eDNA (Meijer et al. unpublished results). a mouse brain eDNA 
library was screened. Six clones (called mbl to mb6) were 
isolated. that hybridized with varying intensity to the Oct2 probe. 
DNA fragments derived from these clones were used as probes 
to screen Nonhero blots containing RNA from differentiating 
PI9 andES cells. It was anticipa-ted, that the expression pattern 
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Fi~re 4. Expn:s~ion of Oct6 mRNA in differe:nt mOU."\e ti:s:;.ue:; and .:~!1 lines. 
Twenty l'l! of d<:natured total &'\!A wa.~ ~ted on~ 1 <;; ~prose g.el in 0.66M 
formaldeh)'d<= ~nd blotted onto Biorrum. blotting membr.~ne. Probe and 
hybridiz:J.tion .:ondiuons J..' in Fig . .:;_ L:!ne 1 -..:.;total R~A from whole embryos 
at day 10 (el0). dJy 13 (e13), day 16 (ei6J and day 19 (el91 of se.tation. Lane 
5-12: Tot;~l RNA from ~dult mouse ti:..~ues. L.:me 13 and l-1; Toml RNA from 
MES6&12 and unditrerentiated CCE ES cells. 
of the Oct6 mR..'JA would correlate with the expression pattern 
of the Oct6 protein in our bandshlft experiments. A pre-be derived 
from clone mb I fulfilled this criterion and detected a tr.mscript 
of approxim:::nely 3 kb (Fig. 2A.B). Interestingly, at day 8 of 
RA induction of P19 cells. expression ofmbl mRNA reappears 
after its high transient expression around day 1. This correlates 
exactly with the reappearance of the Oct6 bandshift complex a.t 
day 8. However at this stage of differentiation, the Oct6 complex 
is obscured by the presence of a protein complex with a slightly 
lower mobility. that first a.ppears at day 4. 
In vitro tr.:mscription/tr.mslation of the mbl eDNA generated 
a protein tha.t did bind to the octamer probe. but gave rise to 
a complex with a slightly higher mobility than the Oct6 complex 
in a bandshift assay (data not shown). Sequence analysis 
indicated. that this clone represented a 5' end truncated eDNA. 
Instead of trying to clone a longer eDNA, the mbl eDNA clone 
was extended at its 5' side with 320 bp of genomic sequences. 
These were derived from a mouse r3 EMBL3 done, that contains 
the genomic counterpart of the 5' end of the mbl eDNA (not 
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1 CGCAGACGGAGCGAGGCGGCGGCGGCGGCGGCGCGCCGCAGGCCGCGGGCCGGCATGCCCACCACCGCGCAGTATCTGCCGCGGGGCCCC 
prrmer MATTAQYLPR~ 12 
91 GGCGGCGGAGCTGGGGGCACAGGGCCGCTCATGCATCCCGATGCCGCCGCGGCGGCGCCAGCGcEGc?;)gJA~~~~CACGCGCGCGCC 
G G G A G G T G P L M H p D A A A A A A A A A E R L H ~ 42 
GCGTACCGCGAAGTGCAGAAGCTGATGCACCACCACTGGCTGGGCGCGCGCCCCGGCCACCCCGTGCGCCTAGCGCACCCTCAATGGCTA 
A Y R E V Q K L M H H E W L G A G A G H P V G L A H P Q W L 
;;;CACGGGAGCACGCGCCCGCGCCCACTCGCCCGGCGGCCCGCACCTCGAACACGGCAAGCCAGGCGGTGGCC~~~bccccccAGCTGAC 
P T G G G G G G D WAG C PH L E H G K A G C cGTc R A 0 
3 61 CACCGCGGCGGTCCCCGCCCTTTCCACGCCCGCCTGGTCCACCAAGGGGCGCCCCACGCGGCCGCGCCATCCGCACAAGGCGGCACAGCG 
).02 
D G G C C G G F H A R L V H Q G A A H A G A A W A Q C C T A 132 
4 51 CACCACTTGGGCCCCGCCATGTCCCCGTCGCCCGGGGC"CGCCGGCGGTCACCAGCCCCAGCCGCTCCGGCTGTACGCTCAGGCGGCCTAC 
HHLGPAMSPSPGAGGCHQPQPLCLYAQAAY 162 
541 CCCGGTGGCGGCGGCGCCCGCCCTGGCCGGGATGCTGGCGGCCGCAGGCGGCGGCGCGCGACCCGGCCTGCACCACGCACTGCACCAGGAC 
P G G G G G G L A G M L A A G G G G A G P G L H H A L H E D 192 
631 GGCCACGAGGCACAGCTGGAGCCGTCGCCACCACCGCACCTGGGCGCACACGGACACGCACACGCA.CATGCACACGCGGGCGGCCTGCAC 
G H E A Q L E P S ? P P H L G A H C H A H G H A H A G G L H 222 
7 21 GCGGCGGCGCCGCACCTCCACCCGGGCGCGGGCGGTGGTGGCTCGTCCGTGGGCGAGCACTCGGACCACCATGCTCCCAGCTCCGACGAC 
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AGCCTGCAACTGCAGAACGAGGTGGTGCGTGTCTGGTTCTGCAACCGGCGGCAGAAGGAGAAGCGCATGACCCC CCGCCGGCCCGGCC 
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12 61 CACCCCCCCATCGACGACGTTTA TCCGCCTGCCGAGCTGGGGCCTGCCGGCGCCACCGCGTCGCCACCTTCT{;CGCCCCCGCCACCCCCG 
H P P M 0 0 V Y A P G E L G P G G G S A S P P S A P P P P P 432 
1 3 51 CCGGCCGCGCTGCACCACCACCACCACCACACACTGCCCCCCTCTGTCCAGTGACCCTGCGGACTCGGTTCCCCGCCGGCGCAGCGCTGC 
L, A A L H H H H H B T L P G S V Q * 449 
14 4 1 CTCCGGCGCGCAGTTAGCGCGCGCGG CCTGGACTCTTTTTCTTGTTTATTCCCTTTTGCTTTGGATTTTACAAAAAG 
Fh:un: 5. Nuck01ide and predictC<J ~mmo ~ctd ,cquenee of the extended mbl eDNA encoding Oct6. Toral length of the pre~cnted -.equence ts J517nt. :-lucleotide 
-.equence of eDNA clone mbl ,l:il1~ ~~ po'ttion 155. The fir..t 154 mare denved from a genomic 510 bp Sacl-Kpnl fr~grnent. Posit ton 1 of the prcscmed 'equence 
repreent, the CAP site of the Oct6 mRNA a.> dctermined by primer extension (Fig . ..\). The POU 'JXcific il!ld POU-HOMEO domain:; are indicated by the boxed 
<Jt"•'tnO~~id :;equen~c:;. Homopolymmc, or qua:.t-homopolymcric ;un.im,) ~cid sequences :ue underlined. The Kpnl 'itc that wa.-. u:.ed to link the genome Ocr6 ,.:quence. 
c,,. o the cOl' A i' indic:~ted. The po~ttion or· the {-)strand oligonucleotide that was used in the primer extension experiment b indic:~tcd with :marrow (pos. 38 to 54). 
shown). As indicated in Fig. 6, the 5' end of the eDNA maps 
at position 155. Downstream of this position. the sequence of 
the genomic DNA and the mbl eDNA are exactly colinear to 
the Kpnl site ar position 344. For convenience the 5' eDNA 
sequences were replaced by genomic sequences from this Kpni 
site on. Upstream of position !55 the reading frame remains open. 
No consensus splice acceptor or donor sites arc present (Fig. 5). 
However. at positions -25 and -80 with respect to the presented 
sequence a TAT A box sequence and CCAA T box are. present 
respectively (not shown). suggesting that this ge:10mic fragment 
also comains part of the Oct6 promoter. To prove tha.t the 
extended eDNA contained the entire Ocr6 open reading frame. 
plus pan of the Oct6 promoter the con$truct was cloned imo the 
SV40 based expression vector pcDX (39) in the antisense 
orientation with respect to the SV40 early promoter and 
transfected into COS-1 cells. In this way an Oct6 protein can 
only be produced when transcription starts from the putative Oct6 
promoter. 
As can be concluded from the results presented in Fig. 3 (see 
also Fig. 6) the extended mbl clone described above produced 
a protein that gives rise to an octamer complex in a bandshift 
assay with the same mobility as the Oct6 complex observed when 
using MES68cl2 nuclear extraCts (an adenovirus Ela tranSformed 
MESJ cell line (44); M.P.M. and A.L. unpublished results). 
Furthermore primer extension experiments indic:ued that the 
CAP site used on the extended eDNA template in transfected 
COS cells is the same as that used in MES68d2 cells (data not 
shown). 
To further corrobornte the identity of the Oct6 protein encoded 
by the cloned DNA with the endogenous Oct6 protein presem 
in the MES68cl2 cell line a protease dipping bandshift experiment 
(PCBA; 28) was performed. The MES68cl2 cell line was used 
as a reference instead of ES cells or RA induced P19 cells, 
because it has a high endogenous level of0ct6 (see Fig. 4) and 
gave a clear degradation pacrem in the PCBA. The prese~ce. of 
Oct4 in ES cells and Pl9 cells would have obscured the chppmg 
pacrem of Oct6. Limited proteolytic dcgrnd::l.tion of the protein 
encoded by the cloned DNA gives rise to thn:e complexes (Fig. 
3, left panel); indicated with triangles. The same degrndation 
products are observed when Oct6 containing MES68c12 nuclear 
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extracts were used (Fig. 3, middle p;mel). The two additional 
bands observed in the MES68cl2 experiment (indicated with a 
dot) are derived from degradation of Octl. as can be concluded 
from the third panel that shows the degradation pattern of Octl 
in a cell line that only expresses Octl (Epi7). 
Taken together these results indicate that the construct indeed 
contains the entire Oct6 open reading frame and that tnnseription 
is initiated from the Oct6 promoter using the authentic CAP site. 
Since the distance between the CAP site and the 5' end of the 
mbl eDNA measures 154 bp, the ORF of the construct is 
extended by 33 amino acids to the methionine indicated as the 
starr codon in Fig. 6. 
Northern biot analysis 
The Oct6 complex was observed in differentiating P19 cells, adult 
brain and ES cells. In order to get a more complete picture of 
the expression of the Oct6 gene, various tissues of adult animals 
and whole embryos at different stages of gestation were analyzed 
using northern blots. The result of this limited survey is shown 
in Flg. 4. No adult tissue other than brain ha$ an appreciable 
level of Oct6 expression. Furthennore, no expression of Oct6 
was observed in whole embryos at day 10, 13. 16 and 19 pc. 
RNA samples ofMES6Scl2 andES cells were included as extra 
controls. 
Sequence of Oct6 
The full length Oct6 clone was sequenced on both strands. The 
complete nucleotide sequence is presented in Fig. 5. Translation 
of the sequence reveals a long opt:n reading frame (ORF), 
encoding a protein of 449 amino acids with a calculated molecular 
weight of 45 kD. As expected. this reading frame contains a POU 
domain (residue 253-397). Comparison of the Oct6 POU 
domain with published POU domain sequences revealed a 100% 
identity with the rat SCIP/Tst-1 POU domain (18, 19). indicating 
that Oct6 is encoded by the mouse counterpart of the rat 
SCIP/Tst-1 gene. Apart from the POU domain, the protein does 
not show a high degree of homology with other members of the 
POU domain gene family. According to the terminology of He 
eta.!. (19) the Oct6 protein is a Class ill POU domain protein. 
The Drosophila Cfla gene is the only other member of this 
subclass of POU domain genes, for which a sequence is published 
(apan from the POU domain itselt) (40). Comparison of the Oct6 
amino acid sequence with Cfla did reveal a short stretch of 
homology in the am.inotennina.l part of the proteins. This 
homology is due to the presence of a relatively long (9) stretch 
of alanine residues. Interestingly the Oct6 protein contains several 
homopolymeric amino acid stretches. Apart from a stretch of 
alanine residues there are several stretches rich in glycine. 
histidine and proline. Glycine rich amino acid domains are also 
present in the Oct4/0ct3 protein (16. 15). This protein is also 
very proline rich. The amino acid sequence of the Oct6 protein 
carboxytenninal of the POU dorn:tin is particularly rich in proline 
residue (25% )_ The fimctiorcl importance of the domains outlined 
above remains to be determined. · 
The Oct6 protein binds to the octamer motif 
To determine whether the Oct6 protein binds to the octamer motif 
contained within the probe DNA. DNA binding competition 
experiments were perfonned. As competitor sequences we used 
two DNA fragments of which the first consists of a six times 
repeated synthetic oligonucleotide, derived from the IG enhancer 
sequence, containing the octamer binding site, while the second 
consists of the same repeat with a mutated octamer binding site 
72 
(FD and Fd respectively (30, 41)). In Fig. 6 it is shown that a 
thousand fold molar excess of FD competitor inhibited the binding 
of Oct6 protein to the radiolabelled probe. while the mutated Fd 
competitor failed to show this effect. Therefore, binding 
competition depended on the presence of an intact ocumer motif 
which showed that interaction between the Oct6 protein ::.nd the 
probe is mediated by these sequences. 
The Oct6 protein binds to other sequence motifs as well 
It has been shown that the Oct! and Oct2 proteins bind to 
sequences differing considcr..tbly from the consensus octa motif 
(49. 50) albeit with lower affinity. The putative binding domain 
(POU domain) of Oct6 differs from that of Octl/Oct2. It is 
therefore possible that the spectrum of DNA binding sites for 
Oct6 differs from that of Octl/Oct2. To test whether the Oct6 
protein shows differential affinities for octamer and octamer 
related binding sites as compared with Oct! we pcrfonned 
bandshift assays using MES6Scl2 nuclear extracts that contain 
Octl and Oct6 protein and different probes known to be binding 
sites for Octl. The probes used are listed in figure 7A and are 
aligned with respect to the consensus octamer motif. The ratio 
between probe shifted by Oct l versus Oct6 is taken as an 
indication of their relative affinities for that site. The three probes 
that contain a perfect match to the consensus octa motif but differ 
in their flanking sequences (ab!I. U2 and ad4) all bind Octl and 
Oct6 albeit with different affinities (Fig. 78). This indicates that 
flanking sequences contribute to binding affinities and that these 
contributions are different for Oct! and Oct6. The ad2 octa motif 
differs at rwo positions from the consensus ocramer sequences. 
However the ratio between Oct! and Oct6 is now shifted in favour 
of the Oct6 complex indicating that this mutation more strongly 
affects Octl binding to the ad.:?: octa motif than Ocr6 binding. 
The strongest differential affinity between Octl and Oct6 is seen 
with the Herpes simplex virus (HSV) ICP4 gene promoter 
TAATGARA.T motif. This site poorly binds to Octl whereas 
Oct6/COS MES68cl2 
~~
competitor: _ f2 ;z: _ f2 CC 
• - -cOct1 
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Figure6. The0CI6 protein binds to the ottuner rnotif. R:.diol:lbc::Jied probe: wa.~ 
incuOO.ted with nuclo:<ll' extrncrs of Oct6 lnmSfected COS cdb (June l to 3) or 
MES6&!2 nuclo:<ll' extrncr (lane 4 to 6) either m the absence rt:mc 1 and 4) or 
in the p=ncc of a 1000 fold molar excc:.s o( cold competitor D~A (lane 2. 
3 ;md S. 6). The FD cornpeutor is o. 300 bp EcoRJ rc:;mction fr.:~gment cont:Urung 
s"1x tandem copie:. of the ~quence; ctgngc=c:.cc:lCCtg£.1,.'1aA ITrGCA Tnc=-
t:tagtcga (30). The Fd competiwr is the '-'~.me a.~ FD exe<:pt that it conoin.~ ;m 
octamer motif muoted at two position.,; ATgTtCAT r..tl). 
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AGTG:C.."(~AT~([~CAATT 
AGTG~~~§.aATATCAGTCGCCATT 
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compOtltor ICP4 
·orobe Jbl 1 
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MES!3Scl2 
Fi~un: 7. The ocr:un<!r binding: fo.C!Ol'!i Oct! and Oct6 bind with different affmitie:s 
to :;equences related to the consen.w,~ octamer motif. Panel A ~how, the ><:quence 
of the different OCTA motif~ preen! in the cb oligonucleotide:; u~d. Nucleotide:; 
fittmg the o.."t:lmcr concensus s.equence are indic..ted in black. Only the octO.mer 
m01if plus t1ank.ing nucleotide:; are shown (o:.cc Materiab and Method:;). abl I: 
mo~ type I c-abl promoter (27). U2: Xenopu:. U2 ~mall nuclear RNA dNa) 
~cquen~ dement 146) adJ: adenovirus -..::rotype 4 ITR (4$). nd::: ~denov1rus 
serotyppe 2 ITR (48) ICP4: HSV immedi:lt~ early ICP4 gene promoter (47) abl 
I (mut): mutated version of abl I hep ·OC'l·: heptamer (boxed) and· octamer 
element:; of the murine 104-2 IgH promoter. hep•OC'l-: intact heptamer mcuf. 
mut:ltcd octa mot1f (50) fBl Band:.hill experiment w1th MES68cl2 nuclear extr.~et:; 
showm~ relnnve aflimt•es of the OC!I ~nd Oct6 protem~ for the different probe~ 
(see Al. F indiC;Jt<::> f~tt frusment. fC) The Oct6 protein bind;. to the hcptamer 
sequenc.:. Bandshift c:xpcnment with ds olisonucleotides hep ·OC'l• and hcp +OC!-
an<J nuclear extract.~ of Oct6 tr.m~fect<:d COS cdls. DNA protein complc:xe~ are 
indicated ns Cl and C2. F indicates free frogmen! (0) Band~hift competition 
experiment to ~y tht n:lauvc a(finiues of Oc!l and Oct6 fore the T MTG-
ARAT motif. MES68cl2 nuclear protems were mcubated with rudiolabeled abl 
I probe in the preenee of incre;c;1ng umoum of cold ICP4 probe (1$ competitor 
(right to left). The competitor W(l$ added in :?.·fold semi dilutions ~tarting with 
a 1000 fold e.xce:;:; of TAATGARA T binding site..~ to octa bind in~ O>ites. 
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it is a good binding site for Oct6. The abll (mut) oligo contains 
three mutations in r.he octa motif. This mutant was shown to 
abolish binding by Octl and Oct2 (30) and has a similar dramatic 
effect on binding by Oct6. 
A second conserved elemenr within the promoters of IgH 
genes. the heptamer motif locared 2-22 bp upsrrC!am of the octa 
element. was shown to be a binding site for Octl and Oct2 (5()). 
Two ds oligonucleotides were used to assay binding of Ocr6 to 
the heptamer motif. The result of this experiment is shown in 
fig. 7C. Clearly Oct6 binds to the heptamer element in the 
abs~nce of ;:m intact octamer motif (complex C2). In the presence 
of an intact octamer element a lower mobility complex (Cl) is 
observed indicating that both binding sites are oc-:upied by Oct6. 
To show that the ratio of Oct! and Ocr6 complexes seen with 
the ICP4 probe indeed reflects the different affinities of the two 
proteins for this binding site we performed a binding competition 
assay. Oct! and Oct6 complex formation on the abU octa motif 
was challenged by increasing amounts of cold ICP4 competitor. 
Clearly the ICP4 oligo more efficiently competes out the 
formation of the Oct6 complex than the fonnation of the Oct! 
complex, reflecting a higher affinity of the Oct6 protein for the 
T AATGARA T motif. From this limited survey it is clear that 
Oct6 binds the same sp.:ctrum of binding sites as Oct! but exhibits 
different affinities. 
DISCUSSION 
During early embryogenesis, the totipotent cells of the inner cell 
mass OCM) of the blastocyst embryo become com.iued to specific 
differentiation pathways. Murine embryonic stem cells and 
embryonal carcinoma cells provide a culture system in which 
it is possible to study these early embryonic events. Here we used 
Pl9 EC cells and CCE ES cells to study oetamer binding factors 
that are differentially regulated during differentiation of these 
cells. Several interesting points emerged from this survey. The 
first change that is observed, when EC cells and ES cells form 
aggregates. is the induction of an Oct4-like complex. that runs 
ahead of the Oct4 complex in a bandshift assay. Whether the 
protein present in this foster migrating complex is encoded by 
the same Oct4 gene remains to be determined. 
Second. a flmi.ly of oetamer binding factors is observed during 
neuronal differentiation of Pl9 cells. These additional complexes 
appear in a temporally ordered fashion during the differentiation 
process. suggesting that eaeh of them plays a role in successive 
steps of differentiation. The Pl9 EC cells provide an excellent 
system to study the role of these ocumer fuctors in the 
establishment of glial and neuronal cell lineage and subsequent 
differentiation of these lineages since the different complexes only 
appear in the RA-induced differentiation of P19 EC cells. Of 
parricular interest is the appearrance of the Oct6 complex as it 
is one of the first complexes to be induced in PI9 cells upon 
RA. additon to the culture. This induction is biphasic; the early 
expression is transient but reappears l:ltcr during differentiation 
(dS). suggesting that the protein may play a role in the 
establishmenr of the neuronal differentiation direction (around 
day I of RA induction). as well as in the establishment or 
induction of a more differentiated phenotype (day S). 
Furthermore. the protein is expressed in undifferentiated ES cells 
~nd is do\Vfl regulated upon differentiation of these cells. As a 
first step in defining the diverse roles of the Oct6 protein in these 
different differentiation processes we cloned a eDNA encoding 
the Oct6 protein. Three lines of evidence suggest that we have 
cloned the gene encoding the Oct6 protein. First. the expression 
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pattern of the gene at the RNA level correlates with the expression 
pattern of the Oct6 complex during Pl9 EC cell and ES cell 
differentiation. This correlation is :ilso found in the cell line 
MES68cl2. which has the highest amount of Oct6 protein and 
n1RNA of all cell lines analyzed. Second. in bandshift assays the 
protein expressed from the extended eDNA construct in COS-I 
cells gave the same mobility shift as the endogenous Oct6 protein. 
present in nuclear extracts of differentiating P19 cells. MES68cl2 
or mouse brain. Third, limited proteolytic degradation 
experiments on the protein expressed from the cloned Oct6 gene 
in COS-I cells revealed a pattern of degradation. that is identical 
to the degradation pattem of the endogenous Oct6 protein in 
MES68cl2 cells. 
As anticip:ued. sequence analysis of the cloned Oct6 gene 
revealed the presence of a POU domain within the longest open 
reading frame. The original eDNA clone mbl appeared to miss 
pan of the N-tenninus of the ORF. since both in vitro 
transcription/translation of this clone. as well os expression in 
COS-I cells produced a protein with a higher mobility in a 
bandshift assay than the endogenous Oct6 protein in ES cells. 
Since the mb 1 sequence started at nucleic acid position 155, the 
in frame methionine at amino acid position 51 pi-obably functioned 
as the stan codon in these experiments. Extension of mbl with 
the homologous genomic sequences. supplies two more in frame 
methionine residues (pos. 1 and 23). Because the presented 
sequence encodes 2. proteinof the same size as the endogenous 
Oct6 protein. we favour the first methionine to be the initiation 
codon. since it has a better resemblance to the Kozak sequence 
(42). The genomic extension of the eDNA clone supplied the 
authentic CAP site :o the coru.'trllct. which was used in the COS-I 
cells transfected with this DNA inscned in an SV-40 based 
expression vector. Therefore. the genomic fragment must at least 
contain the minimal promoter of the Oct6 gene. Since the Ocr6 
mRNA measures 3 kb of which the extended eDNA represents 
half the size. in which the CAP site is contained. the 3' 
untranslarcd region is estimated to be 1.5 kb. From the sequence 
it is obvious tbat the eDNA Jacks the poly (A) addition sequence; 
probably eDNA synthesis was primed from an A-rich sequence. 
present in the 3' UTR. 
The DNA binding competition experiments. with an intact and 
a mur.ated octamer sequence clearly showed that imeracrion 
between the Oct6 protein and the probe DNA was mediated by 
the octamer sequence. 
Bandshift assays using different binding sites reveo.led that Oct6 
does not only bind to the consensus ocr.amcr sequence but also 
to such degenerate sites as the T AA TGARA T and the IgH 
heptamer motif. Clearly Oct6 and Oct! differ in their affinity 
for these sites probably reflecting differences in their POU 
domain. The observation that Oct6 has a higher affinity for the 
ICP4 TAATGARAT morif than Octl (7B and D) might have 
important implications for the transcriptional regulation of the 
HSV IE genes. Activation or inactivation of IE gene expression 
is the important step leading to the lytic cycle or a latent sr.ate 
of the virus (53). Activation of IE genes requires the assembly 
of a multiprotien complex on the TAATGARA.T motif conm.in.ing 
Oct!. the viro.l protein Vmw65 and a third cellular factorx(51). 
Critical determinants of Vmw65/0crl imeraction in the Octl 
protein have been mapped to the homeo domain (52). It will be 
very interesting to see whether the Oct6 protein can interact with 
Vmw65 or whether it can efficiently compete with binding of 
the Octl/Vmw65/X complex to the T AA TGARA T motif. Such 
ant:lgonist action may well be involved in the regulation of HSV 
IE genes. 
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Comparison of the Oct6 POU domain sequence with other 
known POU domains revea:ed a 100% identity with the rat 
SCIPffst-1 POU domain (18, 19). The Oct6 protein is probably 
encoded by the mouse counterpart of this rat gene. This is further 
corroborated by the following observations: First. the length of 
the Oct6 transcript is similar tO that of the reponed SCIP/Tst-1 
mRI\"A (18). Second, Southem blot analysis indicated. that the 
Oct6 gene is a single copy gene (data not shown), excluding the 
possibility that the Oct6 protein is encoded by a gene closely 
rdated to the SCIP gene. And third. the expression patterns of 
Oct6 and SCIP overlap. However. an interesting difference exists 
between Oct6 expression in mouse and SCIP expression in rat. 
SCIP/Tst-1 was reported to be expressed in rat testis (19). No 
expression of Oct6 was observed in mouse testis. Such 
interspecies differences in testic•Jiar gene expression have been 
observed for other genes as well. It is of intcre:::.t to note that 
we have detected expression of Oct2 in mouse testis. while He 
et al ( 19) showed that Oct2 is not expressed in rat testis (Meijer 
et _al. u~published results). The reason for these differences is 
emgmat!C. 
Outside the POU domain the protein contains :1 large number 
of (quasi) homopolymeric stretches of n.limitcd number of amino 
acids: alanine, glycine. histidine and proline. Proline rich protein 
domains have been identified in a number of transcription factors 
(6). It was shown that the carboxytenninal prolmc rich pan of 
CfF/NF-1 functions as a tr.msactivation domain (45). By 
extension it is possible that the Oct6 proteJi acts as a transactivator 
and that this function is mediated by its proline rich domain. 
Indeed prelimenary experiments indica(e that the Oct6 protein 
is capable of activating a minimal promoter linked to a synthetic 
enhancer containin!! a mutimerized octamer motif. Whether this 
function is indeed ;nediated by the proline rich domain of Ocr6 
remains to be determined. 
It was shown. that SCIP/Tst-1 is probably involved in the 
differentiation of PNS and CNS glial cells into myelinating 
Schwann cells and oligodendrocytes (18). Funhennore, in situ 
hybridiz:J.tion data indicated. that SCIP/Tst-1 is also expressed 
by a restricted set of neurons in the adult brain. as well as in 
different regions of the developing ner:ous system during 
embryogenesis (19). Since we used nuclear extracts from whole 
populations of differentiating PI9 cells. we cannot assign any 
of the observed oct:uner factors to individual cell typeS. However 
in differentiating Pl9 cells the main type of glial cells that arc 
formed arc astrocytes. No myclinating cells were found to be 
present (38). This suggests that expression of Oct6 in 
differentiated PI9 cells represents expression in neuronal cells. 
Recently, we have cloned the complete Oct6 gene from a mouse 
genomic library. This will enable us to study the regulatory 
sequences of the gene. that direct expression in the different cell 
lineages. Construction of an Oct6 promoter driven marker gene 
will funher enable us to study the precise temporal expression 
in individual cell types. in relation to different differentiation 
markers. Funher studies will aim at the identification of target 
genes of the Oct6 protein and on the regulation of the Oct6 gene 
itself. 
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Chapter VII 
Mapping the transactivation domain of the Oct6 
POU transcription factor. 
Dies Meijer, Anneke Graus and Gerard Grosveld 
Department of Cell Biology and Genetics, Erasmus University, Rotterdam, 
the Netherlands 
ABSTRACT 
The POU transcription factor Oct6 is expressed in embryonic stem ceJis, glial progenitor ce!ls 
and in a restricted set of neurons in the CNS. The protein has been shown to act as a 
transactivator as well as a repressor. Here we show that the Oct6 protein activates 
transcription from three different promoters in He!a cells. The ability to activate a minimal tk 
promoter via a mu!timerized lgH enhancer octamer motif relies on a domain within the amino 
terminal third of the protein. Parts of this domain can be deleted without abolishing 
transactivation, suggesting that there is functional redundancy within this region. The 
transactivation domain of the Oct6 protein is different from other described activation domains 
in that it is highly glycine and alanine rich. 
INTRODUCTION 
The octamer motif (ATGCAAAT) is a well studied DNA motif present in 
enhancers and promoters of both ubiquitous and cell type specific expressed 
genes [ 1, 2, 3]. This DNA element was shown to be a binding site for a 
family of nuclear proteins present in different cell types and at different 
stages of mammalian development [ 4, 5]. A number of these proteins are 
believed to be involved in determining cell fate through selective regulation 
of target genes. The cloning of different cDNAs encoding several of these 
octamer binding factors revealed that they belong to the POU domain gene 
family [6-13]. This family was defined by a region of extensive sequence 
homology (the POU domain) between three mammalian transcription factors 
(0ct1, Oct2 and Pit1 /GHF1 I and one nematode regulatory protein (Unc86; 
[14] and references therein). The POU domain constitutes the DNA binding 
domain of these proteins and can be subdivided in two regions, separated by 
a short linker [1 0, 12, 15, 16]. The carboxyl terminal part shows homology 
with the classical homeobox proteins (the POU"0 Domain), while the amino 
terminus contains a homology specific for this class of proteins (the POU5 
domain). 
Oct6 was originally defined as an embryonic stem cell specific octamer 
binding factor [4]. Differentiation of these cells in vitro leads to a 
downregulation of the Oct6 protein. However in undifferentiated P19 EC 
cells the Oct6 gene is expressed at very low levels. The gene is transiently 
upregulated when these cells differentiate into neuronal cell types after 
aggregation and addition of retinoic acid to the culture medium. Expression 
increases again after several days of induction, indicating that the protein 
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plays a role in different stages or cell types during neuronal differentiation 
[7]. 
Cloning and sequencing of cDNAs encoding the Oct6 protein revealed 
that the Oct6 gene is the mouse homologue of the rat SCIP\Tst-1 gene [17]. 
The SCIP gene is highly expressed during glial cell development in the 
peripheral and central nervous system. It has been shown that the SCIP 
protein functions as a repressor of meylin specific genes during a period of 
rapid cell division that seperates a premyelinating from a myelinating phase 
in Schwann cell development [ 18]. Furthermore, using a PCR based 
approach, a partial Oct6/SCIP was cloned from neonatal rat testis which was 
named Testes-1 (Tst-1 [19]). Using in situ hybridization it was shown that 
the Oct6/SCIP/Tst-1 gene is also highly expressed in discrete regions of the 
developing nervous system [13, 19]. The Oct6 protein was shown to 
function as a positive as well as a negative regulator of transcription 
depending on the exact promoter architecture [13, 18, 20]. 
Here we show that high level ectopic expression of the 0 ct6 protein in 
H ELA cells can activate transcription from three different promoters. Using 
a series of Oct6 deletion mutants we show that the transactivation domain 
of the protein is located in the first 157 amino acids and is distinct from its 
DNA binding domain. This domain, which is extremely glycine and alanine 
rich, can be subdivided in at least two active subdomains. 
RESULTS 
Oct6 transactivates a variety of promoters when ectopically expressed in 
HELA cells. 
To study the transactivation potential of the Oct6 protein we used three 
different promoter constructs. A simplified promoter in which the octamer 
is located 20 bp upstream of the rabbit ,6'-globin TATA box (pji'O+Cat in 
Figure 1 A) driving a CAT reporter gene. An almost identical promoter 
construct was shown to constitute a B-Cell specific promoter [8, 21 ]. This 
promoter could be readily activated by ectopically expressed Oct2A, Oct4 
and Oct6 proteins [8, 13, 22]. Transcription from this promoter was shown 
to be dependent on an intact octamer motif. A second promoter construct 
consists of a minimal HSV-1 TK gene promoter flanked by a multimerized lgH 
enhancer octamer/J1E4 motif (6WtkCat; [23, 24]). This type of enhancer was 
shown to be at least 1 000 fold more active than its mutated counterpart in 
EC cells (6FdtkCAT in which only the octamer box was mutated;[24]). In this 
particular arrangement the closest octamer motif is 14 7 bp separated from 
the tk TATA box. A third promoter used in this study is the Herpes Simplex 
Virus 1 ICP4(1E175K) gene promoter [25]. This promoter contains one 
TAATGARAT motif at position -260 and a second related motif 
(TAATGGAAT) at position -11 0. The distal TAATGARAT motif of the ICP4 
promoter has been shown to be a strong binding site for Oct6 wheras it is 
a weak binding site for Oct1 [7]. The reporter constructs are schematically 
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depicted in Figure 1 A. In order to express the Oct6 protein in HELA cells the 
Oct6 eDNA was cloned in a CMV promoter/enhancer based expression 
vector ([26]; see M&M for details). The Oct6 expression vector and the 
different CAT reporters were co-transfected in different combinations in 
HELA cells. Reporter gene expression was measured by CAT assays [27]. 
Expression of the Oct6 protein was monitored by a bandshift assay (not 
shown). 
As can be seen in Figure 2A Oct6 activates the simple PO+ promoter 
confirming earlier reports [ 13]. Furthermore this activation is dependent on 
an intact octamer motif (compare lane 2 with lane 5). The same promoter 
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-300 -200 -100 
t~pBO.CAT 
6 x ~E4/0CTA 
6WtkCAT 
TAATGAGAT TAATGGAAT 
--cfoo-o-r'~~piCP4CAT 
' OCTA box 0 TATA box V GCCAAT box 0 GC box 
B 
Oct6 SV40 ori 
CMV/TK 
IVS2-B 
Figure 1. A. Schematic representation of the reporter plasmids used in this study. The 
reporter gene is the bacterial Cloramphenicol Acetyl Transferase gene (CAT). The 
6WtkCAT and the !CP4CAT construct do not contain additional enhancers downstream 
of the CAT gene. The scale bar above the drawing indicates the position (in basepares) of 
the cis-acting elements relative to the transcriptional start site (arrow). 
B. Structure of the Oct6 expression vector. 
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could be activated by Oct2A (lane 4 and [8]) and a chimaeric protein 
POU!VP16. This chimaeric protein consists of the Oct6 DNA binding domain 
(POU domain) coupled to the VP16 transactivation domain ([28, 29];see 
M&M) and is a strong transcriptional activator (see also Figure 4, lane 15). 
Although this promoter construct is clearly responsive, the absolute levels 
of expression are rather low. 
In a second set of transactivation experiments we used the 6WtkCAT 
reporter and its mutated counterpart 6FdtkCAT. Clearly Oct6 is able to 
transcativate the tk promoter via the JgH octamer motif (fig 28, lane 1 and 
2) This results contrasts with an earlier report by Suzuki et a!. [13] who 
reported that the Oct6 protein is not able to activate this reporter (see 
discussion). Furthermore, the HSV1 ICP4 promoter is also strongly induced 
by Oct6. Thus the Oct6 protein is able to activate transcription via octamer 
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Figure 2. A. Oct6 activates transcription from a simple octamer/TATA promoter. The 
expression vectors p0ct6, pPOUNP16 and Oct2A and reporter plasmids were 
cotransfected into Hela cells as indicated. The structure of the Oct6 expression vector is 
outlined in figure 1. The structure of the POU/VP16 vector is described in Materials and 
Methods. The Oct2A vector is described in [8}. When no expression vector is indicated the 
reporter plasmid is cotransfected with an equal amount of the empty expression vector 
pEVRFO. B. Oct6 activates also more complex promoters. 
The Oct6 expression vector (see figure1 l was cotransfected w·lth CAT reporter plasmids 
as indicated. Reporter constructs are as outlined in figure 1. The 6Fdtk promoter construct 
is the mutated counterpart of the 6Wtk promoter [241. The RSVCAT construct serves as 
positive control, in which the CAT gene is driven by the strong Rous Sarcoma Virus 
promoter. 
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and octamer related sequences in different promoter settings. 
Transactivation by ectopically expressed Oct6 is not restricted to Hela cells. 
In an earlier report by Suzuki eta!. it was shown that Oct6 is not able to 
activate transcription from a distal position (with respect to the transcription 
initiation site) when expressed in He Ia cells [ 13]. Similar findings were 
reported tor the B cell specific Oct2A and the stem cell specific Oct4 
proteins [22, 30]. One explanation for the ability of Oct6 to activate 
transcription from a more distal position in the experiments presented here 
is that our Hela cell line contains factors that are missing in their particular 
line or that our cell line misses factors that otherwise would prevent 
transactivation. To test this possibility we performed transactivation 
experiments using the 6WtkCA T reporter in cell lines of different origin. The 
MES cell line is stable derivative of the P19 EC cell line. and CHO is a 
Chinese Hamster Ovarian cell line. As can be seen in Figure 3 Oct6 activate 
the 6WtkCA T reporter gene in all three cell lines tested, indicating that there 
are no qualitative differences between the cell lines with respect to 
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Figure 3. Oct6 transactivates the 6Wtk promoter in different cellular backgrounds. MES, 
CHO and Hela cells were transfected with the expression and reporter plasmids as 
indicated. CaP04 /DNA precipetates were prepared as described and split into three 
portions and applied to the different cells. 
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supporting transactivation. However there are clear quantative diferences in 
the level of activation in the different cellular backgrounds. Transfection 
efficiency and levels of activation are highest in Hela cells. Therefore this cell 
line was chosen for mapping of the transactivation domain of the Oct6 
protein. 
Deletion mapping of the Oct6 transactivation domain. 
In order to map the domain(s) of Oct6 involved in transactivation, a set of 
progressive amino terminal and carboxyl terminal deletions was constructed, 
using natural restriction sites in the Oct6 gene [7]. These truncated cDNAs 
were cloned in frame into CMV/enhancer based expression vectors [26]. All 
mutant Oct6 proteins have an intact POU domain. To test whether the 
different deletion constructs encode stable proteins that bind to the octamer 
motif and are localized in the nucleus, plasmids were transfected into COS-1 
cells. The expressed mutant Oct6 proteins were assayed in a bandshift 
experiment using nuclear extracts from the transfected COS-1 cells and a 
radiolabelled OCTA probe. All constructs express Oct6 mutant proteins of 
the expected size at high levels. These proteins appear to be stable and are 
located in the nucleus (data not shown). 
The transcriptional activation potential of the mutant Oct6 proteins was 
tested in cotransfection experiments with the 6WtkCA T reporter plasmid in 
Hela cells and quantative CAT assays (Figure 4, see also Figure 6). To 
exclude the possibility that differences in CAT activity are due to different 
levels of Oct6 mutant proteins, the amount of protein was estimated in a 
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Figure 4. A. Transactivation of the 6Wtk promoter by truncated Oct6 proteins. Hela cells 
were transfected with the 6WtkCAT reporter plasmid and the different expression vectors 
as indicated except for lane 2 were the reporter plasmid is the 6FdtkCAT construct. Lane1 
shows the basal level of expression of the 6WtkCAT construct (cotransfected with the 
empty expression vector pEVRFO). The structure and the relative transactivation potentials 
of the different Oct6 mutant proteins is outlined in figure 6. B. Bandshift assays with 
whole cell extracts of a fraction of Hela cells transfected with the different truncated Oct6 
proteins. 
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bandshift assay using whole cell extracts of transfected He! a cells. As can 
be seen in Figure 48 all mutant proteins are expressed at a comparable high 
level except for POU/VP16. The fusion of the VP16 transactivation domain 
to the Oct6 POU domain appears to result in a labile protein or alternatively 
influences its DNA binding affinity. Nevertheless, this chimaeric protein is a 
strong transcriptional activator. As can be seen in Figure 4A high level 
expression of Oct6 results in 30-50 fold induction of the 6Wtk promoter 
(compare lane 1 and 3; the percentages conversion obtained in these 
experiments are given in Figure 6). This activation is dependent on an intact 
Octa motif within the 6W enhancer as this stimulation of CAT expression is 
not observed with the mutant version of this promoter (lane 2). Deleting the 
first 11 5 amino acids does not reduce the ability to activate the 6Wtk 
promoter. Although expression of mutants N23 and N44 resulted in a slightly 
lower transcactivation level, the mutants N97 and N 11 5 showed wild type 
activity. Further deleting the Oct6 protein to amino acid 143 resulted in a 
drop of activity to approximately 30% of the wild type level. Deleting beyond 
a.a. 157 completely abolished transactivation. This maps a minimal region 
required for transactivation between amino acid 11 5 and 157, which is rich 
in glycine and alanine residues (19 Gly + Ala). However, this feature is not 
characteristic for this domain, as the entire Oct6 protein is extremely rich in 
glycine and alanine residues, apart from its POU domain. Therefor other 
features than just a high glycine and alanine content must be involved in 
mediating transactivation. 
The Oct6 protein domain carboxyl terminal of the POU domain is rich in 
proline residues ( 13 out of 52). Proline rich transactivation domains have 
been described for a number of transcription factors. However no such 
function can be ascribed to this part of the Oct6 protein as the amino 
terminal deletion mutants N157 to N229 all contain this domain but fail to 
transactivate. Furthermore, the N2C52 deletion mutant in which the entire 
carboxyl terminal domain is removed shows a wild type level of 
transactivation. The POU domain by itself (N229C52) even seems to repress 
basal level of expression (compare lane 14 with lane1 ). 
The experiments described above mapped a minimal transcriptional 
activation domain between amino acid 115 and 157. To check whether this 
domain is required and sufficient tor transactivation or whether there is some 
functional redundancy within the amino terminal third of the protein, a small 
set of internal deletion mutants was constructed and tested for its ability to 
transactivate the 6Wtk promoter. The results of this experiment is shown in 
Figure 5A, while the internal deletion mutants are schematically depicted in 
Figure 6. Surprisingly all internal deletion mutants transactivate the 6Wtk 
promoter albeit at a lower level than the full length Oct6 protein. The level 
of the 1'.94/232 and 1'.11 6/230 proteins is lower than that of the other 
deletion mutants. This was consistently observed in a number of transtection 
experiments, which might indicate a lower stability of these mutant proteins 
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Figure 5. A. Transactivation of the 6Wtk promoter by Oct6 internal deletion mutant 
proteins. Hela cells were cotransfected with the 6WtkCA T reporter plasmid and the 
different expression plasmid as indicated except for lane 1 were the reporter is the 
6FdtkCAT plasmid. The structure and the relative transactivation potential of the different 
Oct6 proteins is depicted in figure 6. B. Bandshift assays with whole cell extracts of Hela 
cells transfected with the different Oct6 mutant proteins. 
{note the smear in lanes 5 and 6 in Figure 5, right panel) leading to 
underestimating the transactivation potential of the mutant proteins. As 
expected, internal deletions in the first 98 amino acids {L\.23/44; lane 3 and 
L\.23/97; lane 4) did not abolish transactivation as these proteins retain the 
domain between a.a. 115 and 157. However, neither deletion of aa 95 to aa 
231 {lane 5) nor smaller deletions in this region {L\.116/230; lane6 and 
L\.144/197; lane 7) resulted in a complete loss of transactivation. 
Thus, the combined analysis of the N terminal and internal deletion 
mutants suggest that the entire amino terminal third of the protein is 
involved in transactivation and can be split up in functionally redundant 
subdomains. 
Interestingly, this amino terminal region contains a long stretch of alanine 
residues {9) that is polymorphic. The Oct6 eDNA cloned by Suzuki et a/. 
encodes an Oct6 protein with a stretch of 8 ala residues and the rat Oct6 
homologue SCIP has 11 ala residues at this position [13, 18]. The alanine 
stretch is located in a large region that is likely to adopt an a helical 
structure. 
DISCUSSION 
The six times repeated lgH enhancer octamer element {6W) was shown to 
strongly enhance transcription from the linked HSV tk promoter in ES and F9 
EC cells. These cells express three octamer binding factors; Oct1, Oct4 and 
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Oct6 [24]. The Oct4 and Oct6 factors are downregulated upon 
differentiation. At the same time the 6W enhancer is extinghuised in these 
differentiating cells, implicating either of the two or both factors in enhancer 
function. However ectopic expression of Oct4 in Hela cells failed to activate 
the tk promoter via the 6W enhancer. In contrast with the results presented 
here, Suzuki et a!. reported that also Oct6 is not able to activate the 6W 
enhancer in Hela cells whereas it activates a simple OCTA/TATA promoter 
(this promoter is similar to the ppo• promoter used here; Figure 2;[13]). It 
is unlikely that this discrepancy is due to intrinsic differences in the cell line 
used, as we show that high level expression of Oct6 results in the activation 
of the 6Wtk promoter in different cell lines. More likely these differences are 
due to differences in the levels at which the effector protein is expressed. It 
is possible that only high levels of Oct6 effectively compete for binding with 
the endogenous Oct1 protein and stimulates transcription in Hela cells. Thus 
our results suggest that the Oct6 protein could play a role in stimulation of 
transcription of several gene promoters in EC/ES cells. 
One of the aims of this study was to localize the domain(s) in the Oct6 
protein involved in the transactivation function of this protein. First we 
tested the responsiveness of three different promoters to high levels of Oct6. 
The three promoters used are different with respect to the number and the 
exact sequence of Oct6 binding sites, the distance of these sites to the 
TA TA box, and the nature, number and position of other cis-acting elements 
(see Figure 1 ). All three promoters can be activated by coexpression of Oct6. 
Thus in our test system Oct6 can activate transcription from octamer and 
octamer related sequences in different promoter/enhancer settings. To 
determine which part of the Oct6 protein is involved in this function we 
constructed a series of deletion mutants of the Oct6 protein that were tested 
for their capicity to stimulate transcription from the 6Wtk promoter. All 
deletion mutants have an intact POU domain and thus retain the ability to 
bind the octamer motif. The data from the Oct6 deletion analysis indicate 
that the transactivation function is located in the amino terminal third of the 
protein. The entire activation domain is extremely rich in glycine and alanine 
residues and is composed of multiple, functionally redundant, subdomains. 
Protein domains have been determined, involved in the transactivation 
function of a large number of transcription factors. There are no apparent 
structural similarities between these domains, although they can be roughly 
classified as being particularly rich in certain amino acids (see [31] and 
references therein). As far as data are available, the transactivation domains 
of the POU proteins are either glutamine- (0ct1) glutamine/leucine/proline-
(0ct2), proline- (0ct3/0ct4) or serine/threonine-rich (Pit1/GHF1) [9, 16, 30, 
32-35]. The transactivation domain of the Oct6 protein would form a new 
class, being glycine- and alanine-rich. 
Interestingly, the proline rich region carboxyl terminal of the POU domain 
is dispensible for Oct6 to activate the 6Wtk promoter, suggesting that a high 
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concentration of a particular amino acid residue is not enough to make up an 
activation domain. This is also illustrated by the fact that the region between 
aa 157 and 229 of the Oct6 protein is also rich in glycine and alanine 
residues but does not activate transcription. A direct approach to address 
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Figure 6. Structure and transactivation potential of the Oct6 deletion mutants used in this 
study. The naming of the different mutants reflects the number of co dons removed from 
the Oct6 ORF either from the aminoterminus {N) or the carboxyterminus (C). The 
construction of the different expression plasm ids is detailed ·In Materials and Methods. The 
N2 Oct6 protein is considered to be the wild type protein. The POU-specific and the 
POU-homeodomain are indicated by shaded boxes. The relative transcriptional activation 
of the 6Wtk promoter by the different mutant proteins is indicated. The percentage 
acetylation refers to the percentage of acetylated forms of chloramphenicol in the 
experiments presented in figure 4 and 5. CAT activity in extracts of the 6WtkCAT 
transfected cells is 2% (lanes 1 in figure 4 and 5). A. Structure of theN- and C-terminal 
Oct6 mutant proteins. B. Structure of internal deletion mutant Oct6 proteins. The portion 
of the Oct6 protein deleted is indicated by the number of the codons at which the ORF is 
fused. C. Structure of the Oct6 protein, highlighting the domain involved in transcriptional 
activation and DNA binding (the POU domain; PO Us and POUH 0 ). 
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this issue for the Oct2 protein has been reported by Gerster et al. [35]. The 
amino terminal transactivation domain of the Oct2 factor is characterised by 
a high content of glutamine, leucine and proline residues. The analysis of 
substitution mutants of subdomain I in which the glutamine residues were 
replaced by asparagine or the leucine residues by isoleucine showed a drastic 
reduction in transactivation potential. Thus the particular arrangement and 
interaction with other residues are critical for the activation function of this 
domain. 
The transactivation domains of the Oct6 and Oct4 factors belong to 
different classes (being glyc/ala rich and pro rich respectively). This might 
indicate that Oct4 and Oct6 interact with different components of the basic 
transcription apparatus or alternatively that they interact with different 
socalled coactivators associated with theTA T A box binding protein(TBP;[36] 
see also [37]. Thus taking into account the interaction with other DNA 
binding proteins and the differences in affinity between the two proteins for 
different octamer binding sites it is likely that the two octamer factors 
regulate different sets of genes in ES/EC cells. 
The importance of interactions between octamer factors and other 
transcription factors is illustrated by the observation that the octamer motif 
can also mediate repression of transcription in F9 EC cells [38]. Obviously 
the sequence context of a cis-acting element is highly critical. Several 
mechanisms can be envisaged by which transcription factors can function 
as repressors (see [39]), one of which is competetive binding. For instance 
the SV40 B element consist of two directly repeated Sph motifs of which 
the junction forms an octamer binding site. Both Sph motifs are required for 
enhancer function in Hela cells, while high level expression of Oct1 or Oct2 
represses the activity of the Sph motif via competetive binding [33]. 
The rat homologue of Oct6, SCIP is expressed at high levels in 
proliferating Schwann cells [17]. The expression of SCIP/Oct6 seems to 
antagonize the expression of glial specific genes like MBP and P0 [18]. 
Transfection of a SCIP/Oct6 expression vector into cultured Schwann cells 
results in the downregulation of cotransfected MBP, P0 and NGF-R 
promoters. These results indicate that the SCIP/Oct6 protein serves as a 
negative regulator of Schwann cell specific genes. Significantly 
downregulation of the P0 promoter by SCIP was also observed when 
cotransfected in the monkey cell line CV-1, indicating that no Schwann cell 
specific components are needed to downregulate this promoter [20]. The P0 
promoter contains five SCIP/Oct6 binding sites that are remotely related to 
the octamer motif. One of the weaker binding sites overlaps with the P 0 
T A TA box. It was suggested that this binding sites serves as a negative 
element for SCIP/Oct6 regulation of P0 gene transcription through a 
competition mechanism [20]. It is not known whether the POU domain of 
SCI P/Oct6 suffices for repression of the P 0 promoter or that in addition other 
domains of the protein are required for this function. It is of interest to note 
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here that a domain capable of mediating repression in He/a and CV-1 cells 
has been identified in the Drosophila Kruppel protein. It was shown that a 
N-terminal alanine rich domain of this protein fused to the DNA binding 
domain of the lac repressor can repress transcription of target genes 
containing lac operator sequences [ 40]. Such an alanine rich region can also 
be found in the Drosophila transcriptional repressors engrailed and 
evenskipped. Similarly, alanine rich domains are present in the Oct6 protein 
interwoven with the transcriptional activation domains as determined in this 
study. It is possible that these regions in the Oct6 protein are also involved 
in mediating repression of glial cell specific genes. 
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MATERIALS AND METHODS 
Construction of Oct6 deletion mutants. 
Deletions of the Oct6 eDNA were created using naturally occuring restriction sites. The different 
deletion constructs were cloned in frame into the CMV based expression vectors pEVRFO, 
pEVRF1, pEVRF2 or pEV3S [26]. These vectors allow expression of N terminally deleted 
proteins as an in frame fusion product with the first four amino acids of the HSV tk protein. 
Cloning of the full length Oct6 eDNA in pEVRFO using the Bal1 restriction site in effect results 
in a protein that has 7 amino acid residues inserted between aa 2 and aa3 as compared to the 
wildtype protein. The first two aa encoded by the tk reading frame are the same as in the Oct6 
reading frame. This expression plasmid is referred to as clone pN20ct6 or Oct6 in Figure 2. The 
N stands for a N terminal truncation and the number following the N refers to the number of 
codons removed from the Oct6 open reading frame. The C stands for a carboxyl terminal 
truncated protein and the number following the C indicate the number of co dons removed from 
the carboxyl terminus of the Oct6 protein. The translated linker sequence of the truncated 
clones is as follows: N2, MASWGSGTP; N23. MASWGSGTL; N44, MASWGSGTH; N97, 
MASWGSGVP; Nll5, MASWGSGTL; N143, MASWGSGVP; N157, MASWGSGTH; N182. 
MASWGSGT; N197. MASWGSGVP; N229, MASWGSGY. The chimaeric clone POU/VP16 was 
constructed by replacing the 3' part Oct6 eDNA from the Sac! I to the Xbal site (encoding the 
51 aa carboxyl terminus of Oct6l in clone N229 for the 3' part of the HSV1 Vmw65 (VP16) 
gene. In this way the Oct6 POU domain is fused to the 80 aa carboxyl terminus of the VP16 
protein. This part of the VP16 protein is a strong transactivator I29]. Internal deletion mutants 
were made by excising part of the Oct6 open reading frame in clone pN20ct6. The numbers 
represent the codons at which the Oct6 ORF is fused. All fusion points were checked by 
dideoxy sequencing. All deletion constructs were tested by expression in COS cells. Using 
nuclear extracts of transfected COS cells in a bandshift assay indicated that all mutants were 
stable, bind to the octamer sequence with high affinity and were located in the nucleus. 
Reporter plasmids 
The reporter plasmids 6WtkCAT and 6FdtkCAT are described in detail in [221 and were a kind 
gift of Or Hans SchOler. The ,BOCTA promoter was constructed by PCR amplification using a 
5' sense oligo containing an OCTA box or a mutated version thereof and a 3' anti-sense oligo 
mapping in front of the rabbit ,8-globin start codon. A genomic subclone in pBR327 containing 
88 
the entire rabbit,B-globin gene was used as a template. 5' sense oligo, GCGGATCCATTTGCAT-
TACATAGTTCAGGACTTGG; 3' ant;-sense ol;go, GCGCTCGAGTCTGTTTTGGGGGA TTGC The 
amplification products were cloned in front of the CAT gene in p8LCAT3 [231. The integrity of 
the po+ and po· promoter constructs were checked by dideoxy sequencing. The full sequence 
of these promoters ;s as follows; GGA TCCA TTTGCA TT ACA T AGTTCAGGACTTGGGCA T AAAA-
GGCAGAGCAGGGCAGCTGCTGCTTACA 
The 1CP4 CAT (1E175CAT) construct was a kind gift of Dr Peter O'Hare. This construct 
contains the 1E175 (!CP4l promoter from -330 to + 20 [25, 41 ]. 
cell transfections 
Using the CaP04 precipetate method, Hela, MES or CHO cells were transfected with 5 pg of 
reporter plasmid and 2.5.ug of Oct6 expression vector (or with 2.5pg of the empty expression 
vector pEVRFOJ and 12.5 .ug of pTZ19 plasmid DNA as carrier [27]. Transfected cells were 
harvested 48 hrs after removal of the CaP04 precipetate. Eighty percent of the cells were used 
to prepare cell extracts for a CAT assay and the remaining 20 % was used to prepare whole 
cell extracts for monotoring Oct6 protein expression in a bandshift assay. CAT assays were 
performed with equal amounts of protein (20 pg). Acetylated and non-acetylated forms of 14C 
labeled chloramphenicol were seperated using standard thin layer chromatography. The ratio 
between acetylated and non-acetylated forms of chloramphenicol were calculated aher 
quantitation of the signals using a Molecular Dynamics Phosphorimager. 
Bandshift experiments and whole cell extracts 
Whole cell extracts of transfected Hela cells (20%; see above) were prepared by resuspending 
the cells in 40 ,ul of 20mM Hepes-KOH pH7 .9, 400mM KCI, 1 mM EDTA, 10% glycerol, 1 OmM 
OTT, 1mM PMSF, 5pg/ml !eupeptin, 5pg/ml pepstatin and 10pg/ml chymostatin.Resuspended 
cells were subject to 4 cycles of freezing in liquid nitrogen and thawing on ice. The cellular 
debris was removed by centrifugation at 14000g for 5 minutes at 4°C. Equal amounts of 
cellular extract were used in a bandshift assay using 3 fmol of a 32P endlabelled double stranded 
OCTA probe. Probe and protein were incubated on ice for 20 minutes in 20 mM Hepes-KOH 
ph7.9, 1mM EDTA, 1 mM EGTA, 4% Ficoll in a total volume of 20 .ul. Complexed and free 
probe were seperated on a 4% polyacrylamide gel in 0.25 x TBE. 
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The mouse Oct6 gene and its regulatory 
sequences. 
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ABSTRACT 
The gene encoding the POU factor Oct6 is expressed in embryonic stem cells, during early 
development of the nervous system, in a subset of neuronal cells and in glial cells of the central 
and peripheral nervous system. Here we describe the genomic organization of the Oct6 gene 
and a preliminary characterization of the promoter of the gene. The Oct6 gene is a single exon 
gene that generates a 3 kb mRNA. The promoter and the entire protein coding part of the gene 
are located in a CpG island.The chromatin structure of the Oct6 gene promoter region is 
ONAasel hypersensitive in ES ce!ls, but not in non-expressing MES cells. The Oct6 promoter 
is a typical cell type specific promoter in that it contains a TATA and CCAAT box at canonical 
distances from the transcriptional initiation site. From transient transfection experiments it is 
tentatively concluded that the promoter region does not contain all the information for cell type 
specific expression but that additional downstream sequences are required for this. 
INTRODUCTION 
The POU domain gene family is defined by a bipartite DNA binding domain 
which is composed of a class specific homeo box and a POU specific domain 
([1] and references therein). Members of this class of proteins have been 
implicated in cell fate determination through selective regulation of target 
genes [2, 3, 4]. For example the mouse Pit-1 gene has been shown to be 
mutated in two different alleles of the mouse dwarf locus [5]. These 
mutations interrupt the normal development of the anterior pituitary gland 
which results in the loss of expression of growth hormone, prolactin and 
thyroid-stimulating hormone and hypoplasia of their respective cell types. 
Other members of the POU domain family for which no genetic data are 
available are supposed to be involved in cellular differentiation processes 
mainly on the basis of a restricted expression pattern during development 
and by association. A number of POU proteins bind with high affinity to the 
octamer sequence (ATTTGCAT), which constitutes a strong enhancer 
element in embryonic stem cells and B lymphocytes [6, 7]. One of these 
POU proteins, Oct6; also called SCIP and Tst-1, is expressed in 
undifferentiated embryonic stem cells, in early embryonic and adult neuronal 
cells and in glia cells of both the central as well the peripheral nervous 
system [8-12]. In Schwann cells the Oct6 gene is highly expressed during 
a phase of rapid cell division that separates a premyelinating from a 
myelinating state [13]. Expression of the Oct6 gene correlates with the 
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negative regulation of a number of Schwann cell specific genes. Indeed 
cotransfection analysis has shown that the Oct6 protein can repress 
expression from the P 0 promoter in non glial cells, while other promoters can 
be activated [ 1 2, 14, 1 5]. Thus the protein can either act as a positive or 
negative regulator of gene expression. An important question is how these 
cell type specific transcription factors themselves are regulated during 
development and homeostasis. As a first step towards understanding the 
regulation of the Oct6 gene we describe here the genomic organization of 
the gene and its promoter. The Oct6 gene is a single copy, single exon gene 
in the mouse genome. The protein coding part and the promoter are part of 
a CpG island. The promoter region of the gene is associated with a DNAasel 
hypersensitive chromatin structure in ES cells but not in the non-expressing 
MES cells. Transient transfection assays using 5' truncated promoter 
deletion mutants driving the bacterial CAT reporter gene identified an 
important element upstream of the CCAAT box. However these promoter 
constructs were equally active in cells expressing or not expressing Oct6, 
suggesting that additional regulatory elements are missing from these 
promoter constructs. 
RESUlTS 
Cloning of the mouse Oct6 gene. 
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Figure 1. Genomic map of the mouse Oct6 gene. 
- ~ ~I 
II 
A. Schematic representation of the one lambda clone out of ten that was further analysed. 
This clone contained a 18 kb genomic fragment generated by partial Sau3A digestion of 
total genomic mouse DNA cloned in the BamHI site of the AEMBL3 phage. The Sail sites 
are part of the phage and flank the Bam HI cloning site. 
B Detailed restriction map of the 6.4kb EcoR! fragment derived from AMBi-4. The eDNA 
sequence is aligned with the genomic clone to show that they are co linear over the entire 
length of the eDNA. The EcoRI sites in the Oct6 eDNA represent artificial cloning sites. 
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Clones were isolated by screening of an EMBL3 mouse genomic library at 
high stringency with an Oct6 eDNA probe (300bp Pvull fragment covering 
the POU domain). Ten strongly hybridizing clones were plaque purified in a 
second screening. Two of these clones were further analyzed by restriction 
mapping (Figure 1 A). Hybridization of restriction fragments of the larger of 
the two genomic clones with a 1.4kb eDNA clone (covering 95% of the 
Oct6 open reading frame) revealed that the entire eDNA sequence was 
present on a 6.3kb EcoRI fragment and is not interrupted (data not shown, 
see Figure 1 B). This fragment was subcloned in the plasmidvector pTZ18. 
The size of this EcoRI fragment corresponds with that of the Oct6 eDNA 
hybridization signal on genomic Southern blots, indicating that we have 
isolated the Oct6 gene and not a pseudogene or other closely related PO U 
domain gene (see Figure 4). 
The _6.3kb EcoRI fragment contains all of the Oct6 coding sequences. 
The Oct6 gene expresses a 3 kb mRNA in ES cells, brain and Schwann cells. 
As the longest eDNA molecule we isolated is 1 .4 kb, additional coding 
information must be present in the 6.3kb EcoRI fragment or flanking 
fragments. Previously we have shown that the 5' part of the open reading 
frame plus 5 ' UTR is contained within a 450bp Saci/Kpnl fragment 
A pc0ct6 
SV40 or! 
IIIII!~"'""" 
p, 
B pg0ct6/sv 
...... ~--...l.I..J.I ,'*c'±····::::lll'"mloo--..L--....IIll ___ ji, ...... 
Po 
pg0ct6/Py 
ti ~ 
......... ~::::llllmiililWo--.l---.JIJ.I __ ___.!..,..,, 
Figure 2. Schematic representation of Oct6 expression vectors 
A. pc0ct6. The Oct6 eDNA {see figure 1 l was extended at its 5' end by linking the 
genomic Saci/Kpnl fragment to the Kpnl site. This extended eDNA was cloned as a Sac! 
fragment in the pcDX vector in the opposite orientation with respect to the SV40 early 
promoter {Pel/origin of replication (SV40 ori). Transcription termination and 
polyadenylation signals on both strands are derived from the SV40 genome (SV40 pA). 
B. pg0ct6/sv and pg0ct6/Py. The genomic 6.4 kb EcoR! fragment was cloned downstream 
of the SV40 promoter/ori fragment that is derived from pcDX. No SV40 termination and 
po!yadenylation sequences are present. The pg0ct6/Py clone was constructed by linking 
the genomic Saci/EcoRl fragment to the polyoma virus PyF441 enhancer fragment. The 
enhancer fragment is derived from the pMC1 neoPolyA plasmid [31 ]. 
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immediately flanking the eDNA homologous region. To prove that this 
fragment also contains the minimal promoter region of the Oct6 gene we 
designed a functional assay. The 1.4kb Oct6 eDNA (mb1 in chapter VI) was 
extended by fusing the eDNA with the genomic fragment on the Kpnl site, 
and this construct was cloned in the SV40 based expression vector pcDX 
([16], called pc0ct6 in Figure 2 and 3). The orientation of the Oct6 insert is 
antisense with respect to the SV40 early promoter. Thus expression of a 
functional Oct6 protein only occurs when the Saci/Kpnl fragment contains 
promoter activity (see Figure 2 for details). Two transcripts are expected to 
be generated; one antisense RNA of 1 .9kb transcribed from the SV40 
promoter and one sense transcript of approximately 5kb transcribed from the 
putative Oct6 promoter. The pc0ct6 construct was transfected into COS 
cells and expression was monitored in a gel retardation assay and by 
northern blotting (Figure 3A and 8). As can be seen in Figure 3A, lane 1, 
transfected COS cells express high levels of Oct6 indicating that the 
Saci/Kpnl fragment indeed contains promoter activity. Northern blot analysis 
using an Oct6 eDNA fragment as probe revealed two major and one minor 
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Figure 3. Bandshih and Northern blot analysis. Nuclear proteins and total cytoplasmic RNA 
was extracted from transfected COS cells. The presence of the Oct6 protein in nuclear 
extracts was determined in a bandsh.lft asssay using the radio labelled OCTA probe (see 
chapter V). The Oct6 mRNA is detected with the 200bp Oct6 Pvull probe (see chapter IV). 
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RNA species. As outlined above, the abundant transcript of 1 .9kb most likely 
corresponds to the Oct6 antisense RNA generated from the SV40 early 
promoter. The low abundance 4.8kb transcript probably corresponds to the 
sense Oct6 RNA transcribed from the Oct6 promoter. The origin of the 
intermediately sized RNA is not clear. Thus despite the high level of 
antisense RNA the sense mRNA seems to be translated efficiently enough 
to generate high levels of Oct6 protein. To exclude the possibility that sense 
transcripts are generated from a cryptic promoter within the Saci/Kpnl 
fragment we performed primer extension experiments on RNA from 
transfected COS cells and from an Oct6 expressing cell line (MES68; data 
not shown). Extension products of exactly the same length were observed 
in both cells indicating that transcription in the transfected COS cells is 
initiated from the correct CAP site. 
To test whether the 3' end of the gene is also present on the 6.3kb 
EcoRI fragment a functional assay was used, similar to the one described 
above. The generation of stable RNA requires proper termination and 
polyadenylation of primary transcripts. We asked whether the 6.3kb 
fragment contained all the neccassry sequences by introducing the gene in 
COS cells and monitoring expression by gel retardation assay and northern 
blots. Two constructs were made (Figure 2). The 6.3 EcoRI fragment was 
cloned in a nonreplicating (in mammalian cells) vector and the fragment was 
flanked by a polyoma virus enhancer element to boost transcription from the 
Oct6 promoter (pg0ct6/Py). A second construct was made by cloning the 
6.3 kb fragment 3' of the SV40 early promoter/ori (pg0ct6sv). This plasmid 
will replicate in COS cells. Both constructs were transfected in CO.S cells. 
Bandshift analysis of transfected cells showed that only pg0ct6/sv expresses 
high levels of Oct6 protein. It has been shown previously by Yamaguchi and 
Matsukage [17] that DNA replication can overrule cis-acting silencing 
elements. The Oct6 gene is normally not expressed in COS cells. Therefore, 
the most likely explanation for the fact that pg0ct6/sv expresses Oct6 and 
pg0ct6/Py not, is that only pg0ct6/sv replicates in COS cells. Northern 
analysis of pg0ct6/sv transfected COS cells showes that the plasmid 
expresses an abundant Oct6 transcript of 3kb and several shorter RNAs 
(Figure 3B). Probably the shorter RNAs result from the use of cryptic 
polyadenylation sites. As we used total RNA we do not know whether all the 
detected RNAs are actually polyadenylated. Thus the pg0ct6/sv clone 
expresses an Oct6 mRNA of correct size and a functional DNA binding 
protein, suggesting that the entire Oct6 gene is located on the 6.3kb 
genomic EcoRI fragment. Since it is unlikely that the 3'UTR of the gene is 
separated in more exons it is highly likely that the Oct6 gene is a single exon 
gene. Recently the rat homologue of the Oct6 gene, SCI P, has been 
described and it was shown to be a single exon gene [20]. 
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The promoter region of the Oct6 gene contains DNAsel hypersensitive sites 
in expressing cells. 
The chromatin stucture of promoter and enhancer regions of actively 
transcribed genes is often hypersensitive for nucleases, while the entire 
transcribed region and beyond shows an increased generalized sensitivity 
when compared with non-transcribed genes ([18, 1 9] for review). This 
hypersensitivity reflects the accessibility of the DNA in vivo for nucleases 
and other molecules like transcription factors. Thus the presence of 
hypersensitive sites within a region of interest is taken as a first indication 
of the presence of important cis-acting elements. To further delineate the 
elements involved in the regulation of the Oct6 gene, we examined the 
presence of DNAsel hypersensitive sites within the 6.3kb genomic EcoRI 
A 
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a 
ES Cells 
EeoR1!Xhol 
probe; u 
-:'2.7 
the mouse Oct6 gene 
ES Cells 
EcoRI/Xhol 
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0 
~ 
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ES Cells 
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II 
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L...........J 
MES Cells 
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Figure 4. Mapping ONAaser hypersensitive sites within the mouse Oct6 gene. Panel A 
shows the genomic region covered by the probes used (a, b and c). The DNAasel 
hypersensitive sites are ·Indicated with vertical arrows. The longest arrow indicates the 
position of the major hypersensitive site (see panel 8). DNAasel fade outs. Southern blots 
of Xhol/EcoRI restricted DNA isolated from DNAasel treated ES cell nuclei were probed 
with the probes indicated in panel A. MES cell DNA was digested with EcoRI and Hind !II 
and probed with probe c. 
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fragment in Oct6 expressing cells (ES cells) and non-expressing cells (MES 
cells). Nuclei of ES or MES cells were incubated with various amounts of 
DNAsel for a short period of time (see M&M). DNA was extracted from the 
nuclei, digested with restriction enzymes and separated on agarose gels. 
Southern blots of these gels were probed with various DNA fragments 
covering the 6.3 EcoRI fragment (Figure 4). The position of the probe 
fragments on the Oct6 map is indicated in panel A. Probe a detects an 
EcoRI/Xhol DNA fragment of 2.7kb that disappears with increasing DNAsel 
concentration. One major band and two smaller bands of lower intensity 
appear and disappear again. The major band has an estimated size of 
1.45kb. Fragment b detects the same 2. 7kb EcoRI/Xhol fragment but probes 
it from the 3' side. A major band of 1.25kb and a minor band of 1.15kb 
appear with increasing DNAsel concentration. As the sum of the length of 
the DNAsel generated fragments is the length of the EcoRI/Xhol fragment 
these fragments result from one major DNAsel hypersensitive site that is 
located approximately 1.25kb 5' of the Xhol site and 150bp 5'of the 
transcription initiation site. The position of this site and that of the lower 
intensity bands are indicated in Figure 4. The position of these sites is only 
approximate ( + or - 25bp) because of the limitations in determining the 
length of restriction fragments in· agarose gels. Fragment c detects the 
3'3.5kb EcoRI/Xhol band. This band gradually disappears with increasing 
DNAsel concentration. No additional bands appear indicating that there are 
no DNAsel hypersensitive sites in this part of the Oct6 gene. The presence 
of the DNAsel hypersensitive site detected by the a and b fragments 
correlates with the active state of the Oct6 gene as this sites are not present 
in the non-expressing cell line MES. Thus DNAsel hypersensitive sites are 
only associated with the 5' region of the Oct6 gene suggesting that 
important regulatory elements are clustered in this region. However it should 
be stressed that the analysis presented here only covers the 6.3kb EcoRI 
fragment. It is possible that additional important regulatory elements are 
located further away from the gene. 
Sequence of the Oct6 gene promoter region. 
From the results presented thus far it is clear that promoter and putative 
regulatory elements are located within the 900bp Kpnl fragment (see Figure 
4). The nucleotide sequence of this fragment was determined on both 
strands. Part of this sequence is presented in Figure 5. The promoter 
sequence of the rat Oct6 homologue, SCIP, has recently been published and 
is highly homologous to the mouse Oct6 promoter sequence [20]. Nucleotide 
differences are indicated above the Oct6 promoter sequenc in Figure 5. 
Because of the high degree of conservation between the mouse and rat 
sequence the alignment is not very informative with respect to pinpointing 
sequences that might be important for transcription regulation of the Oct6 
gene. The position of the transcription initiation site as determined by primer 
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extension is indicated with an arrow (Figure 5). The sequence of the Oct6 
promoter region is extremely rich in the dinucleotide CpG, as is the entire 5' 
region of the Oct6 coding sequence. Thus the gene is located in a CpG island 
of approximately 1 kb. Indeed this region is undermethylated in expressing 
and non-expressing cells (data not shown). This is a remarkable finding as 
most CpG islands are associated with the promoter region of housekeeping 
genes [21]. Notable other exceptions are the a globin and the Thy1 gene 
[22, 23]. Interestingly the Oct6 promoter has all the hallmarks of a tissue 
specific promoter. At around -30bp with respect to the transcriptional 
initiation site there is a TATA-box like sequence and at -90bp there is a 
typical GCCAAT box. This latter sequence element is highly homologous to 
the CTF/NF1 binding site in the a globin promoter. The TATA box sequence, 
TTT AA, resembles the TA TA element of the Schwann cell specific P, 
promoter [24]. A computer search identified further a number of additional 
putative transcription factor binding sites (several sites are indicated in Figure 
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The Oct6 Promoter Region 
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E~RS 
GAGAGCGGGGCCCACGCAGCCGGQACCGGAGGGGGjpCGGTCCCAGTGCCACCCCCGCGC 240 
~ C . ~ GG 
CACT CCCCACGTGGCGG&.£_Gg_QCCGGGGCGTGAATGT GT ACGC~GGT dGT GGG 300 
'-+-282£X 
• CBP A 
GGTCATGAATGAAGCCCCAGCGG~CAA1ICAGCACTGCCGGCGCGCGGGACCCCGGGAGCG 360 
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---~ MAT CAGACGGAGCGAGGCGGCGGCGGCGGC~~GGGCGCGGGGCGGCATGGCCAC 600 
Figure 5. Nucleotide sequence of the Oct6 gene promoter. 
The position of the transcriptional start site is indicated ( + 1) _ The transcribed region is 
underlined- Several putative cis acting element are boxed. The 5' deletion endpoints of the 
promoter constructs shown in figure 7 are indicated. Nucleotides that are different in the 
rat SC1P/Oct6 promoter are indicated above the sequence, while dots indicate nucleotides 
not-present in the SCIP/Oct6 sequence [20] 
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5 with the name of the factors that could bind to these sequences). Not 
unexpectedly there are at least eight binding sites for the factor Sp1 and 
several sequences that resemble recognition site for GCF, ETF, Krox 20 and 
Krox24 [25, 26, 27, 28]. Interestingly around -330 there is a sequence that 
perfectly matches the concensus binding site for the papilloma virus protein 
E2 (this region is strongly protected against limited DNAasel digestion by 
nuclear proteins from ES ad MES68 cells but not kidney). The DNAasel 
hypersensitive site as mapped in ES cell nuclei is located between -1 60 and 
-90. This region is extremely G + C rich and contains a sequence that is very 
similar to a region found in the NGF-R promoter, as noted earlier for the SCIP 
-150-
[ $ -~--<! 
- 50~ : -soi 1-~. ~ l 
TATA[ ~.;::•]<>} -100~~--- ~ 
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Figure 6. DNAasel footprinting of the Oct6 promoter region. Endlabelled probes were 
incubated with nuclear extracts as indicated and briefly exposed to DNAasel. Protected 
regions are indicated with brackets and the transcription initiation site with an arrow (5'). 
Pronounced DNAasel sensitive phosphodiester bonds ai"e indicated with an open 
arrowhead. 
101 
promoter [20, 29]. The NGF-R gene is expressed in Schwann cells as is the 
SCIP/Oct6 gene. This sequence could therefore represent a common 
regulatory element within these promoters. 
Footprint analysis 
To get an impression of the DNA elements within the Oct6 promoter that 
interact with nuclear factors and to see whether we could detect differences 
between expressing and non-expressing cells, we performed ONAsel 
footprinting assays using probes covering the proximal promoter region up 
to -150nt. This region contains the major DNAsel hypersensitive site in ES 
cells. Three different crude nuclear extracts were used , ES cells, MES68 
cells and kidney. ES and MES68 cells both express the Oct6 gene, while 
kidney cells do not express the gene. Probes were either labeled at the 
coding or noncoding strand. The results of these experiments are presented 
in Figure 6. The whole of the non-coding strand of the Oct6 promoter from 
the CAP site to >-150 is protected against limited degradation by DNAsel 
(lane 3, left panel, the protected regions are highlighted by brackets on the 
right hand side). Three ONAsel sensitive sites are not protected (indicated 
with an open triangle, left panel). Strong protection is seen between nt -40 
and -150 using ES cell extracts and to a lesser extend in MES68 cells. The 
region from -90 to -150 seems not to be protected by kidney nuclear 
extracts. However a strong protected area on both strands, overlapping the 
T A TA box, is observed with kidney extracts (lane 5 in left and right panel 
indicated with a curved line). Since kidney cells do not express the Oct6 
gene, it is possible that this factor is involved in the repression of the gene. 
Thus the clearest differences in protection patterns between expressing and 
non expressing cells are found in the region upstream of the GCCAAT box 
at -90. Possibly these sequences are involved in the regulation of the Oct6 
gene in ES and M ES68 cells (see below). 
Functional dissection of the Oct6 promoter 
Expression of the Oct6 gene is restricted to undifferentiated embryonic stem 
cells, neuronal cells and glial cells of both the peripheral and central nervous 
system. Oct6 gene expression in ES cells is downregulated upon RA induced 
differentiation of these cells. To see whether the Oct6 promoter region 
contains all the information for cell type specific expression and regulation 
we tested several promoter deletion constructs by transient transfection of 
a limited number of cell lines. The cell lines we used are ES and MES68 cells 
both of which express Oct6 and MES cells which don't express the gene. 
The promoter deletion mutants, driving a CAT reporter gene, used in this set 
of experiments are depicted in Figure 7 A. The activity of the different 
promoter deletion mutants was measured in a CAT assay using cell extracts 
of transiently transfected" cells (Figure 78). The longest promoter construct 
tested contains all of the DNAsel hypersensitive sites (-538BX in Figure 4 
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and 7). This promoter construct is active in ES cells. Activity is retained in 
the deletion mutants -282 and -160 but drops dramatically (5 fold) when the 
promoter is deleted to -88 and is completely lost when further deleted to 
-53. The region between -160 and -88 thus contributes significantly to the 
activity of the Oct6 promoter. This region also contains the major DNAsel 
hypersensitive site and is strongly protected against limited DNAsel digestion 
by ES cell nuclear proteins (Figure 4 and 6). The same set of mutants shows 
a similar activity in MES68 cells (Figure 7, panel D). However the same is 
observed forMES and differentiated ES cells. (panel B and C in Figure 7). 
Thus the Oct6 promoter constructs do not show tissue specificity and are 
not downregulated upon RA induced differentiation of ES cells suggesting 
that important regulatory elements are missing or that transient assays are 
not suitable for analyzing the Oct6 promoter (see discussion). 
DISCUSSION 
The data presented here strongly suggest that the mouse Oct6 gene is a 
single exon gene located on a 6.4 kb EcoRI fragment. Mapping of the Oct6 
eDNA to this genomic EcoRI fragment indicates that the eDNA is colinear 
with the genomic DNA. The 5'UTR is 55nt long and is also not interrupted 
by introns. Thus the whole of the ORF and the 5'UTR are encoded by one 
exon. The sequence of the 1.5kb 3'UTR is not known as yet. However 
functional data presented here suggest that the 3'UTR maps to the 6.3 kb 
EcoRI fragment (Figure 3).This rather sketchy picture is in line with the 
organization of the rat SCIP gene (the rat homologue of Oct6) that has 
recently been described [20]. Mapping and sequencing of eDNA molecules 
covering the 3'UTR of the SCIP gene revealed that indeed the entire gene is 
encoded by one exon. The 5' part of both the rat and mouse genes are 
extremely rich in CpG dinucleoti"des. This region of high CpG content extends 
well beyond the transcriptional initiation site of the gene. However the Oct6 
promoter has all the hallmarks of a typical cell type specific promoter in that 
it is characterized by the presence of a CCAA T and TAT A box at canonical 
distances from the transcription initiation site. Thus the Oct6 gene presents 
an exceptional situation in which a cell type specific promoter is interwoven 
with a CpG island. As expected this CpG island is undermethylated in the 
different cell lines we looked at (MES, ES, ES + RA and MES68 cells). From 
this we infer that the methylation state of the CpG island does not correlate 
with the activity of the Oct6 promoter. It has been suggested by Kuhn eta/. 
that the intronless SCIP/Oct6 gene arose through gene duplication involving 
a processed mRNA intermediate [20]. Possibly this duplicated gene 
intergrated in a CpG island that constitutes the regulatory region of a 
constitutively expressed gene. As expression on the Oct6 sense strand is cell 
type specific, ubiquitous expression from this CpG island then is expected 
to be on the opposite strand and divergent from the Oct6 gene. Whether this 
is the case remains to be determined. 
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The Oct6 gene is expressed at low levels in isolated Schwann cells and 
8103 neuroblastoma cells. The level of expression is drastically increased 
upon stimulation of these cells with cAMP. However no concensus cAMP 
response elements (CRE) are found in the promoter region although they 
could be present further away from the transcription initiation site. Instead 
two AP-2 like binding sites are found at position -90 and -540. The AP-2 
element has been shown to mediate cAMP induced transcription [30]. In 
accordance with this, prelimenary data indicate that a -1 60 promoter/CAT 
construct transiently transfected in 8103 cells is still cAMP inducible, 
suggesting that the most proximal AP-2 element is involved in mediating the 
cAMP effect (Ronald Zwart personal communication). 
Transient transfection of deletion mutants of the Oct6 promoter suggest 
the presence of important enhancer elements in a region of approximately 
SObp, upstream of the CCAAT box. This region coincides with the major 
DNAsel hypersensitive site in ES cells and shows homology with a region in 
the NGF-R promoter. As yet the importance of these findings is still obscure 
because the promoter constructs used here did not show cell type restricted 
activity. As the Oct6 promoter contains binding sites for ubiquitous 
transcription factors it is not surprising that it has a high basal activity in all 
cell types. Unfortenately, even the levels of activity are comparable in all cell 
lines tested (compare activity with the RSV promoter control). This lack of 
cell type specificity could be either a consequence of the transient assay 
itself or it might indicate that additional sequences are needed for proper cell 
type specific regulation, despite the inclusion of all the sequences that are 
DNAsel hypersensitive in ES cells. The latter possibility seems likely for the 
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following reason. Transienttransfection ofthe pg0ct6!Py construct into COS 
cells did not result in the production of Oct6 protein as assayed by bandshift. 
In this construct the strong polyoma enhancer is cloned 5' of the Oct6 
promoter at position -1 60 (Figure 28, compare with construct -1 60CA T in 
Figure 7) driving the rest of the Oct6 gene. This result could indicate that 
sequences within the Oct6 gene from the start codon to the 3' EcoRI site are 
involved in the regulation of the promoter, or alternatively, that the Py 
enhancer downregulates the Oct6 promoter in the pg0ct6/py construct. The 
inclusion of this part of the gene in the CAT constructs described in Figure 
7 and transfecting them to different cell types would give an answer to this 
question. If the failure to obtain cell type specific expression from the Oct6 
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Figure 7. Functional dissection of the Oct6 promoter. A. CAT constructs.A Xhol site was 
introduced at the ATG codon of the Oct6 ORF (+55) by PCR and used to clone the 
different promoter constructs in the right orientation upstream of the CAT gene in 
pBLCAT3. The numbers indicate the number of nucleotides upstream of the CAP site 
present in the individual deletion constructs (see Figure 5). 
B. CAT assays. RSV is the Rous Sarcoma Virus promoter and 6Wtk is the minimal HSV 
TK promoter as present in pBLCAT2 with a multimerized lgH enhancer upatream of it [7, 
32, 33]. Note that the 6Wtk promoter is strongly expressed in undifferentiated ES cells 
but is downregulated upon RA induced differentiation of these cells. 
105 
promoter constructs is due to the nature of the transient assay the 
constructs can be tested in stable transfected 8103 and MES cell lines. The 
advantage of this approach would be that the promoterconstructs are 
analysed while integrated in the cells chromosomes and thus in a normal 
chromatin configuration. Any integration position effects could be 
circumvented by analysing large pools of transfectants instead of clonal 
lines. The obvious and ideal alternative would be to generate transgenic mice 
using an easy identifiable reporter gene like the E.coli lacZ gene. This would 
enable the analysis of Oct6 expression during all stages of mouse 
development. Clearly more experiments need to be done to link individual 
cis-acting sequences with extra and intra cellular stimuli that modulate Oct6 
gene expression. 
MATERIAL AND METHODS 
Mapping of DNAasel hypersensitive sites. 
Cultured cells (MES and CCE ESJ were washed twice with ice cold PBS. Cells were suspended 
;n 3 ml of ;ce cold HS-buffer (15 mM Tr;s-HCI pH 7.4. 60 mM KCI. 15 mM NaCI, 0.2 mM 
EDTA, 0.2 mM EGTA and 5% glycerol, supplemented with 1 mM OTT, 0.15 mM spermine and 
0.5 mM spermidine, just before use}. The cefls were disrupted by passing 5 to 10 times through 
a 0.5x16 mm {25G) needle. The disruption was followed by examining a drop of the suspension 
under the microscope. Nuclei were collected by a brief centrifugation at 2500 rpm and 
resuspended to a final concentration of approximately 5x1 07 nuclei per mililitre of HS-buffer (the 
nuclei do not pack thightly after this centrifugation step). Limited DNAasel digestion of 
chromatin was carried out in a final volume of 500 pi of HS-buffer containing 5x1 0 6 nuclei, 
SmM MgCI2 and DNAasel, varying in concentration from 0 to 400 units. The reaction was 
incubated for 15 or 30 minutes on ice, stopped by adding 10 pi of 0.5 M EDTA, 12.5 pi of 
20% SDS and 50 pi of a 1 Omg/ml Proteinase K solution and the mixture was further incubated 
overnight at 37 C. After phenol/chloroform extracf1on the DNA was collected by isopropanol 
precipetation. The DNA was dissolved in 175 pi TE and restricted with EcoRI and Xhol or with 
EcoRI and Hindi II. Restriction fragments were resolved on a 0.8% agarose gel and blotted onto 
nylon membrane (Zeta Pro bel. The blots were hybridized to the probes indicated in Figure 4. 
All other methods used have been described in the previous chapters. 
REFERENCES 
1. Herr, W., R.A. Sturm, R.G. Clerc, l.M. Corcoran, D. Baltimore, P.A. Sharp, H.A. 
Ingraham, M.G. Rosenfeld, M. Finney, G. Ruvkun and H.R. Horvitz. 1988. The POU 
domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and 
Caenorhabditis elegans unc-86 gene products. Genes & Dev 2: 1513-6 
2. Rosenfeld, M.G. 1991. POU-domain transcription factors: pou-er-ful developmental 
regulators. Genes & Dev. 5: 897-907 
3. Ruvkun, G. and M. Finney. 1991. Regulation of transcription and cell identity by POU 
domain proteins. Ce/164: 475-8 
4. SchOler, H.R. 1991. Octamania: The POU factors in murine development. Trends Genet 
7: 323-9 
5. li, S., E.B. Crenshaw Ill, E.J. Rawson, D.M. Simmons, l.W. Swanson and M.G. 
Rosenfeld. 1990. Dwarf locus mutants lacking three pituitary cell types result from 
mutations in the POU-domain gene pit-1. Nature 347: 528-33 
6. Kemler, I. and W. Schaffner. 1990. Octamer transcription factors and the cell 
106 
type-specificity of immunoglobulin gene expression. Faseb J 4: 1444-9 
7. SchOler, H.R., R. Balling, A.K. Hatzopoulos, N. Suzuki and P. Gruss. 1989. Octamer 
binding proteins confer transcriptional activity in early mouse embryogenesis. Embo J 8: 
2551-7 
8. He, X., M.N. Treacy, D.M. Simmons, H.A.Ingraham, LW. Swanson and M.G. Rosenfeld. 
1989. Expression of a large family of POU-domain regulatory genes in mammalian brain 
development. Nature 340: 35-41 
9. Meijer, D., A. Graus, R. Kraay, A. langeveld, M.P. Mulder and G. Grosveld. 1990. The 
octamer binding factor Oct6: eDNA cloning and expression in early embryonic cells. 
Nucleic Acids Res 18: 7357-65 
10. Monuki, E.S., G. Weinmaster, R. Kuhn and G. Lemke. 1989. SCIP: a glial POU domain 
gene regulated by cyclic AMP. Neuron 3: 783-93 
11. SchOler, H.R., A.K. Hatzopoulos, R. Salling, N. Suzuki and P. Gruss. 1989. A family of 
octamer-specific proteins present during mouse embryogenesis: evidence for 
germline-specific expression of an Oct factor. Embo J 8: 2543-50 
12. Suzuki, N., H. Rohdewohld, T. Neuman, P. Gruss and H.R. SchOler. 1990. Oct-6: a POU 
transcription factor expressed in embryonal stem cells and in the developing brain. Embo 
J 9: 3723-32 
13. Monuki, E.S., R. Kuhn, G. Weinmaster, B.D. Trapp and G. Lemke. 1990. Expression and 
activity of the POU transcription factor SCIP. Science 249: 1300-3 
14. He, X., R. Gerrero, D.M. Simmons, R.E. Park, C.J. lin, LW. Swanson and M.G. 
Rosenfeld. 1991. Tst-1, a member of the POU domain gene family, binds the promoter 
of the gene encoding the cell surface adhesion molecule Po. Mol Cell Biol11: 1739-44 
15. Meijer, D., A. Graus and G. Grosveld. 1992. Mapping the transactivation domain of the 
Oct6 POU transcription factor. submitted for publication 
16. Okayama, H. and P. Berg. 1983. A eDNA cloning vector that permits expression of eDNA 
inserts in mammalian cells. Mol Cell Bioi 3: 280-9 
17. Yamaguchi, M. and A. Matsukage. 1990. DNA replication can overcome the silencer 
function on transcription. New Bioi. 2: 343-350 
18. Gross, D.S. and W.T. Garrard. 1988. Nuclease hypersensitive sites in chromatin. Annu 
Rev Biochem 
19. Svaren, J. and R. Chalkley. 1990. The structure and assembly of active chromatin. 
Trends Genet 6: 52-6 
20. Kuhn, R., E.S. Monuki and G. Lemke. 1991. The gene encoding the transcription factor 
SCIP has features of an expressed retroposon. Mol Cell Biol11: 4642-50 
21. Bird, A. 1987. CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3: 
342-347 
22. Bird, A.P., M.H. Taggart, R.D. Nicholls and D.R. Higgs. 1987. Non-methylated CpG-rich 
islands at the human alpha-globin locus: implications for evolution of the alpha-globin 
pseudogene. Embo J 6: 999-1004 
23. Spanopoulou, E., V. Giguere and F. Grosveld. 1988. Transcriptional unit of the murine 
Thy-1 gene: different distribution of transcription initiation sites in brain. Mol Cell Biol8: 
3847-56 
24. Lemke, G., E. Lamar and J. Patterson. 1988. Isolation and analysis of the gene encoding 
peripheral myelin protein zero. Neuron 1: 73-83 
25. Kadonaga, J.T., K.R. Carner, F.R. Masiarz and R. Tjian. 1987. !solation of eDNA encoding 
transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51: 
1079-90 
26. Kageyama, R. and I. Pastan. 1989. Molecular cloning and characterization of a human 
DNA binding factor that represses transcription. Cell 59: 815-25 
27. Lemaire, P., C. Vesque, J. Schmitt, H. Stunnenberg, R. Frank and P. Charnay. 1990. The 
serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional 
activator. Mol Cell Biol10: 3456-67 
28. Chavrier, P., C. Vesque, B. Galliot, M. Vigneron, P. Dolle, D. Ouboule and P. Charnay. 
107 
1990. The segment-specific gene Krox-20 encodes a transcription factor with binding 
sites in the promoter region of the Hox-1 .4 gene. Embo J 9: 1209-1 8 
29. Sehgal, A., N. Patil and M. Chao. 1988. A constitutive promoter directs expression of the 
nerve growth factor receptor gene. Mol Cell Bioi 8: 2543-50 
30. lmagawa, M., R. Chiu and M. Karin. 1987. Transcription factor AP-2 mediates induction 
by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51: 
251-60 
31. Thomas, K.R. and M .R. Capecchi. 1987. Site-directed mutagenesis by gene targeting in 
mouse embryo-derived stem cetls. Cell 51: 503-12 
32. Gorman, C. 1985. High efficiency gene transfer into mammalian cells. in "DNA Cloning", 
D. M. Glover IRL Press, Oxford 
33. Luckow, B. and G. Schutz. 1987. CAT constructions with multiple unique restriction sites 
for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids 
Res 15: 
108 
Chapter IX 
CONCLUDING REMARKS 
The work described in this thesis concerns the identification and 
characterization of octamer binding transcription factors that could play a 
role in several aspects of cellular differentiation processes. Two mouse genes 
encoding octamer binding factors have been characterized and studied. The 
Oct2 gene is highly expressed in B cells, in brain and in meiotic male germ 
cells, while the Oct6 gene is expressed in early embryonic cells, the 
developing and adult nervous system and in differentiating glia of the 
peripheral and central nervous system (Chapter Vand [1-4]). In the absence 
of genetic data, a role for these factors in differentiation is mainly inferred 
from their tissue and stage specific expression patterns and the fact that 
they can function as transcription factors. As the testis specific expression 
of the mouse Oct2 gene and its putative role in germ cell development has 
been discussed extensively in Chapter V, I will restrict myself here to a 
discussion of a number of aspects of the Oct6 gene and its regulated 
expression. 
We used P19 EC cells to study the regulated expression of a number of 
octamer binding factors, focusing on the Oct6 protein (Chapter VI). The 
direction of differentiation in vitro of this cell line can be manipulated using 
different culture conditions in combination with differentiation inducing 
agents such as retinoic acid IRA) or dimethylsulfoxide (DMSO) [5, 6, 7]. 
Aggregation of P19 cells followed by administration of RA leads to 
differentiation in a neurectodermal direction. The Oct6 gene is transiently 
induced during the first period of differentiation and reappears at a later 
stage, suggesting that the gene plays a role at an early commitment stage 
and at a later stage in the establishment of differentiated cell types [4]. This 
assumption is in line with what is known about the expression of the Oct6 
gene in the developing embryo and during postnatal development of the 
nervous system. Using in situ hybridization histochemistry, Oct6 mRNA 
could be detected in day 8 rat embryos at the egg cylinder stage. At later 
stages of mouse and rat development, the expression of the gene is confined 
to discrete regions of the developing central nervous system, while in new 
born animals high levels of expression are observed in differentiating glia of 
the peripheral as well as the central nervous system. Furthermore, Oct6 
expression could also be detected in discrete regions of the adult brain [1, 
3, 8]. Despite its obvious limitations, the P19 EC cell system might be useful 
as a model system to study the possible role(s) of the Oct6 gene during 
some aspects of neuronal differentiation. In particular the early expression 
of the gene, preceding morphological differentiation of the P1 9 cells, is 
intriguing (Chapter VI). It is possible that the expression of the gene is 
involved in an early step that commits the cells to follow a neurectodermal 
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differentiation pathway. At present it is not known whether all differentiating 
cells express Oct6 at this early stage, or that expression is limited to a 
subset of cells. The use of antibodies directed against Oct6 in conjunction 
with antibodies against different differentiation markers should enable us to 
address this question. Studying the neuronal differentiation capacity of P19 
cells in which the expression pattern of the Oct6 gene is altered might give 
insight into the role this gene plays in the differentiation process. 
Manipulation of the Oct6 expression pattern in P19 cells could be done either 
by constitutive expression of the gene, or by inhibiting the expression of the 
gene through the use of anti-sense expression vectors or anti-sense 
oligonucleotides. An alternative approach would be the creation of Oct6 
mutant mice through the targeted disruption of the Oct6 gene in ES cells 
followed by reintroduction of these cells into blastocyst embryos. Breeding 
of germ line chimeric animals to homozygosity will hopefully give insight into 
the role of the Oct6 gene in normal development. 
The rat homologue of the Oct6 gene, called Tst-1 or SCIP, has been 
shown to be expressed in rat testis. However we could not detect 
expression of the Oct6 gene in mouse testis by conventional Northern blot 
experiments, or by PCR amplification of POU domain protein encoding 
mRNAs using degenerate oligonucleotides. The last approach was also taken 
by Goldsborough et a/.[9]. They obtained cDNAs for Oct1, Oct2, Brn3 and 
a gene which they called Oct11, but not Oct6. In contrast with these 
results, Suzuki et a/. detected a very low expression of the Oct6 gene in 
mouse testis [8]. As described in Chapter V, the Oct2 gene is highly 
expressed in mouse testis, whereas this gene does not seem to be expressed 
in the rat testis. So there are clear differences between rat and mouse testis 
with respect to the POU domain genes they express. The reason for these 
differences is unclear but might indicate that the different POU proteins are 
functionally redundant in testis. 
Given the observation that the Oct6 protein is a sequence specific DNA 
binding protein that is capable of stimulating or repressing transcription, it is 
likely that the protein is involved in cellular differentiation through regulation 
of a set of downstream genes. However, the Oct6 protein is one of a family 
of proteins that bind to the octamer sequence, and many cell types contain 
multiple octamer binding proteins that could compete for the same binding 
site. For example, ES cells express three octamer binding factors; Oct1, 
Oct3/4 and Oct6. This poses the question as to how a specific set of target 
genes can be regulated by individual members of the octamer binding protein 
family. Obviously, there are two levels at which specificity can be achieved: 
differences in DNA binding specificity for different binding sites, and 
differences in the spectrum of proteins with which the individual oct factors 
interact via protein-protein contacts. Thus although embryonic stem cells 
express three different proteins that bind to the octamer sequence in vitro, 
the affinity for this sequence and related sequences differs for the individual 
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proteins, reflecting differences in their respective POU domains. We have 
studied the differential affinity of the Oct1 and the Oct6 protein for a number 
of octamer and octamer related binding sites {Chapter V). It was concluded 
that these two proteins bind to a different but largely overlapping set of 
binding sites. A comparison between the seven Oct6 binding sites studied 
here and the five Oct6 binding sites as present in the P0 promoter yielded the 
following rather loose consensus; AfT ATG/TNA/TAA TNA/C {see figure). 
It was shown for the Pit-1 protein that phosphorylation of a serine residue 
in the amino terminal cluster of the homeodomain results in altered DNA 
binding affinities for different Pit-1 DNA binding sites [11]. Similarly, 
phosphorylation of the Oct1 protein as a function of the cell cycle modulates 
its DNA binding affinity for the octamer element [12]. Thus phosphorylation 
of POU proteins might be a general mechanism by which the 
specificity/affinity of DNA binding is regulated. Whether this is also true for 
the Oct6 protein remains to be established 
Given the fact that the DNA binding specificity of Oct6 overlaps greatly with 
that of Oct1 and other Oct factors, it is not likely that DNA binding alone 
determines the specificity for the genes that are regulated by the individual 
Oct6 DNA binding sites 
Relatlve affinity 
AblOct GGAAATGCAAATTCCT +++ 
lgHOct AGAAATGCAAATTACC +++ 
ad4 TAATATGCAAATAAGG +++ 
ad2 CAl'. TAT GAT AATGAGG +++ 
ICP4 TCGGGCGGTAATGAGA +++ 
EN26 CATACTTAAAATTCAA + 
Cf1a CATAAATCAAATTGTA + 
Po I CCTGCTTAAAATCCCC + 
Po IT AGCAGTTTAAATGATC ++ 
Po m TACCATTCTAATACGA +++ 
P0 mas TAGAATGGTAATTCAG +++ 
Po IVas TGCACTAGGAATACCA ++ 
Po vas GATAAGGGAAATAAGG + 
A G A A 
Consensus: AT N AATN 
T T T c 
Consensus DNA binding site for the Oct6 protein. It should be noted that the relative 
affinity of Oct6 for the first seven DNA binding sites was based roughly on the amount 
of complexed DNA in a bandshift experiment using equal amounts of crude nuclear 
extracts. The relative affinities of the P0 DNA binding sites were taken from experiments 
by He eta!. {1 0] and can therefore not be directly compared to our experiments. 
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proteins. From a number of examples it is clear that further specificity is 
achieved through interaction with other transcription factors, depending on 
determinants in the POU domain as well as outside the POU domain (see 
Introduction). Thus the Oct2 protein is capable of activating a simple 
promoter consisting of a minimal P-globin promoter and flanking octamer 
motif, whereas Oct1 is not [13, 14]. These proteins do not differ in their 
DNA binding affinity for the octamer element ([15, 16], and references 
therein). Both Oct1 and Oct2 contain an amino terminal transcriptional 
activation domain, while Oct2 has an additional activation domain carboxyl 
terminal of the POU domain [13, 17, 18]. Through the use of chimeric 
molecules it was shown that transcriptional activation by Oct2 depends on 
the presence of both the amino terminal and the carboxyl terminal activation 
domain [13]. Activation of the IE genes of HSV depends on the productive 
interaction between the viral protein VP1 6, Oct1 and at least one other 
cellular factor on the IE response element [19-22]. The interaction between 
Oct1 and VP16 depends on critical amino acid residues within the Oct1 
homeodomain. The Oct2 protein is not capable of interacting with VP1 6 
[23]. Thus intrinsic differences between Oct1 and Oct2 determine whether 
a promoter can be activated or not. 
A synthetic promoter consisting of a minimal tk promoter flanked by a 
multimerized lgH octamer/pE4 enhancer (6W) was shown to be highly active 
in undifferentiated EC andES cells. However, ectopic expression of the Oct4 
protein in Hela cells failed to activate this promoter, suggesting that 
additional cell type specific factors are missing or that the promoter is 
repressed in He Ia cells [24, 25]. Activation of this promoter in He Ia cells 
could be achieved when the Oct4 protein was coexpressed with the 
adenovirus E1 A gene. Overexpression of either Oct4 or E1 A resulted in a 
reduced activity of the 6Wtk promoter. Furthermore, bandshift experiments 
suggested that the Oct4 protein and E1 A interact directly. Activation of the 
6Wtk promoter is dependent on an intact transcriptional activation domain 
of the Oct4 protein. The interaction between Oct4 and E1 A is specific, as 
Oct2 failed to stimulate the 6Wtk promoter in the presence of E1 A. Thus the 
E1 A protein functions as a bridging factor that mediates the transcriptional 
activation effect of the Oct4 protein to the promoter. It was suggested that 
the viral protein mimics the action of a stem cell specific factor with which 
Oct4 interacts in these cells, and that this factor is the elusive E 1 A like 
activity [26]. Thus different sets of gene promoters can be regulated by 
different Oct factors through a combination of DNA binding specificity and 
selective interaction with other factors. 
Although most Oct factors are clearly involved in transcriptional 
regulation, a number of observations implicate these factors also in cellular 
proliferation, reflecting a direct or indirect role in DNA replication. For 
example the Oct1 and Oct2 proteins stimulate adenovirus DNA replication 
in vitro. The stimulation of viral DNA replication does not depend on the 
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transcriptional activation domains of these proteins, as an intact POU domain 
is sufficient [27]. Furthermore, the specific inhibition of Oct3/4 mRNA 
translation in fertilized mouse eggs resulted in a failure of these cells to 
undergo cell division. Co injection of in vitro transcribed Oct3/4 mRNA could 
revers the effect. This inhibitory effect on the first cell division could also be 
obtained by injection of double-stranded oligonucleotides containing an 
octamer binding site. A direct role of the Oct3/4 protein in DNA replication 
is suggested by the following observations. Treatment of one-cell mouse 
embryos with high concentrations of o-aminitin, which inhibits RNA 
polymerase II and Ill mediated transcription, does not block the first cell 
division but results in a developmental arrest at the two cell stage. 
Furthermore, the injection of Oct3/4 anti-sense oligonucleotides resulted not 
only in a block of cell division but also in a 87% reduction of DNA replication 
[28]. The fact that the block in the first cell division can be relieved by 
coinjection of in vitro transcribed Oct3/4 mRNA opens the possibility to test 
whether this function solely depends on the Oct3/4 DNA binding domain or 
that the transcriptional activation domain is essential as well. A role for the 
Oct6 protein in cellular proliferation has been suggested on the basis of its 
high expression in proliferating Schwann cells, and is down regulated when 
these cells differentiate and stop to divide [3]. It is possible that the high 
transient expression of the gene during early neuronal differentiation of P19 
cells is linked in a similar way to the proliferation of precursor cells. Again 
the P19 cell system could prove to be a valuable system to study the 
proposed function of the Oct6 protein in cellular proliferation. If it is true that 
the Oct6 protein is involved in the proliferation of precursor cells, and that 
down-regulation of the gene is required for further differentiation, it is 
anticipated that a sustained expression of the gene will block terminal 
differentiation of these cells. It would be very interesting to study the effects 
of sustained expression of Oct6 in Schwann cells and oligodendrocyte 
precursor cells in mice. This would require the generation of transgenic 
animals carrying the Oct6 gene, preferably under control of a Schwann cell 
specific promoter. The Oct6 promoter itself would be the ideal promoter to 
use, provided that it is possible to identify and selectively mutate the 
cis-acting element(s) that govern the down regulation of this promoter during 
terminal cell differentiation. Clearly a detailed study of the Oct6 promoter is 
mandatory. 
One remarkable piece of data from the preliminary characterization of the 
Oct6 gene as presented in Chapter VIII, is that the Oct6 promoter is a 
classical cell type specific promoter although it is embedded in a CpG island. 
CpG islands are a characteristic feature of promoter regions of ubiquitously 
expressed genes [29]. Most of these promoters lack a TATA box, and some 
generate transcripts from both DNA strands. Transcription is mostly 
promiscuous with respect to the transcriptional initiation site used. It is 
possible that this CpG islands represents the promoter of a housekeeping 
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gene that is located on the bottom strand and is thus transcribed in the 
opposite direction with respect to the Oct6 gene. If so, transcription on the 
Oct6 sense strand from this CpG promoter must be actively prevented. In 
this respect it is interesting to note that we observed a strong footprint 
overlapping the TA TA box when using nuclear extracts from kidney in 
DNAase I protection assays. Since kidney cells do not express the Oct6 
gene, this factor could be involved in the repression of the Oct6 promoter in 
these cells. Thus, it is possible that the Oct6 gene is under positive as well 
as negative control. A first dissection of the Oct6 gene promoter might be 
undertaken using the 8103 cell line and promoter deletion constructs. This 
cell line expresses the Oct6 gene at a very low level, but expression is 
increased upon stimulation of these cells with cAMP. As a consequence of 
cAMP stimulation, the cells differentiate morphologically and start to express 
the Schwann cell specific marker gene PLP. Thus this cell line will be useful 
to study one aspect of Oct6 gene regulation that might be relevant for its 
regulation in developing Schwann cells. Ultimately, the promoter deletion 
constructs must be tested in transgenic animals to asses the relative 
importance of the individual promoter elements. Using then these cis-acting 
DNA elements as probes we will be able to study the factors that are 
involved in the tissue specific modulation of the Oct6 gene itself. 
A detailed study of the Oct6 promoter and enhancer sequences and the 
protein factors that interact with them, will give insight into the regulatory 
mechanisms that incorporate intra- and extra-cellular cues to modulate the 
expression of the Oct6 gene, and place the Oct6 gene in the proposed 
hierarchy of events that lead to the acquisition of a fully differentiated 
phenotype. 
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SUMMARY 
Molecular genetic studies on Drosophila and C.elegans have suggested the 
existence of a hierarchy of regulatory genes that operate during 
embryogenesis. The sequential activation of these genes accomplish the 
transformation of genetic information into body form and structure through 
a spatial and temporal regulation of effector genes, which in turn determine 
cell identity. 
The work described in this thesis aimed at the elucidation of mechanisms 
that govern cellular differentiation events in male germ cell development, 
especially during the post-meiotic phase, and in embryonal carcinoma cells. 
The experimental work focused on the characterization of a class of cell type 
specific transcription factors, the octamer binding factors, that could play a 
role in the cellular differentiation events mentioned above. These factors 
belong to the POU domain protein family. In Chapter I this family of proteins 
is introduced and their role in cellular differentiation is briefly discussed. The 
first part of this thesis (Chapters II to IV) is mainly concerned with the testis 
specific expression of the c-abl gene. In the second part of this thesis 
(Chapters V to VIII) two genes encoding octamer binding factors (Oct2 and 
Oct6) are described that are expressed during distinct stages of male germ 
cell development (0ct2) and neuronal differentiation of P19 EC cells (0ct6). 
Their supposed role in cellular differentiation is discussed in Chapters V and 
VIII, respectively. 
In Chapter II, the molecular characterization is described of the testis 
specific c-abl mRNA. The c-abl gene expresses two mRNAs of 5.3 and 6.5 
kb in all cell lines and tissues tested, both encoding a non receptor type 
tyrosine specific kinase that is involved in an as yet uncharacterized signaling 
pathway. The high expression of a shorter c-abl transcript of 4 kb (TSabl) in 
post-meiotic male germ cells suggested an involvement of the c-abl protein 
in the terminal cytodifferentiation of these cells. The TS abl mRNA is 
transcribed from the proximal of the two c-abl promoters and is alternatively 
processed, resulting in a removal of most of the 3'UTR, that does not affect 
the coding capacity of the mRNA. The high levels of this mRNA in round and 
elongated spermatids could be due to two not mutually exclusive 
mechanisms, i.e. a higher stability of this mRNA or/and ongoing expression 
of the mRNA during the later stages of spermiogenesis. Indeed ActinomycinD 
chase experiments showed that the TSabl mRNA in round spermatids has a 
longer halflife than the two c-abl RNAs expressed in other cell types. In 
Chapter Ill we describe experiments that were designed to test the 
involvement of the 3'UTR in determining messenger halflife. It was shown 
that the removal of the 3'UTR of the c-abl mRNA did not have an appreciable 
effect on the rate at which this RNA is turned over in COS cells. Nor does 
it alter the translatability of the RNA. Therefore, it remains unclear what 
function the alternative polyadenylation plays in TSabl RNA maturation and 
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what factors cause the high stability of the transcript in spermatids. 
S1 Nuclease protection assays indicated that the TSabl mRNA is transcribed 
from the proximal of the two c-abl promoters. A prelimenary analysis of the 
proximal c-abl promoter is presented in Chapter IV, using DNAsel footprinting 
and gel retardation assays. Four regions were identified that are protected 
from limited DNAsel digestion by nuclear protein extracts from testis, 
spermatids, liver and pre-8 cells. There are no obvious differences between 
the footprints obtained. In a gel retardation experiment, we observed a testis 
specific complex with a probe that contained the octamer sequence. This 
specific complex, however, most likely resulted from proteolytic degradation 
of the ubiquitous Oct1 protein. 
The initial observation of a testis specific octamer complex stimulated us 
to undertake the experiments described in Chapter V. These experiments 
aimed at the cloning of testis specific cDNAs encoding octamer binding 
factors. We show that the POU domain gene Oct2 is highly expressed in 
spermatogenic cells, generating two transcripts through a mechanism of 
alternative processing and/or promoter usage. The two cDNAs analysed 
potentially encode octamer binding factors of 44 and 39 kD. At the moment 
it is still unclear whether these proteins play a role in the post-meiotic 
expression of the c-abl gene, for two reasons. First, the Oct2 gene is highly 
expressed during the pachytene stage of spermatogensis whereas the TSabl 
is expressed after completion of meiosis, and second, it is as yet unclear 
whether the ts0ct2 mRNAs are actually translated in male germ cells as no 
octamer complexes of the expected size were observed in a gel retardation 
assay using testis nuclear extracts. This failure to detect the ts0ct2 
complexes does not seem to be due to an intrinsic inability of the ts0ct2 
mRNAs to be translated, as the two ts0ct2 complexes were observed when 
using nuclear extracts of ts0ct2 transfected COS cells. At the same time, 
a second POU domain gene, called Tst-1, was reported to be expressed at 
high levels in rat testis. However, we found that the mouse homologue of 
this gene is not expressed in mouse testis but is expressed in 
undifferentiated embryonic stem cells and in differentiating P19 embryonal 
carcinoma cells. Chapter VI describes the temporally regulated expression of 
a number of octamer binding factors during the neuronal differentiation of 
P19 EC cells. One factor, called Oct6, is expressed in a bi-phasic pattern 
suggesting that it might play a role at different stages of development. This 
factor is further characterized by cloning of the cognate eDNA, and was 
found to be the mouse homologue of the rat Tst-1 gene. The eDNA encodes 
a protein of 45 kD that belongs to the POU domain protein family. The Oct6 
gene generates a single mRNA of three kb and is expressed, apart from 
differentiating P1 9 EC cells, in undifferentiated ES cells and in brain. In 
Chapter VII we show that the Oct6 factor is capable of activating different 
promoters via octamer, and octamer related, sequences. The transcriptional 
activation potential resides in the amino terminal third of the protein, a 
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domain that is extremely rich in glycine and alanine residues, and is distinct 
from the DNA binding domain (the POU domain). In Chapter VIII, the 
genomic organization of the Oct6 gene is described. The entire protein 
coding region and the promoter are part of a CpG island. Nevertheless, the 
Oct6 promoter has all the hallmarks of a classical cell type specific promoter 
in that it contains a TA TA and CCAAT box at canonical distances from the 
transcription initiation site. The Oct6 promoter is associated with a DNAsel 
hypersensitive chromatin structure in Oct6 expressing ES cells but not in 
non-expressing MES cells. A prelimenary functional characterization of the 
Oct6 promoter suggests that sequences upstream of the CCAAT box are 
neccessary for full activity. A more detailed analysis of the Oct6 promoter 
is needed to identify the cis-acting elements that govern the strict tissue 
specific expression of the gene. Characterization of the protein factors that 
interact with these cis-acting elements will enable us to study the 
mechanisms that regulate this transcriptional regulator and place the Oct6 
gene in a hierarchy of events that lead to a fully differentiated phenotype. 
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Samenvatting 
Moleculair genetisch onderzoek aan Drosophila en C.elegans suggereert dat 
er een hierarchie van regulerende genen bestaat. De opeenvolgende 
activering van deze genen gedurende de embryogenese 'vertaalt' de 
genetische informatie in vorm en structuur van het organisme, door de 
temporele en spatiele regulatie van andere genen welke op hun beurt de 
uiteindelijke identiteit van de lichaamscellen bepaalt. 
Het in dit proefschrift beschreven werk had tot doe I inzicht te verkrijgen 
in de moleculaire mechanismen welke de differentiatie van cellen reguleren, 
met name de differentiatie van de mannelijke kiemcellen en embryonale 
carcinoma cellen. Het experimentele werk concentreerde zich op de 
karakterisering van een klasse van eel type specifieke transcriptie factoren, 
de octameer bindende factoren, die een rol zouden kunnen spelen in de 
hierboven genoemde cellulaire differentiatie processen. Deze factoren 
behoren tot de POU domein eiwit familie. In Hoofdstuk I wordt deze familie 
van eiwitten ge·introduceerd en wordt de rol van twee van deze eiwitten in 
verschillende cellulaire differentiatie processen beschreven. Het eerste 
gedeelte van dit proefschrift (Hoofdstukken II tot en met IV) behandelt 
voornamelijk de testis specifieke expressie van het c-abl gen. In het tweede 
gedeelte (Hoofdstukken V tot en met VIII) worden twee genen beschreven 
die octameer bindende transcriptie factoren coderen (0ct2 en Oct6). Het 
Oct2 gen komt tot expressie in een specifiek stadium van de zich 
ontwikkelende mannelijke zaadcel terwijl het Oct6 gen tot expressie komt 
gedurende de neurale ontwikkeling van P1 9 EC eel len. De veronderstelde rol 
die deze eiwitten spelen in cellulaire differentiatie wordt respectievelijk 
bediscussieerd in Hoofdstuk V en VII. 
Hoofdstuk II beschrijft de moleculaire karakterisering van het testis 
specifieke c-abl mANA. Het c-abl gen expresseert twee mANAs van 5,3 en 
6,5 kb in aile celtypen. Seide mANAs coderen voor een niet-receptor type 
tyrosine kinase eiwit dat betrokken is bij een tot nu toe niet ge·identificeerd 
signaal transductie systeem. De hoge expressie van het kortere testis 
specifieke c-abl (TSabl) mANA in haplo"ide spermatiden suggereert dat het 
een rol speelt bij de terminale differentiatie van deze cellen. Het c-abl gen 
heeft twee promoters. Het TSabl mANA wordt afgeschreven van de 
proximale promotor en wordt op een alternatieve manier gemodificeerd, 
hetgeen resulteert in de verwijdering van het grootste gedeelte van de 
3' UTA. Dit heeft geen consequenties voor het te coderen eiwit. Het hoge 
expressie niveau van het TSabl mANA in ronde en elongerende spermatid en 
kan een gevolg zijn van twee elkaar niet uitsluitende mechanismen: Het 
TSabl mANA is zeer stabiel en/of transcriptie van het TSabl mANA persisteert 
tot de latere stadia van de spermiogenese. Met behulp van zogenaamde 
ActinomycineD experimenten konden we aantonen dat het TSabl mANA in 
spermatiden inderdaad veel stabieler is dan de twee c-abl mRNAs in andere 
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eel typen. In Hoofdstuk Ill worden experimenten beschreven die er op gericht 
waren om de mogelijke betrokkenheid van de 3'UTR bij de mRNA stabiliteit 
te onderzoeken. Uit deze experimenten bleek dat de 3'UTR nauwelijks 
invloed heeft op de stabiliteit van het c-abl mRNA in COS eel len. Truncaties 
van de 3'UTR hebben ook geen invloed op de transleerbaarheid van het 
mRNA. Het is daarom niet duidelijk geworden wat de functie is van de 
alternatieve modificatie van het TSabl mRNA en welke factoren de hoge 
stabiliteit van het TSabl mRNA in spermatiden veroorzaken. 
S 1 Nuclease protectie experimenten wezen uit dat het TSabl mRNA 
getranscribeerd wordt van de proximale c-abl promotor. In Hoofdstuk IV 
wordt een eerste voorlopige karakterisering beschreven van deze promotor, 
gebruik makend van zogenaamde DNAsel footprinting en gelretardatie 
experimenten. Vier regie's werden op deze wijze ge"ldentificeerd in de c-abl 
promotor welke beschermd werden tegen een beperkte digestie met het 
nuclease DNAsel na incubatie met ruwe kernextracten van testis, 
spermatiden, lever en pre-8 cellen. Er werden geen duidelijke verschillen 
gevonden tussen de footprint patronen die verkregen werden met de 
verschillende kernextracten. Echter in een gelretardatie experiment vonden 
wij een testis specifiek complex met een DNA probe die een octameer 
sequentie bevatte. Dit specifieke complex was hoogst waarschijnlijk het 
gevolg van proteolytische afbraak van het Oct1 eiwit. De observatie van een 
testis specifiek octameer complex stimuleerde ons de experimenten te 
ondernemen zeals beschreven in Hoofdstuk V. Deze experimenten waren er 
op gericht testis specifieke cDNAs te cloneren die octameer bindende 
factoren coderen. We vonden dat het POU domein gen Oct2 hoog tot 
expressie komt in mannelijke germinale cellen in de vorm van twee mRNAs, 
die gegenereerd worden door een mechanisme van alternatieve processing 
en/of promotor gebruik. De twee cDNAs coderen mogelijk octameer bindende 
factoren van 39 en 44 kD. Op het moment is het nog niet duidelijk of deze 
twee eiwitten een rol spelen in de post-meiotische expressie van het c-abl 
gen. Er zijn twee redenen om aan te nemen dat dit niet het geval is: Het 
Oct2 gen komt tot expressie gedurende het pachyteen stadium van de 
meiose, terwijl het c-abl gen hoog tot expressie komt nadat de kiemcellen de 
reductie deling voltooid hebben. Ten tweede, het is onduidelijk of de ts0ct2 
mRNAs wei vertaald worden aangezien geen octameer complexen van de 
verwachte grootte werden waargenomen in gelretardatie experimenten met 
testis kernextracten. Het feit dat de ts0ct2 complexen niet werden 
waargenomen is hoogst waarschijnlijk niet het gevolg van een intrinsiek 
probleem in de transleerbaarheid van de ts0ct2 mRNAs. Dit werd 
geconcludeerd uit het feit dat expressie van de twee ts0ct2 cDNAs in COS 
cell en aanleiding geeft tot specifieke octameer complexen in een gelretardatie 
experiment. Rond die tijd werd de expressie beschreven van een tweede 
POU domein gen in rat testis. Dit gen werd Tst-1 genoemd. Echter, wij 
konden geen expressie aantonen van dit gen in de testis van de muis, maar 
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vonden dat het tot expressie komt in ongedifferentieerde embryonale stam 
cellen (ES cellen) en in differentierende P19 embryo carcinoma cellen (EC 
cellen). In Hoofdstuk VI beschrijven wij de tempo reel gereguleerde expressie 
van een aantal octameer bindende factoren gedurende de neurale 
differentiatie van P19 EC cellen. Een factor, die Oct6 genoemd werd, komt 
tot expressie in een bi-fasisch patroon wat suggereerde dat de factor een rol 
zou kunnen spelen tijdens verschillende stadia van de neurale differentiatie 
van deze cellen. Deze factor werd nader gekarakteriseerd door clonering van 
het corresponderende eDNA. Dit eDNA bleek het muizen homoloog te zijn 
van het ratten Tst-1 gen. Het eDNA codeert voor een 45 kD eiwit en behoort 
tot de POU domein eiwit familie. Het Oct6 gen in de muis genereert een 3 
kb mRNA en komt, naast differentierende P19 cellen, tot expressie in 
ongedifferentieerde ES cellen en in de hersenen. De experimenten 
beschreven in Hoofdstuk VII Iaten zien dat het Oct6 eiwit een transcriptie 
factor is, dat in staat is verschillende promoters te activeren via octameer en 
octameer gerelateerde sequenties. Het eiwit domein betrokken bij deze 
functie bevindt zich in het aminoterminale gedeelte van het eiwit en is rijk 
aan de aminozuren glycine en alanine. Een mutant eiwit dat uitsluitend 
bestaat uit het POU domein, bond nog steeds DNA maar was niet in staat 
transcriptie te activeren van een test promotor. Hoofdstuk VIII beschrijft de 
genomische organisatie van het Oct6 gen. Het gehele eiwit coderende 
gedeelte en de promotor maken deel uit van een CpG eiland. Desondanks 
heeft de Oct6 promotor de karakteristieke eigenschappen van een eel-type 
specifieke promotor zoals het voorkomen van een TAT A en CCAA T box 
sequentie op de juiste afstanden van de transcriptie initiatie plaats. De Oct6 
promotor is geassocieerd met een DNAsel hypersensitieve chromatine 
structuur in expresserende ES cellen, maar niet in MES1 cellen die geen Oct6 
expresseren. Een eerste functionele karakterisering van de Oct6 promotor 
suggereert dat sequenties 5' van de CCAAT box belangrijk zijn voor de 
activiteit van de Oct6 promotor. Een meer gedetailleerde analyse van de 
Oct6 promotor is noodzakelijk om de DNA sequenties te identificeren die de 
eel-type specifieke expressie van het Oct6 gen dicteren. Karakterisering van 
de eiwitten die een interactie aangaan met deze DNA sequenties zullen ons 
in staat stellen de mechanismen te bestuderen die de expressie van het Oct6 
gen reguleren. Op deze wijze kan een beeld verkregen worden van de plaats 
die het Oct6 gen inneemt in een hierarchie van cellulaire regulatie 
mechanismen welke uiteindelijk leiden tot een volledig gedifferentieerd 
fenotype. 
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in het Laboratory of Gene Structure and Expression van het National Institute 
for Medical Research in Mill Hill, London. Onder Ieiding van Dr F. Grosveld 
en Dr J.-P. Julien werd daar onderzoek verricht naar de structuur en 
expressie van de neurofilament genen. Na terugkeer in Nederland werd de 
vervangende militaire dienstplicht vervuld in het instituut Genetica van de 
Erasmus Universiteit te Rotterdam. In april 1987 volgde een tijdelijke 
aanstelling als 'onderzoeker' a an het zelfde instituut. Gedurende de peri ode 
in Rotterdam werd het in dit proefschrift beschreven werk uitgevoerd onder 
Ieiding van Dr G. Grosveld en Prof. Dr D. Bootsma. Sinds october 1991 is 
schrijver dezes wederom werkzaam in het Laborotary for Gene Structure and 
Expression te Mill Hill, London, ditmaal financieel gesteund door de 'Bruno 
Mendel research fellowship' hem toegekend door de Royal Society. 
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Hoewel op de omslag van dit proefschrift slechts mijn naam prijkt zal het 
duidelijk zijn dat het hier beschreven werk niet door mij aileen is uitgevoerd. Een 
woord van dank aan al diegenen die direct of indirect aan dit werk hebben 
bijgedragen, danwel hun interesse hebben getoond is dan oak op z'n plaats . 
............ , bedankt voor je bijdrage. 
Mijn promotor, Professor Dirk Bootsma ben ik zeer erkentelijk voor het in mij 
gestelde vertrouwen. 
Gerard Grosveld, mijn co-promotor, ben ik uiteraard veel dank verschuldigd 
voor de vele discussies en goede suggesties. Je hebt je altijd zeer onbaatzuchtig 
opgesteld, mij in alles mijn gang Iaten gaan, en mij daarin oak gesteund. 
Anneke Graus, 'mijn' analiste, ben ik veel dank verschuldigd voor de 
voorbeeldige, nauwgezette uitvoering van talloze experimenten. Hoewel je tijd 
in ons lab niet zonder problemen geweest is, kijk ik terug op een goede 
samenwerking (Okkie & co). Bedankt voor je inzet en loyaliteit. 
Robert Kraay, An Langeveld en Maarten Mulder bedankt voor jullie bijdrage 
aan het Oct6 werk. Ton de Wit, bedankt voor de Oct2 primer extensie 
experimenten en voor die keren dat je mij met squash hebt Iaten winnen. 
Dank aan aile (ex-) led en van 'voorheen de CML groep' voor hun interesse en 
de talloze taartjes, stroopwafels, roomsoezen en andere megajoule eetwaren. 
Marieke von Lindern, de freule, goede vriendin en wapenbroeder, bedankt 
voor je nuchtere kijk op de zaken des labs en des Ievens. Bedankt oak voor die 
'deadline' van 10 juni! 
Sjozef van Baal, computerwizard, zonder jouw hulp zou ik nu nag een 
computer analfabeet zijn. Aan jouw inzet is het te danken dat er op een 
beschaafd niveau met computers gewerkt kan worden binnen de afdeling 
Genetica (en ver daarbuiten). 
Maarten Fornerod en Martine Jaegle bedankt datjullie mijn paranimfen wilden 
zijn. Maarten, met jou deelde ik mijn liefde voor de muziek van Tom Waits, Bob 
Dylan en andere obscure blues muziek, tot wanhoop van andere 'vhCMLers'. 
lk hoop dat je de strijd voortzet. 
Sandra d' Azzo, bedankt voor je interesse in het werk en je vriendschap. Hans 
Morreau, bedankt voor je vriendschap, je humor en je mooie verhalen. 
Peter Verrijzer ben ik veel dank verschuldigd voor zijn hulp en zijn interesse 
in het Oct1 t/m 1 0 werk. 
Mirko Kuit en Tom de Vries Lentsch bedankt voor al het fotografische werk. 
Rita Boucke en Jeannette Lokker, bedankt voor de gezelligheid en het regelen 
van vliegtickets. 
Frank Grosveld en Ernie de Boer, bedankt voor jullie gastvrijheid en 
vriendschap. lk vrees dat ik de bijnaam 'den uitvreter' ondertussen wei verdient 
heb. Frank, bedankt voor je (niet geheel belangeloze) aansporingen om dat 
proefschrift maar eens te schrijven, en je geduld. En niet te vergeten je 
aanmoedigingen, zowel in het lab als op het voetbalveld! 
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